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Abstract
Background'.
Hodgkin's Disease (HD) is quite a rare cancer but is the most common malignancy in males
age 16-34 years and in the top five for females of the same age in Scotland. Molecular
evidence of the Epstein-Barr virus (EBV) has been found in 35% of HD cases (EBV +ve) in
developed countries but the proportion is smallest for the 16-34 years age group. There is a
variety of evidence to suggest that HD has an infectious aetiology, especially in the 16-34
years age group. As well as evidence suggesting an infectious aetiology other risk factors for
HD have been reported including general and family health characteristics, immune and
hormonal system variables.
Aiw.
The aim of this study is to examine further the risk factors for HD both in total and in sub¬
groups by age and EBV status. The focus will be on whether the risk factors for EBV-status
and/or age-at-diagnosis subgroups differ. Risk factors related to an infectious aetiology,
family health and physical activity will be considered.
Methods'.
1) Analysis of the seasonal presentation of HD using data from 2093 cases (age 0-34 years)
from four Scandinavian cancer registries (Denmark, Finland, Norway, Sweden).
Ecological analysis.
2) Analysis of infectious illness, general health, and family health risk factors for HD using
data from a young adult (age 16-24 years) matched case-control study (YHHCCS) with
EBV status known. Observational study.
3) Conduct of a large (493 cases, 512 controls) case-control study (SNEHD) with EBV
status known. Role in writing, piloting, interviewing and analysing this study.
4) Analysis of infectious illness, general health, and family health risk factors for HD using
data from a large (493 cases, 512 controls) case-control study (SNEHD) with EBV status
known. Observational study.
5) Analysis of physical activity risk factors for HD using data from SNEHD. Observational
study.
Results:
1) The results of the analysis of the Scandinavian cancer registry data show a statistically
significant seasonal presentation ofHD with a peak in January.
2) Greater numbers of childhood infectious illnesses were associated with a lower risk of
HD in the total series and EBV +ve and EBV -ve HD in the YHHCCS study. Childhood
infectious illnesses when aged >5 years were associated with an increased risk of EBV
+ve HD and a decreased risk of EBV -ve HD. Infectious mononucleosis (IM) was
associated with a significantly increased risk of HD in the total series and this effect was
limited to EBV +ve HD. The difference between EBV subgroups was statistically
significant for both of these variables.
3) SNEHD results show a statistically significant positive association of tonsillectomy with
HD diagnosed age 16-34 years but not at older ages. HD (OR 5.17, 95% CI 1.12-23.79)
or any haematological malignancy (OR 2.39, 95% CI 1.07-5.38) in a first-degree relative
was associated with a significantly increased risk of HD. There were no significant
differences between EBV-status subgroups for general or family health variables.
Childhood infections aged >5 years were associated with an increased risk of EBV +ve
HD and a decreased risk of EBV -ve HD. The difference between EBV-status subgroups
was statistically significant (p=0.043). Infectious mononucleosis (IM) was associated
with a significantly increased risk of HD limited to the 16-34 years age group. The
largest effect of IM was for EBV +ve HD presenting age 16-34 years.
4) The results of physical activity analysis show very little evidence of an effect of short-
term activity (i.e. persisting for 3-10 years) on risk of HD. Consistent inactivity was
associated with an increased risk of HD in the total series and all subgroups. Results did
not differ significantly by EBV status.
Discussion:
The data presented here both confirm the literature and provide new results. Overall they
support an infectious aetiology of HD, especially for the 16-34 years age group. However,
there is no evidence of any specific infectious illness being involved in the aetiology of HD,
apart from IM. The role of IM in risk of HD has been confirmed and , for the first time,
evidence is provided that this relationship is strongest for EBV +ve HD in the 16-34 years
age group. Support is given for tonsillectomy increasing risk of HD in the young adult (age
16-34 years) peak. The finding that risk ofHD is increased with consistent inactivity is also
novel and will require confirmation. In both the YHHCCS and SNEHD studies there was
evidence of an association between the EBV status of the cases and childhood risk factors
(childhood illness, IM). In future the epidemiological profile of HD by EBV status must be
distinguished as a matter of course.
1. The epidemiology ofHodgkin's Disease.
1.1 Introduction:
Malignant lymphomas are divided into two groups: Hodgkin's Disease (HD) and
Non-HodgkiiTs lymphoma (NHL) (30% and 70% of lymphomas respectively). HD was first
reported by Thomas Hodgkin in 1832 when he described a process originating in lymphatic
tissues (Hodgkin. 1832). Hodgkin was the first person to contribute a constellation of
pathologic and physiologic findings to a specific malignancy of the lymph nodes rather than an
infectious disease or inflammation. Sternberg first described the cell that was thought to be
pathognomic for the disease in 1898 and Reed, in 1902, further characterised this cell.
1.2 Definition and general background:
HD is a lymphoproliferative disorder characterised by the presence of large cells in
the tumour tissue. These cells are called Hodgkin's cells if they are mono-nucleated and Reed-
Stcrnbcrg cells in the case ofmulti-nuclearity (HRS cells). It is estimated that less than 1% of
the total lymphoid cells in diseased tissues are HRS cells (Drexler, 1992). The lack of tumour
cells means that the cellular origin of HRS cells remains controversial and has been allocated
to almost every lvmpho-haemopoeitic cell type in the body (Gruss et al, 1997). HRS cells are
not unique to HD and. therefore, to make the diagnosis HRS cells must be present in an
appropriate cellular background (Jarrett, 1992).
The disease is characterised by progressive painless enlargement of the lymphoid
tissues throughout the body. General features may include progressive weight loss, drenching
night sweats and fever (Takvorian et al. 1993).
Traditionally HD has been subdivided by clinical staging (not discussed here, see
Carbone ct al, 1971) and histology.
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Histological Classification:
The first histological classification to gain wide acceptance was that of Jackson &
Parker (1944) which divided HD into three sub-groups: paragranuloma, granuloma, and
sarcomatous disease. The categories of paragranuloma and sarcoma identified the most and
least favourable prognostic groups, respectively, but 80% of cases remained in the indistinct
middle category, granuloma. In the 1960s Lukes identified six subtypes ofHD and viewed the
various histologic sub-groups as indicative of differing host responses to a single disease
process (Lukes & Butler, 1966; Lukes ct al, 1966a). Almost immediately, this schema was
simplified and a nodular sclerosis category added, becoming the Rye classification (Lukes et
al, 1966b).
Based on the cellular composition and the histological appearance of the tumour the
Rye classification groups HD into four types: nodular sclerosing (NS); mixed cellularity
(MC); lymphocyte predominant (LP); and lymphocyte depleted (LD).
The vast majority of HD cases arc NS and MC. NS is the most common subtype,
accounting for 40-60% of cases and is becoming more common as the rate for this subtype
increases (Mcdciros & Grcincr, 1995). NS occurs more frequently in females than the other
subtypes and is rare over the age of 50. In general survival is good (84% at 5 years (Williams,
1990)). Approximately 30% of HD cases are MC. Patients generally present with advanced
stage disease. This subtype can occur at any age but is proportionally more frequent in older
people. 5 year survival is around 65% (Williams, 1990). The natural history and treatment of
NS and MC are similar and for all intent and purposes are managed as the same disease.
Historically, LD accounted for 5-10% of cases but with current immuno-phenotyping
this subtype is increasingly rare as NHLs. which may previously have been wrongly included
as HD, arc removed. LD is proportionally more frequent in older, male patients and is
considered the most aggressive subtype. Patients generally present with constitutional
2
symptoms and widespread disseminated disease. 5 year survival is poor (32% survival at 5
years (Williams. 1990)). LP accounts for 5-10% of cases and is proportionally more common
in males under 35. It generally presents with Stage I disease. There are two forms of LP:
nodular and diffuse. Patients with LP rarely have systemic symptoms and the prognosis is
usually favourable. (98% survival at 5 years (Williams, 1990)).
Problems with the classification ofNHL led to the development of a new lymphoma
classification system that removed the historical anachronism that separated HD from the
other lymphomas. The Revised European American Lymphoma Classification (REAL)
developed by the Lymphoma Group is a list of well-defined "rcaf' lymphomas (Harris et al,
1994). Cases that do not fit into one of the defined categories are left unclassified, reflecting
the fact that not everything is understood about them. The REAL classification takes account
of evidence that suggests that LP differs morphologically, immunophenotypically, and
clinically from classic HD (Table 1.1) and should, therefore, be treated as a separate entity.
The REAL classification keeps the old categories of NS, MC, and LD (Classical HD).
Nodular LP is no longer considered to be an HD subtype, while diffuse LP is classified within
a new subtype (Lymphocyte rich Classical HD).
Other authors have suggested that HD could be classified into aetio-subgroups by age
(MacMahon. 1966) or geography (Corca & O'Conor, 1971).
Classification of HD into actio-subgroups:
Correa & O'Conor (1971) suggested that there are at least three different
geographical epidemiological patterns of HD (see section, the geography of HD, p. 10).
MacMahon (1966) proposed three distinct forms of HD, with differing aetiologies, by age: a
childhood form (0-14), a young adult form (15-34), and an older adult form (>55 years).
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Table 1.1: The REAL classification ofHD.
Classical HD (NS, MC & LD) LP HD
Atypical cells Diagnostic HRS cells, mono¬





Diagnostic cells always present rare to absent
CD 15 usually +ve -ve
CD 30 usually +ve often +ve
CD 20 usually -ve usually +ve
CD 45 usually -ve +ve
EBV (in large cells) often +ve (20-70%) usually -ve
(Harris et al, 1994)
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Search Methods:
MEDLINE and BIDS were searched back to 1990 to find English language studies
that investigated the aetiology of HD using the following key words: Hodgkin's disease,
aetiology, geography, socio-economic status (SES), birth order, sibship, education, infection,
seasonal, EBV, LMP-1, EBNA, cluster, infectious mononucleosis, immune,
immunodeficiency, HIV, AIDS, transplantation, heart, kidney, liver, tonsils, tonsillectomy,
appendix, appendectomy, occupation, familial, parity. Additional references cited in primary
material were also investigated, if pertinent, to get as complete a picture as possible of
individual risk factors. Factors associated with risk of HD will be discussed following a
section on the descriptive epidemiology of the disease.
1.3 Descriptive Epidemiology:
Incidence:
The annual age-adjusted (to the WASR) incidence rate of HD was 2.9 per ICf in
Scottish males and 1.6 per Kf in Scottish females in 1996 (ISD, 1999).
Generally HD occurs in childhood and in older adults in developing countries but in
developed countries there is a marked incidence peak in young adults (15-34 years) after
which incidence remains fairly stable (Figure 1.1). This peak means that HD is one of the
commonest malignancies in young adults, as data from Scotland make clear (Table 1.2).
There is another peak in older adult years (>50 years) in some regions and time periods.
Incidence varies greatly with the highest rates in northern Italy and the USA and the lowest in
Asia (Coleman et al, 1993) (Table 1.3).
In Europe HD incidence has been either stable or declining since 1970. Within this
general decline, most countries had an increase in incidence in young adults. In each 5 year
5
Figure 1.1: Age-incidence curves ofHodgkin's disease by sex and subtype.
(reproduced with permission from Alexander et al, 1995a)
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Table 1.2: Incidence and relative frequencies for the five most frequently diagnosed cancers in
Scotland, by sex and age group, total 1986-95.
Males Females
Under 15 years Incidence Relative
Frequency
Under 15 years Incidence Relative
Freq.
Leukaemia 240 34.2% Leukaemia 187 33.0%
Brain & CNS 144 20.5% Brain & CNS 149 26.3%
Bone & Connective 66 9.4% Bone & Connective 44 7.8%
tissue tissue
NHL 66 9.4% Kidney 32 5.7%
Kidncv 42 6.0% Hodgkin 's disease 27 4.8%
Age 15-34 years Incidence Relative
Frequency
Age 15-34 years Incidence Relative
Freq.
Testis 852 32.1% Cervix 701 20.8%
Hodgkin's disease 301 11.3% Breast 661 19.6%
Malignant melanoma 256 9.6% Malignant
melanoma
520 15.5%
NHL 234 8.8% Hodgkin's disease 242 7.2%
Brain & CNS 197 7.4% Ovary 173 5.1%
Age 35-64 years Incidence Relative
Frequency
Age 35-64 years Incidence Relative
Freq.
Lung 9285 26.0% Breast 15826 36.1%
Large Bowel 4507 12.6% Lung 5104 11.7%
Bladder 2669 7.5% Large Bowel 3902 8.9%
Stomach 1965 5.5% Ovary 2481 5.7%
Prostate 1907 5.3% Cervix 2309 5.3%
(Harris et al, 1998)
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Table 1.3: Highest and lowest rates of HD in the world (per 105/yr) directly age standardised
to the world standard population.
Sex Highest rates (SE) Lowest rates (SE)
Male Italy (Parma) 4.5 (0.7) China (Qidong) 0.1 (0.1)
USA (Connecticut) (white) 4.4 (0.2) Japan (Yamagata) 0.1 (0.0)
Female USA (Hawaii) (Chinese) 5.0 (2.6) The Gambia 0.1 (0.1)
Scotland (North) 4.4 (0.9) Japan (Hiroshima) 0.1 (0.1)
(Crosignani et al, 1996)
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period 1973-87 there was up to a 25% increase in male incidence at ages 15-44 in: Spain;
France; UK; Scotland; Hungary; Yugoslavia; Israel; and Finland (Coleman et al, 1993).The
same pattern is seen in female data from European registries e.g. France, Spain, Scotland but
the increases were not as large.
Over three time periods (1973-77, 1978-82, 1983-87) the Surveillance, Epidemiology
and End Results (SEER) programme of the National Cancer Institute (NCI) collected 9418
confirmed cases of HD in designated geographical regions considered representative of the
USA as a whole. As in the European data the incidence of HD in the young adult group had
increased since 1973 (Mcdciros & Greiner, 1995). Chen ct al (1997a) reported time trends of
HD incidence 1935-92 in Connecticut alone and they also found that incidence of HD had
increased dramatically in young adults (aged 20-44 years). The increase in young adults here
and in the overall SEER data has been put down to a marked increase in the NS subtype
which predominates in this age group (Figure 1.1).
1973-77 to 1983-87 the age-adjusted incidence rate (details of standard population
used not given) of NS increased from 1.1 to 1.6 per 105. By 1983-87 NS accounted for 57.7%
of all HD cases. The proportion of MC (23.4% ofHD) and LP (6.0% ofHD) remained stable,
while LD (3.8% of HD) fell as more cases were classified as NHL (Mcdeiros & Greiner,
1995). Glaser & Swartz (1990) have observed this increase in the incidence of the NS subtype
in other data from the USA 1969-1980 and Chen et al (1997a) in data from the Connecticut
cancer registry 1935-92.
Mortality:
The annual age-adjusted (to the WASR) mortality rate of HD was 0.6 per 10s in
Scottish males and 0.3 per Kf in Scottish females in 1996 (ISD, 1999).
La Vecchia ct al (1991) found that from the 1960s onwards HD mortality has fallen
in western European countries in all age groups, from 20-30% (Spain. Portugal, Greece) to
9
70% (Nordic countries). This decrease in mortality has been due to the success of therapy.
The stable incidence rates and falling mortality have resulted in an increase in the incidence:
mortality ratio e.g. for Denmark. Finland, Norway and Scotland combined the ratio was 1.35
in 1960 and 2.38 in 1980 (La Vecchia et al, 1991) (Figure 1.2).
This general pattern of stable or falling incidence (except in young adults) and falling
mortality is seen in most areas of the world including Asia, Oceania and North America.
The geography ofHP:
There arc geographical differences in incidence of HD and a variation in the
distribution of histologic subtypes and age at presentation. Correa & O'Conor (1971)
described three main types of male HD. Type I prevails in developing countries and is
characterised by relatively high incidence and mortality rates in children, low incidence in the
third decade of life, and another incidence peak in the older age groups. A great majority of
cases arc MC or LD. Type III prevails in developed countries and is characterised by very low
rates in children and a pronounced initial peak in young adults. NS is the prevalent subtype.
An intermediate pattern, Type II. is found in areas that lie between developed and developing
e.g. central Europe. Additionally in some Asian countries e.g. Japan, Singapore, India there
may be a Type IV pattern characterised by a relative paucity of cases in all age groups.
Correa & O'Conor (1971) observed a strong inverse relationship (r = -0.9) within
individual selected countries between the incidence of HD in children (age 5-14 years) and the
incidence of the disease in young adults (age 20-34 yrs). Where the childhood incidence of HD
was high the incidence in young adults was reciprocally low (type III). However, MacFarlane
et al (1995) using data from registries reporting in Parkin et al (1992) split into levels of
economic development found little evidence of this inverse relationship in males
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Figure 1.2: Comparison in trends in mortality and incidence rates in five European
countries, circa 1960 to 1980.
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(La Vecchia et al, 1991)
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1983-87 (a similar finding to Cozen et al, 1992). HD rates are fairly low and it is possible that
large variations in rates, especially among smaller registries may obscure this relationship.
Therefore, MacFarlane ct al (1995) restricted the analysis to the larger registries (those with at
least 5x10° person-years of observation) on a subset of the data for 1963-67. The original
observation of a strong inverse relationship between the incidence of HD in children and the
incidence of the disease in young adults in 1971 was confirmed, but in data from later periods
this strong inverse relationship no longer existed (MacFarlane et al, 1995).
The bimodality of HD disease rates first described by MacMahon (1957) while still
evident in the incidence rates from some registries is not always present. In the US the two
incidence peaks have become less marked, 1973-80 to 1983-87 (Glaser, 1987). This is due
primarily to increasing incidence in the age group 40-59 years and a fall in rates in older age
groups. This flattening of the bimodal distribution has also been seen in the UK (McKinney et
al, 1989).
Some Latin American countries have rates that are consistent with the type I pattern
e.g. Brazil, Puerto Rico. However, others do not e.g. in Costa Rica rates increase consistently
with age, while those in Cali, Columbia show little change with age. The absence in some
instances of the defined type I pattern of rates associated with developing countries may be a
result of continuing economic development with corresponding changes in the pattern of
occurrence of disease to that associated with economically developed areas (type III). Correa




Attention was first called to the bimodality of HD incidence with peaks in young
adults (15-34) and in the elderly by MacMahon (1957, 1966) and this has been confirmed by
later work (Grufferman & Dclzcll, 1984) (Figure 1.1). Although these two peaks appear to be
flattening there is little doubt that HD is still an unusual cancer in that the age pattern is not
consistent with a simple increasing trend.
Sex:
A male excess of HD is apparent (Figure 1.1). Muir ct al (1987) examined 77 HD
incidence rates from 34 countries (excluding the USA). The mean male: female ratio was 1.7
(0.9-3.3). The age-specific curves for female HD for ALL countries resembles that of wealthy
countries (Corrca & O'Conor. 1971). The greatest male: female ratio occurs in children aged
<10 years and in the later reproductive years (age 35-54 years).
Males account for the overwhelming majority of childhood cases (85%) (MacMahon,
1966). Glascr (1994) found the largest male excess of HD in early childhood, but by age 10-
14 years the male and female rates converged and remained similar throughout adolescence. A
possible explanation for this is that at least some forms of the disease have an infectious
aetiology. Males are more susceptible than females to infectious diseases in childhood,
especially in the first 5 years of life (Washburn ct al. 1965). Resistance to infection may
explain the lower risk of HD in female children. In the later reproductive years it may be that
a protective effect of childbirth is responsible for lower rates in women.
Ernster et al (1979) observed that married white women aged 35-44 and 45-54 years
had lower average annual incidence rates of HD than single women did in the USA (2.2/10"'
married vs. 3.7/10" single aged 35-44 yrs; 2.5/10" vs. 3.5/10" respectively aged 45-54 vrs).
Other lymphomas did not have this age-specific pattern. Hormonal factors have been a
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neglected area of HD research but studies have recently been carried out looking at parity and
HD risk (see section Hormonal factors and HD, p.50).
Race:
Whites in the USA have a higher incidence of HD than blacks and other ethnic sub¬
groups (Horn et al, 1996). This pattern could be due to the lower socio-economic status of
non-whites in the USA. Orientals have the lowest incidence (Table 1.3). However, Mason &
Fraumcni (1974) compared the HD mortality of Japanese in the USA and Japanese in Japan
which is a low risk area (at this time mortality was an adequate proxy of incidence). They
found that mortality was greater for Japanese Americans than Japanese in Japan. Table 1.3
also makes clear that Chinese women in Hawaii have the highest incidence of HD.
Environmental and ethnic factors appear to interact.
1.5 Socio-Economic Status and related factors:
Socio-economic status (SES) is a measure of the social and economic standing of a
person or a group of people. "The different patterns of the disease (HD) appear to be closely
related to the economic stratification of the population at risk" (Corrca & O'Conor, 1971).
In the poverty stricken communities of Columbia there is a high frequency of disease
in male children. These cases usually belong to MC and LD subtypes of the disease with
relatively poor prognosis. In contrast in wealthy communities the disease develops more
frequently in young adults, at which time more favourable forms predominate, particularly NS
(MacFarlane ct al. 1995).
While there is a wcll-recogniscd international pattern of variation in the incidence of
HD by SES the effect of SES within countries is less clear. Alexander et al (1991a)
investigated 486 UK cases of HD in people aged <25 years diagnosed 1984-88. They found a
RR of HD for high community SES vs. low of 1.21 (95% C.I. 1.01-1.46). Other authors have
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found in developed countries that HD risk is higher in rural areas (Zambon et al, 1981;
Hardcll & Bcngtsson, 1983) where SES may be expected to be lower depending on the
country.
HD, especially in young adults, has been consistently associated with factors e.g.
family size (small), number of playmates (few), high level of parental education, which
suggest a high standard of living in childhood. High SES is important because it is a proxy for
other factors e.g. late exposure to infection. Corea & O'Conor (1971) suggest that, in a given
population, susceptibility to the agent or agents that cause HD is related to host response and
immunity which, in turn, is dependent on environmental and socio-economic factors. In the
more developed countries children arc usually well nourished and increasingly protected from
infectious disease. In these populations HD in children is uncommon but shows an initial peak
in young adults. In developing countries and in communities with poverty and overcrowding
nutrition is poor and susceptibility to all kinds of infection is high, especially in children. It is
in such populations that HD in children is more common.
Childhood Social Class:
Studies investigating the risk of HD by childhood social class (as measured by
various parental variables) arc shown in Table 1.4. Few results are statistically significant but
a higher level of parental education is related to an increased risk of HD in young adults in
some studies. There is a different effect of social class on the risk ofHD in children and young
adults. Gutensohn & Shapiro (1982) found high parental social class to be protective for HD
in children in the USA. In contrast, Zwitter ct al (1996) investigated cases of HD aged 17-50
years in the USA and found higher parental class to be associated with a greater risk ofHD.
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Table 1.4: Risk ofKD and parental social class.
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16
Family size:
Studies investigating the risk of HD and sibship size can be seen in Table 1.5. All,
apart from Zwitter ct al (1996), show a decreasing risk of HD with increasing sibship size,
although not all the results are statistically significant. Wcstergaard ct al (1997) in a large
record linkage study make it clear that large sibship size has opposite effects in children (age
<15 years) and young adults (age >15 years). In Denmark large sibships gave rise to higher
risks of HD in children but lower risks of HD in young adults. The trend among the young
adults was statistically significantly different from that seen in children (p<0.05).
Birth Order:
Table 1.6 has the results of studies investigating risk ofHD by birth order. Being later
in the order is associated with a decreased risk of young adult HD. Again Westergaard et al
(1997) found opposing trends in the young adults compared to the children. For HD diagnosed
aged <15 years the adjusted RR of being born 4th vs. 1st was 1.50 (0.42-5.33), whereas for
HD diagnosed aged >15 yrs the RR for the same category was 0.30 (0.1-0.97).
Own Education:
Studies investigating risk ofHD by own educational level are in Table 1.7. All studies
have investigated cases aged over 15 years and found an increased risk of HD with higher
educational levels. However, another study that looked at young adult cases alone had
statistically significant results. Most studies have looked at a wide range of ages. Mueller et al
(1989) found that older cases had less education than controls, although this result was not
statistically significant.
Socio-Economic Status and related factors: Conclusion:
There is a consistent body of evidence that HD is associated with factors in childhood
that influence the age of infection with infectious agents and bacteria. The majority of work
looking at childhood social environment has looked at all ages ofHD
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Table 1.5: Family size and risk of HD.
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Table 1.6: Birth order and risk ofHD.




C/C study 225 cases











(aged 17-50) & 496
controls (age- &
residence-matched)







70 cases (age <79)
& 70 controls (age-
& sex-matched)
Pairs of birth order no sig.
tendency for




















C/C study 152 cases
(age 15-77) & 613
hospital controls
(i) 3rd + v. 1st (all
subtypes)
















registry => 378 HD
(age 0-42)
(i) HD aged <15.
4"' +vs. Is'
(ii) HD aged >15,









NS (not statistical y significant) = p>0. 0
19
Table 1.7: HD risk and educational level.
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combined. When individual age groups are considered most work has been performed on
young adults (age 15-34 years). There are limited data that suggest that children who develop
HD are of lower SES (Gutensohn & Shapiro, 1982; Medeiros & Greiner, 1995; Westergaard
et al, 1997). These children may be at increased risk of early infection. In contrast, among
young adults the occurrence of HD is consistently associated with factors that suggest the
delay or avoidance of childhood infection. For cases aged over 50 years there is no
association of indicators of childhood social class with risk of HD.
1.6 HD and infection:
HD has a clinical course with many characteristics of an infection e.g. unexplained
persistent fever, frequent sweating and weight loss. MacMahon (1966) proposed that an
infectious agent caused HD in young adults (age 15-34 years) whereas at older ages (age ^50
years) it was more of a traditional neoplasm.
Late-host-response model:
The evidence for an infectious aetiology of young adult HD is consistent with the
late-host-response model under which exposure to an infectious agent (or group of agents) is
relatively benign in early childhood but may lead to oncogenic change if delayed until school
or adolescence (Gutensohn & Cole, 1977). After childhood, infection with several common
viruses tends to be more clinically severe (Mueller et al, 1989). It has been proposed that if
such infection results in unstable or incomplete immunity against a latent virus, persistent or
intermittent viral activity may trigger a chain of molecular events that lead to the
development of HD (Meuller et al, 1989). The infectious agent could be relatively common.
If the agent was both ubiquitous and geographically uniform then this model would not
require any case-to-case contact and would not result in case clustering.
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The late-host response model is related to the paralytic polio model, under which, like
paralytic polio, HD is the rare manifestation of a common infection with the probability of
disease development increasing as the age at infection is delayed. Prevailing socio-economic
conditions would determine the age of exposure to the causative agent and this determines the
likelihood of those exposed developing the disease. The late host-response and the polio
models agree for young adult HD but differ in their views of disease causation in children. In
the paralytic polio model the same agent causes childhood and young adult HD.
If the late host-response model is correct factors which delay the age at which
common infections are first encountered should be associated with increased risk of young
adult HD e.g. few siblings, late birth order. These have been discussed above. In addition, a
variety of evidence suggests HD, in particular young adult HD, could have an infectious
aetiology: clustering investigations, the relationship of HD to various viruses, and its seasonal
pattern of presentation.
Clustering:
There is a long history of research into disease clusters to find clues regarding
causation but, there is no clearly accepted definition of a cluster. A cluster could be considered
to be a focus of a higher than expected number of cases. The approach to clustering has
undergone three eras (Boyle et al, 1996): the anecdotal report; the wide ranging search; and
the statistical review. The statistical review can be divided up into space-time clustering and
spatial clustering.
Space-time clustering: Vianna ct al (1973) described 12 people with HD who were included
among or could be '"linked'' by social contact to the members of one graduating high school
class. This interlinked group was later extended to 31 cases. These authors stressed that social
contacts were close and repeated and inferred that there was transmission of an aetiologic
agent from case to case, either directly or through healthy contacts. It is difficult to assess the
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significance of the findings in this report as the cases were identified retrospectively on the
basis of shared exposures and thus, it was impossible to select a control population
(Gutensohn & Cole, 1977). This deficiency was largely overcome by a later study in Nassau
and Suffolk counties, New York.
Vianna & Polan's (1979) New York study was based on data from an area that had
not previously been investigated for clustering. In 8 public high schools that had had a case of
HD (student or teacher) 1960-64 there were 10 HD cases 1965-69. In the other 143 high
schools of comparable size there were only 9 cases over the same time period. These authors
also found that after the occurrence of a 'primary' case in 20 schools there were 21 cases in
students and 7 in teachers in the same schools during the decade. The expected number of HD
cases in students was 9.3 and in teachers it was 0.3. These results arc of interest but have been
criticised due to underascertainment of cases. The disease incidence that they reported was
lower than the HD mortality for the same area 1960-69 (Gruffcrman et al, 1979).
Other attempts to detect space-time clustering have been made but two other studies
have reported essentially negative results (Alderson & Nayak, 1971; Kryscio et al, 1969).
However, if the period between contact and appearance of clinical symptoms is several years
and variable and the population is mobile, space-time clustering may not be evident for
clinical disease, even if its agent is transferred from person to person (Chen ct al, 1984). In
general studies of space-time interaction have given rise to inconclusive results (Kryscio ct al,
1973; Grccnberg et al, 1983). This is not surprising as these analyses have low statistical
power for the putative aetiological models for HD (Chen ct al, 1984).
Spatial clustering: More recent studies have concentrated on spatial clustering using the
nearest neighbour test (NNA) and other methodologies. Alexander ct al (1991b) used the
NNA test and showed significant evidence of spatial clustering amongst younger cases (aged
0-34) but not in older cases (aged 50-79). The NNA test found 15% of cases aged 0-24 were
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clustered (p<0.01) which lends support to young onset HD having an infectious aetiology.
However, most evidence for this is in the 15-34 age group and this was not specifically
addressed by the study. More recently Alexander et al (1995b) tested 494 young adult HD
cases in the Yorkshire Health Region for spatial clustering. 18% of the cases in young people
were classified as clustered (p<0.05) while no clustering was seen in the older cases.
There is significant evidence for weak clustering in HD cases. The pattern of
clustering is consistent with an aetiology involving either delayed exposure to a common, but
not ubiquitous, virus or infection with a virus with a long latent period (Jarrctt, 1992).
Seasonal variation;
If an infectious agent is involved in the aetiology of HD a seasonal variation in
presentation might be expected depending on the behaviour of the agent, the length and
variability of the latent period and the method of spread. Thirteen studies have investigated
this question (Cridland, 1961; Inncs & Newell, 1961; Fraumeni & Li, 1962; Bjelke et al,
1969; Modan ct al, 1969; Newell et al, 1972; Bogger-Gorcn et al, 1983; Aldcrson & Nayak,
1971; Newell et al, 1985; Niclly et al, 1995a & b; Douglas et al. 1996; Westerbeek et al,
1998; Douglas et al, 1998) (discussed in detail in Chapter 6). The first seven of these only
observed the number of cases occurring each month with four studies concluding HD did have
a seasonal presentation (Cridland, 1961; Innes & Newell, 1961; Fraumeni & Li, 1962;
Bogger-Goren et al, 1983).
The latter six studies have used more formal statistical methodologies, either a test
devised by Edwards (1961) or cosinor analysis. All six found a statistically significant
seasonal presentation ofHD. Interestingly, three of the studies divided cases by age and found
the effect to be confined to the young adult age group (age 15-39 years Newell et al (1985);
age <40 years Ncilly et al (1995a & b) and Douglas et al (1996)). Douglas ct al (1998) only
found a significant seasonal presentation for NS subtype at all ages. However, the majority of
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this effect was seen in the 0-44 years age group. The peak of presentation in all of these
studies was at the beginning of the year (January-March).
The seasonal presentation of HD could reflect the seasonal pattern of a causal
agent(s) or the pattern of a disclosing agent (one which promotes the diagnosis of an existing
pre-clinical condition).
Infectious illness:
If the latc-host-response model is correct then, assuming similar transmission routes
to agents causing ordinary childhood infectious illness, young adult cases of HD should have
fewer childhood infections. Infection may also occur at older ages. Studies of childhood
infection and HD risk are presented in Table 1.8. Only one study, Paffcnbarger et al (1977)
found that men who reported common contagious disease in childhood were less likely to
develop (fatal) HD. These results are particularly strong as it was a prospective study and,
therefore, uninfluenced by recall bias.
It may be expected that cases would be infected older than controls, however, only
one stud>' (Evans & Gutensohn, 1984) found the age of onset of infection distinguished cases
from controls, while three others (Paffcnbarger et al, 1977; Kirschoff et al, 1980; Gutensohn
& Cole, 1981) did not.
There is no consistent evidence linking any of the infections in Table 1.8 with HD.
However, one virus has been consistently related to HD: Epstein-Barr virus (EBV).
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Table 1.8: Risk ofHD following childhood infection.
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HodukiiTs Disease and the Epstcin-Barr virus:
EBV definition and background: EBV is a B-ccll lymphotrophic virus with infectious and
oncogenic properties (Hanto ct al, 1981). Higginson et al (1992) estimated that about 95% of
people have antibodies to this virus. In the great majority of EBV carriers infection is
completely apathogenic, yet the virus is potentially oncogenic because a subset of its genes
have the capacity to de-regulate cell growth (Rickinson, 1994). EBV is involved in the
aetiology of African Burkitts lymphoma and nasopharyngeal carcinoma.
Primary infection generally occurs during the first few years of life, where it is
usually asymptomatic. However, when infection is delayed until adolescence or later it often
manifests clinically as infectious mononucleosis (IM). In IM the tonsils and cervical lymph
nodes contain HRS cells showing strong latent membrane protein (LMP-1) expression
(O'Grady et al, 1994). It is still not known why primary infection in infancy is almost always
asymptomatic whereas later in life it can produce overt disease. It may relate to the size of the
initial dose of the virus rather than to age per se. High doses of an orally transmitted virus are
much more likely to be delivered by salivary exchange between consenting adults than from
adult to child or child to child. Infection with a large virus dose makes it much more likely that
virus driven expansion of the B-ccll pool will exceed a critical threshold beyond which the
atypical T-cell response is activated and disease ensues (Rickinson. 1994).
Infectious Mononucleosis and Hodgkiir s Disease:
The first suggestion that EBV was associated with HD came from observations that
the age incidence curves for IM and HD are very similar. The HRS cell, which is pathognomic
for HD, has been observed in the lymph nodes of some IM patients. The results of cohort
studies investigating the risk ofHD follow ing IM are shown in Table 1.9.
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Table 1.9. Summary of results of prospective studies investigating IM & HD.
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Previous IM is associated with an increased risk of HD in all cohort studies (Miller & Beebe,
1973; Connolly & Christie, 1974; Rosdahl et al, 1974; Carter ct al, 1977; Munoz et al, 1978;
Kvale et al, 1979), with one exception (Kumio & Karjalainen, 1993). These cohort studies
combined consist of almost 42000 people with, overall, an approximately 3-fold increase (39
HD observed/12.78 expected) in the risk ofHD.
There are problems associated with studying the relationship between HD and IM.
Risk of young adult HD is increased among those of higher SES, as is the incidence of IM.
Thus, the findings of the cohort studies could simply reflect confounding by other risk factors
related to susceptibility to late infection. Therefore, studies comparing HD incidence in IM
and healthy cohorts should control for social class. In case-control studies which have
controlled for social class the relationship between previous IM and HD remains.
Newell et al (1973) compared 176 cases and 176 matched population controls aged
<44 years (matched for age, sex, race, and SES). Prior IM was associated with a non¬
significant increase in risk of HD (RR=1.4). Gutensohn & Cole (1981) also found more cases
than controls aged 15-39 years reported IM one or more years prior to diagnosis with HD
after controlling for birth order, family size and housing (relative incidence 1.8, 95% C.I
lower boundary 1.1). Evans & Gutensohn (1984) found a RR of 1.5 (95% C.I lower boundary
0.96) for a previous history of IM in a study of 262 HD cases aged 15-54 years and 250
sibling controls.
Another problem which occurs when investigating the association of IM to HD is
potential misclassification bias which arises in some people who, in the course of developing
HD, are temporarily diagnosed with IM as the diseases have similar symptoms.
Combined the evidence from available studies suggests a role for previous IM in
increasing HD risk and this in turn implicates EBV.
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HP and EBV Serology;
Serological methods have been used to investigate the potential role of many viruses
in HD (rubella, measles, parainfluenza, herpes simplex, varicella zoster, cytomegalovirus,
Human Herpes Viruses 6 and 7) but the most consistent findings have come from EBV.
Antibodies to viral capsid antigen (VCA) are found in all individuals who have been exposed
to EBV and antibodies to early antigen (EA) are detected during primary infection and during
viral reactivation.
Many case-control studies have been performed which show that patients with HD
have elevated levels of antibodies to EBV (Hcnle & Hcnlc. 1973; Hesse et al, 1977; Evans &
Gutensohn. 1984). The majority of these have found increased antibody titres to both VCA
and EA. However, treatment affects EBV antibody levels as does the presence of HD itself.
Thus, the elevated antibody titrcs seen in HD could be due to viral reactivation secondary to
therapy or onset of disease.
Mueller et al (1989) conducted a nested case-control study of 43 HD cases and 96
controls in a cohort with serum stored prior to diagnosis to test the association between
elevated antibody titres to several EBV antigens. Relative risk of developing HD was
significantly elevated in people with higher antibodies to the VCA and EA. These findings
were confirmed by a second prospective study (Lehtinen et al. 1993). Elevated EBV antibody
levels during a period before the onset of recognisable disease suggests EBV could have a role
in the pathogenesis of HD. Alternatively, raised antibody levels could be a marker for
infection by another virus (Jarrctt, 1992).
HD and presence of EBV viral DNA:
The presence of the virus in current biological samples can be found by molecular
methods including Southern blot analysis. Polymerase Chain Reaction (PCR), DNA and RNA
in situ hybridisation (1SH) and immunohistochemistry (Armstrong at al, 1993). Southern
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blotting has the advantage of determining the clonality of the infected tumour with respect to
the viral terminal repeat sequences. 1SH has the advantage of precise localisation of the viais
in infected tumours (Gulley & Raab Traub, 1993). PCR is a very sensitive technique that tests
for the presence of a virus in a biopsy sample, but not necessarily in the tumour cells. Given
the ubiquitous nature of EBV, the PCR technique may amplify the EBV DNA from the
reservoir of non-pathogenic cells. The results of PCR analysis have been criticised for over¬
estimating the presence of EBV in HD by a factor of two (Dclsol et al, 1992).
The ideal assay for the analysis of HD samples should be reproducible, sensitive,
permit cellular localisation and be applicable to the study of archive material (Armstrong et al,
1993). EBER 1SH meets all these requirements and is the 'gold standard' of all molecular
techniques for defining cases of EBV associated HD (Gulley & Roab Traub, 1993).
Table 1.10 summarises studies that have utilised the EBV EBER ISH assay or EBV
LMP-1 immunohistochemistry in adult HD or HD at any age. These studies are emphasised
as these techniques permit the localisation of EBV to the HRS cells. The proportion of EBV-
associated HD ranges from 19% (Bclkaid et al, 1995) to 94% (Chang et al, 1993) (EBV-
associated HD means evidence of EBV has been found in the HRS cells). This variation may
be because many of the series arc small, of different ages, ethnicity and histology.
While many studies have used one or other of the techniques some have used both
allowing a comparison of the results from each method to be made. Authors have found
identical (Bclkaid ct al, 1995; Paulino et al, 1996) or very similar (Hcrbst et al, 1992; Chang
et al, 1993; Zhou et al, 1993; Kanavaros et al, 1994; Park et al, 1994; Li et al, 1995; Kusada
et al, 1998) proportions of EBV-associatcd cases using each method. However, Huh et al,
(1996) found 60/87 (69%) of cases to be EBV-associated using EBV EBER ISH but only
31
Table 1.10. Summary of results of studies using EBER ISH and/or LMP-1 immuno-
histochemistry to investigate EBV-association rates in adult HD and HD at any age.




MC (%) NS (%)
Broussct et al (1991) France 54 (age 10-81) 16/54 (30) 12/26 (46) 4/22 (18)
Pallesen ct al (1991) Denmark 84 (no ages) 40/84 (48) 23/24 (96) 16/50 (32)
Weiss etal (1989) USA 36 (no ages) 11/36 (31) 6/8 (75) 4/12 (33)
Delsol et al (1992) France 107 (no ages) 36/107 (34) 32/55 (58) 4/40 (10)
Herbst et al (1992) Germany 46 (no ages) 23/46 (50) 10/18 (56) 10/24 (42)
Khan et al (1993) UK 77 (age 3-72) 25/77 (32) 15/22 (68) 9/38 (24)
Pinkus et al (1994) USA 186 48/186 (26) 27/39 (69) 18/127 (14)
Poppema & Visser Canada 72 (no ages) 19/72 (26) 12/14 (86) 7/53 (13)
(1994)
Bclkaid et al (1995) France 21 (med. age 29) 4/21 (19) 2/NA* 2/NA*
Jarrctt et al (1996) UK 130 (all ages) 37/130 (28) 20/42 (48) 13/68 (19)
Kordeck et al (1996) Poland 135 (all ages) 44/135 (33) 21/34 (62) 23/90 (26)
Leocini ct al (1996) Italy 65 (age 5-86) 3 1/65 (48) 12/13 (92) 17/37 (46)
Enblad etal (1997) Sweden 107 (age 6-87) 27/107 (25) 8/13 (62) 18/81 (22)
Europe & USA 1120 361/1120 (32) 198/308 (64) 143/642 (22)
Zhou etal (1993) China 28 (age 4-80) 17/28 (61) 10/11 (91) 6/14 (43)
Park et al (1994) Korea 25 (no ages) 19/25 (76) 11/13 (85) NA*
Chan ct al (1995) H. Kong 23 (age 5-82) 15/23 (65) 5/5 (100) 6/16 (56)
Li et al (1995) Japan 40 (all ages) 17/40 (43) NA NA
Tomita et al (1996) Japan 57 (age 5-80) 32/50 (64) 21/25 (84) 11/25 (44)*+
Huh et al (1996) Korea 87 (mean age 38) 60/87 (69) 38/51 (75) 10/17 (59)
Paulino et al (1996) Philipine 21 (age 11-64) 9/21 (43) 6/9 (67) 3/10 (30)
Bcnharroch et al Israel 106 (all ages) 32/106 (30) 15/33 (45) 14/64 (21)
(1997) 42 (age 15-34) 10/42 (23)
Peh et al (1997) Malaysia 55 (age >15) 26/51 (52) 19/22 (86) 6/27 (22)
Kusada et al (1998) Japan 46 (age 6-82) 27/46 (49) 12/18 (67) 5/14 (36)
Liu et al (1998) Taiwan 70 (age 7-75) 44/70 (63) 18/26 (69) 23/36 (64) i
Mourad et al (1998) S. Arabia 62 (age 3-72) 29/62 (47) 8/9 (89) 21/45 (47)
Asia/Middle East 620 327/609 (54) 163/222 (73) 104/243 (43)
Belkaid ct al (1995) Algeria 47 (mcd. age 26) 16/47 (44) 12/NA 4/NA*
Weinrcls et al (1996) Kenva 48 aged >16 32/48 (67) 2/2 (100) 26/39 (67)
Leocini et al (1996) Kenya 92 (age 2-76) 85/92 (92) 44/44 (100) 35/40 (88)
Kusada ct al (1998) Kenva 48 (age 4-65) 38/48 (79) 28/33 (85) 4/7 (57)
Africa 235 171/235 (73) 74/79 (94) 65/86 (76)
Chang et al (1993) Peru 32 (age 2-75) 30/32 (94) 18/20 (90) 7/7 (100)
Quintanilla-Martinez Mexico 39 (adults) 28/39 (72) 10/15 (67) 6/12 (50)
et al (1995)
Zorate-Osorno el al Mexico 27 (age 5-65) 18/27 (67) 7/7 (100) 6/13 (46)
(1995)
Montcrosso et al Costa Rica 40 (age 6-84) 16/40 (40) 12/14 (86) 3/20 (15)
(1998)







* not in totals. + AOS. all other subtypes.
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39/87 (45%) to be associated using LMP-1 immunohistochemistry. The authors suggest that
this difference could be result from technical variations in the formalin fixation they used. In
the studies where there is a difference between the two methods ISH generally gives higher
proportions of EBV-association, as it is a more sensitive method.
As well as the cellular localisation of the EBV genomes the clonality of the virus must
be determined before a meaningful association between EBV and HD can be deduced.
Monoclonality signifies that cells in the tissue specimen arose from one precursor cell and
indicates a cancerous process whereby one cell divides continually without proper control.
Polyclonality implies that the cells are distinct and arise secondary to inflammation indicating
a benign reactive process. Several studies have assessed the clonality of the EBV genomes
within HD tumours (Weiss et al. 1986, 1989; Anagnostopoulos et al, 1989; Boicchi et al,
1989; Staal ct al, 1989; Gledhill et al, 1991; Jarrett et al, 1991). In the majority of cases the
infected cells have been found to be clonal with respect to EBV.
The EBV genome has the capacity to encode for over 80 proteins and there is
evidence that many of these are transcribed during viral replication (Baer et al, 1984). B cells
which have been immortalised by EBV in vitro are known to express nine proteins: six nuclear
proteins, the EBNAs; three membrane proteins, the latent membrane proteins (LMP-1, 2A,
2B). There are also two small RNAs, EBER-1 and 2, which may play a role in viral RNA
processing. EBNA-1 is a DNA binding protein that enables the viral genome to exist in an
cpisomal or plasmid state. EBNA-2 and LMP-1 proteins appear to play a critical role in cell
immortalisation. Studies have demonstrated that EBV is transcriptionally active, as
demonstrated by the presence of EBER RNA, EBNA-1, and LMP-1. To date the evidence for
HD is that HRS cells show a latent infection with EBV comparable to that found in
nasopharyngeal carcinoma (EBNA-1 +, LMP-1 +, EBER RNA +) (Brousset & Delsol, 1991).
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The presence of monoclonal EBV genomes and localisation of the EBV viral DNA in
the tumour cells supports the concept of an actiological role of EBV in the pathogenesis of a
significant proportion ofHD cases (Efcrbst ct al, 1992).
EBV association bv histological subtype:
Table 1.10 also shows a comparison of the proportion of EBV-associated HD by MC
and NS subtype. In all series, except Chang et al (1993), the MC subtype has a higher
proportion of EBV-associatcd cases (overall 72% for MC and 33% for NS). The proportion
of EBV-associatcd MC is statistically significantly higher than NS (Vcstlcv et al, 1992;
Chang et al, 1993; Kordcck et al. 1996; Leocini et al. 1996; Bcnharroch et al, 1997; Peh et al,
1997; Enblad ct al. 1997). Others have noted the smaller number ofNS cases associated with
EBV but statistical testing has not proved significant (Glcdhill ct al, 1991; Boiochhi et al,
1989).
Glaser et al (1997) produced a meta-analysis to discover the factors that predispose to
EBV-associatcd HD summarising the findings of twelve research groups. They analysed 1546
cases of HD. including 368 unpublished cases. Of the 1546 cases, 618 (40%) were EBV-
associatcd (compared with 45% overall in Table 1.10). The proportion of EBV-associated HD
cases varied significantly across histologic subtype, age, sex, ethnicity, country of residence,
and regional economic level (all p>0.001) when entered separately as explanatory variables.
These factors do not necessarily remain significant if entered into a model together (see p38).
In the total series 70.4% of the MC subtype was EBV-associatcd compared with only 23.2%
ofNS. This difference across subtypes remained after stratification for age. In the summary of
published studies in Table 1.10 72% of MC and 33% of NS cases were EBV-associatcd, a
finding similar to Glaser et al (1997).
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EBV-association by age:
The first authors to report the association of EBV status of HD by age were Jarrctt et
al (1991). These authors found 54% of E1D cases aged less than 15 years and 71% of cases
older than 50 years were EBV-associated. For cases aged 15-34 years the corresponding
figure was less than 15%. Studies of EBV-association rates in paediatric HD can be seen in
Table 1.11. Overall, 59% of published paediatric HD cases are associated with EBV
(compared to 45% older cases (Table 1.10)). Within the 0-14 years age group several authors
have found that the highest proportion of EBV +ve HD occurred at the youngest ages (0-4
years) and falls as age increases (Armstrong et al (1993): Precidio ct al (1995); Jarrctt et al
(1996); and Andriko ct al (1997). MC subtype again has the highest percentage of EBV-
associatcd HD (83% MC vs. 53% NS). Where tests were performed the difference in EBV
association between MC and NS was found to be statistically significant (Wcinreb et al, 1992
& 1996).
Chang et al (1993) and Pch et al (1997) found the difference in EBV-association by
age at diagnosis to be statistically significant. Li et al (1995), Chan et al (1995), Huh et al
(1996), and Liu et al (1998) also observed higher EBV-association rates in children and the
elderly although no statistical tests were performed. Glcdhill et al (1991), Zhou et al (1993),
and Tomita et al (1996) found an increasing trend for the proportion of EBV-associatcd HD
cases increasing with age. In the meta-analysis by Glaser ct al (1997) the proportion of HD
cases associated with EBV differed by age, with the highest percentage in children aged <10
and adults aged >80 years and the lowest in young adults aged 15-29 years. Jarrett et al
(1996) calculated that age at diagnosis was a statistically significant predictor of cases being
associated with EBV, even after adjustment for histiologic subtype and sex.
However, Boiocchi ct al (1989), Quintanilla-Martinez ct al (1995), and Leocini et al
(1996) failed to detect an association between EBV status and age. This failure may well
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Table 1.11. Summary of results of studies using EBER 1SH and/or EBV LMP-1
immunohistochemistry to investigate EBV-association rates in paediatric HP,
ll




MC (%) NS (%)
Jarrett et al (1991) UK 24 (age <15) 13/24 (54) NA NA
Weinreb et al (1992) UK 74 (age <15) 37/74 (50) 17/20 (85) 14/35 (39)
Ambinder et al
(1993)
USA 25 (age <15) 9/25 (36) 6/7 (86) 2/15 (13)
Armstrong et al
(1993)
UK 22 (age <15) 13/22 (59) 7/7 (100) 4/12 (33)
Khan ct al (1993) UK 24 (age <15) 6/24 (25) 2/4 (50) 4/19(21)
Claviez et al (1994) Germany 22 (age 4-17) 10/21 (48) NA NA*
Kanavaros et al
(1994)
Greece 22 (age 3-15) 12/22 (54) 8/11 (73) 4/10 (40)
Weinrcb ct al UK 75 (age <16) 38/75 (51) 16/19 (84) 15/37 (41)
(1996) Australia 16 (age <16) 11/16 (69) 3/3 (100) 8/11 (73)
Greece 22 (age <16) 20/22 (91) 6/7 (86) 11/12(92)
Razzouk et al (1997) USA 26 (mcd. age
7.5)
15/26 (58) NA NA*
Andriko et al (1997) USA 44 (age < 15) 17/44 (39) 3/4 (75) 5/13 (39)





8 (age <15) 7/8 (88) 5/5 (100) 2/2 (100)
Li et al (1994) China 82 (age <15) 67/82 (82) NA (91)" NA*
Wcinrcb et al Egypt 14 (age <16) 7/14 (50) 4/7 (57) 2/3 (67)
(1996) Jordan 16 (age <16) 8/16 (50) 5/8 (63) 2/7 (29)
UAE 10 (age <16) 6/10 (60) 3/4 (75) NA"
Iran 8 (age <16) 7/8 (88) NA" NA"
Benharroch et al
(1997)
Israel 11 (age 0-14) 8/11 (73) NA" NA*
Peh et al (1997) Malaysia 24 (age <15) 14/15 (93) 8/9 (89) 6/6 (100)
Kusada et al (1998) Japan 4 (age <15) 4/4 (100) 3/3 (100) 1/1 (100)
Liu et al (1998) Japan 6 (age <15) 4/6 (67) NA' NA
Asia & Middle East 183 132/174 (76) 28/36 (78) 13/19 (68)
Weinrcb ct al S. Africa 18 (age <16) 9/18 (50) 6/10 (60) 2/4 (50)
(1996) Kenya 56 (age <16) 56/56 (100) 18/18 (100) 26/26 (100)
Kusada et al (1998) Kenya 18 (age <15) 16/18 (89) 12/13 (92) 2/3 (67) I
Africa 92 81/92 (88) 36/41 (88) 30/33 (91)
Ambinder et al
(1993)
Honduras 11 (age <15) 11/11 (100) 6/6 (100) 3/3 (100)
Armstrong et al
(1993)
Brazil 25 (age <15) 18/25 (72) 10/12 (83) 7/10 (70)
Precidio ct al (1995) Argentina 29 (age 3-15) 12/29 (41) 10/15 (67) 0/7 (0)
Weinreb et al (1996) Costa Rica 42 (age <16) 34/42 (81) 10/10 (100) 19/24 (79)
Razzouk ct al (1997) Brazil 26 (med. age 9) 15/26 (58) NA" NA"







* not in total.
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reflect the small number of paediatric and older cases likely to be present in non-selected
series (Jarrett, 1992).
The study results shown in Table 1.11 and the results of Jarrett ct al (1991), who
found no association of EBV with sub-type after adjustment for age, support the hypothesis
that HD in different age groups may have different aetiologies. EBV may have a pathogenic
role in HD in children and older age groups but not in most young adults or HD not associated
with EBV. If the virus were an innocuous passenger in HD it would be expected that the
proportion of EBV-associated cases would be lower in childhood than adult disease. In fact
this is not the case, even amongst tumours presenting in the first 10 years of life. This
suggests that EBV plays an actiological role in the development of childhood HD. De novo
infection may be important in the pacdiatric group, a reactivation of latent infection, possibly
as a result of decreasing T-ccll immunity, more likely in older cases (Jarrett et al, 1991).
Patients who are infected with HIV arc also at an increased risk of developing EBV-associated
HD and this lends some support to the suggestion that an impairment of T-cell function may
precede EBV-associatcd HD (see HD and the immune system, p.40).
EBV-association and aeoaraphv:
The proportion of EBV-associatcd HD can be related to geography. In the meta¬
analysis by Glaser et al (1997) country of residence was identified as a statistically significant
predictor of the proportion of EBV-associated cases of HD. EBV has been identified in: 40-
94% of cases from South America; 30-76% of cases from Asia and the Middle East; 34-92%
from Africa. This compares to 19-50% from Europe and North America. Averaged across all
studies in each region Europe and North America had the lowest proportion of EBV-
associated HD (32%), followed by Asia and the Middle East (54%), South America (67%),
and Africa (73%) (Table 1.10). The proportion of EBV-associated HD is high for all
histologic subtypes in Africa and South America. In contrast the proportion of EBV-
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associated HD is highest for the MC subtype in Europe/North America and Asia/Middle East.
However, these geographical relationships could be due to factors such as the age and
histological subtypes of the cases.
The larger proportion of EBV-associatcd HD from developing countries could be due
to lower socio-economic status which may be associated with a chronic immunosuppressed
state predisposing to viral infections (Chang et al, 1993). In Glaser ct al's (1997) meta¬
analysis a variable for country SES based on world rank of GNP was used and found to
significantly predict the proportion of EBV-associated HD (p<0.001) but not after adjustment
for age, subtype, sex, and ethnicity. Razzouk ct al (1997) also found, after only adjusting for
histologic subtype and age, the association between EBV and HD was independent of
geographical location. Thus, all the potential variables explaining the proportion of EBV-
associatcd HD should be entered into the predictive model together, especially age and subtype
before a relationship is confirmed.
EBV Conclusion:
EBV has been implicated in the aetiology of HD ever since it was found that HD risk
was increased following 1M and that people with HD had raised anti-EBV titres compared
with healthy controls. More direct evidence has come from numerous studies demonstrating
the presence of EBV viral genomes in the HRS cells. However, there is a lack of correlation
between raised antibody titres to EBV and EBV-associatcd HD (Broussct et al, 1991;
Alexander ct al, 1995b; Enblad ct al, 1997).
The biological mechanism by which EBV could cause HD is not known. EBV may
cause the activation of an unidentified oncogene; down regulate cellular genes which could be
used to circumvent immunosurveillance; or induce growth advantages to neoplastic cells (Bai
et al, 1994).
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The majority of HD eases aged <15 and >50 years arc EBV-associatcd, whereas the
minority of eases aged 15-34 years are. The available data also suggest that MC eases are
more likely to be EBV-associatcd than NS. There is now strong evidence to suggest that EBV
is causally involved in a proportion of cases of E1D (IARC, 1997). The variation of EBV-
association by age and subtype is consistent with the multiple aetiology model first proposed
by MacMahon (1966). Substantially increased risk of EBV-associatcd HD in children
compared to young adults suggest that the timing of infection greatly affects the association of
EBV with HD (Glascr et al, 1997). The variation in the magnitude of the age effect with
regional economic level also points to the importance of socio-economic conditions in
predicting association of EBV and HD. However, analyses that investigate this question
should be performed with adjustment for the effects of age and histological subtype, as they
are likely to be confounding variables. HD may be a rare response to underlying EBV
infection with the nature of the response depending on other factors correlated with the degree
of affluence of the population.
HD and Infection: Conclusion:
There is now a great deal of evidence supporting an infectious aetiology of HD. This
evidence includes clustering and seasonal presentation of HD and applies particularly to the
young adult age group and NS subtypes. However, EBV appears to play a role in children and
older adults and the MC subtype. Other agents, possibly other viruses, may be involved in
young adults (Jarrctt, 1992). The latc-host-rcsponse model may hold for the virus that is
involved in the young adult form of HD. The identification of a specific infection as a cause of
haematological malignancies in young adults could pave the way for effective preventative
measures (Lehtinen & Lehtincn, 1998).
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1.7 Hodgkin's Disease and the immune system:
HD patients show a severe impairment in their cellular immune responses (Slivnick et
ah 1990). There is some evidence that immune deficiency is present prior to HD diagnosis
(Staal et al, 1989: Bjorkholm et al, 1990) and, unlike NHL, immune deficiency persists even
after cure (Staal et al, 1989). Altered cell-mediated immunity is characteristic of HD. It is
possible that chronic antigenic stimulation together with defective regulation of the immune
response may cause excessive lymphoid proliferation, which subsequently undergo genetic
mutation, either occurring spontaneously or induced by oncogenic viruses or drugs and leading
to the development of a lymphoma (Penn, 1981). If these assertions are true people who are
inununo-suppresscd would have an elevated risk ofHD.
This section on HD and the immune system will be quite detailed as it forms the
background to chapter 9 on physical activity and risk ofHD.
HD in patients with HIV:
San Francisco County has a high prevalence of HIV infection. Mcdeiros & Greiner
(1995) used SEER data to investigate the incidence of HD in this area. Age-adjusted incidence
rates ofHD in males increased from 5.0 per 105 1973-77 to 6.4 per 105 in 1983-87. Over the
same time period incidence in females fell from 3.5 to 2.9. The percentage distribution of HD
in females in San Francisco was similar to the distribution in all SEER regions. The
distribution in men was skewed towards an increase in MC and miscellaneous HD while NS,
LP, and LD remained stable. HD in HIV-infected people is usually MC or hard to classify and
more common in males.
Several cohort studies have been performed which show the incidence of HD to be
increased in the HIV-infected population, although not nearly as much as Kaposi's sarcoma or
NHL (Table 1.12).
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Tabic 1.12: Cohorts investigating the c langing incidence of HD associated with HIV.
Studv Population HD cases SMR/S1R Incidence rate
Hessol et al
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Of thirteen cohorts studied only two (Rabkin et al, 1993; Ragni et al, 1993) have
failed to show a statistically significant increase in HD in HIV-infected populations, and both
of these were performed earlier in time and had shorter follow-up. Where calculated, incidence
rates of HD in HIV-infcctcd populations range from 6/10' PY to 85/105 PY. Goedcrt et al
(1998) compared the risk of HD in the pre- and post-AIDS periods and found that risk had
increased significantly (p-trcnd<0.0()01). This assertion is supported by the work of other
authors who have found the risk of HD to be increased in later time periods compared with
earlier (Reynolds et al, 1993; Rabkin & Ycllin, 1994; Koblin et al, 1996; Franceshi et al,
1998).
However, some of the HD cases in the HIV-infcctcd population may be misdiagnosed
B-cell lymphomas (Dclabie & Dc Wolf-Peters, 1992). Thus, the apparent increase in HD may
be due to pathological misclassification ofNHLs, which have a greatly increased incidence in
the HIV-infcctcd population. False positive diagnosis of HD which is truly NHL does occur
but this error is small in younger patients (aged <55 years) diagnosed in the 1980s (Glaser &
Schwartz, 1990). Alternatively the increased incidence of HD in HIV infected cohorts could,
at least partly, be independent of HIV i.e. HD occurs most frequently in young adults in the
USA, the same age group for which HIV infection is most common. There is evidence that
HD incidence is increasing in the young adult population but this is generally the NS subtype,
not MC. Neither of these potential problems appear able to explain the increase in HD.
Evidence from cohort studies suggests that incidence of HD in the HIV-infected
population is elevated. The increase is statistically significant, but the statistics are based on
small numbers of cases and short time periods. The slight differences in the results of
published studies may be due to differences in the populations studied and the risk groups
analysed e.g. male vs. female, homosexual vs. haemophiliac (Dichl & Tesch, 1995).
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Presentation ofHP in patients with HIV:
There are many case reports of HD in HIV infected people. These range from single
case reports at the beginning of the HIV epidemic (Robert & Schneidermann, 1984; Schieb &
Scigel, 1985; Di Carlo et al, 1986) to large case series which have been reported more
recently (Errantc et al, 1994; Tirclli ct al, 1995).
HD in HIV infected people has a particular presentation when compared with HD
occurring in immuno-competent patients. There is an increased frequency of more advanced
anatomical stages (Ann Arbor stages III and IV) (68% of 398 published cases with stage
given). A predominance of MC subtype characterises HD in HIV patients (59% of 442
published cases with subtype given). HIV-infected patients have a more frequent presence of
B symptoms and mediastinal involvement is unusual.
HD in HIV infected people is more frequently EBV-associatcd. 298 cases with details
of EBV status have been published of which 243 (87%) are EBV-associated. Less than 45%
of HD in the general population is EBV-associated (Table 1.10). Uccini ct al (1990) found
significantly more HD in HIV infected people to be related to positive EBV status than HD
not associated with HIV (p<0.01).
HD in HIV infected people: Conclusion:
HD is still not recognised as an HIV-related malignancy (CDC 1992). However, the
results of cohort studies suggest the incidence ofHD is increased in HIV infected populations.
Also, due to the profound immunologic deregulation that constitutes its background, HD in
HIV infected people presents with morphologic, immunologic, pathogenetic, and clinical
features that are characteristic and different from HD occurring in the general population
(Ioachim ct al. 1991). An association between HD and HIV seems to be well established,
although with an SIR much lower than that for NHL (IARC, 1996).
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HP following transplantation:
The existence of a relationship between immune deficiency and neoplasia had been
recognised more than 10 years before the AIDS epidemic (Jaffe ct al, 1983; Curran et al,
1984). The incidence of malignancies is markedly increased following transplantation;
malignancies develop in 6% of renal transplant recipients, which is 100 times more than in the
general population (Penn, 1978). Immunosuppression and cytotoxic therapy have been
implicated as actiologic agents. The majority of tumours developing in immune deficient
individuals arc lymphomas. NHLs in immune deficient patients differ from those in immune-
competent patients in relation to their location, histology, natural history and response to
treatment. This observation may also apply to HD. The development of HD has relatively
rarely been reported in transplant recipients.
Several studies have analysed cohorts of patients who have undergone specific
transplants e.g. heart (Weintraub & Warnkc, 1982). bone marrow (Withcrspoon et al, 1989),
kidney (Kinlcn ct al, 1979), liver (Raymond et al, 1995; Hoover & Fraumeni, 1973). These
studies combined consist of over 9500 transplant recipients in which only one case of HD has
occurred. These results have led Kinlcn (1996) to conclude that there is no increased risk of
HD following transplant. B cell hyperplasia is not a feature of iatrogenic immunosuppression,
as it is for HIV infection, which may explain why certain types of lymphoma e.g. HD and
Burkitt's lymphoma, are relatively frequent in AIDS patients but not in transplant recipients
(IARC, 1996).
However, HD does appear to present differently post-transplant. Case reports of
thirty patients have been published in the literature (Doyle et al, 1983; Jarcard et al, 1994;
Gamier et al, 1996; Cerilli et al, 1977; Sterling ct al, 1974; Morcau ct al, 1996; Goyal et al,
1996; Bcdrossian et al, 1995; Biennan ct al, 1996; Hood ct al, 1996; Oldhafcr et al, 1989).
57% were MC subtype, while NS was quite uncommon. Evidence for EBV involvement in
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HD following transplantation has been found in 90% cases, a proportion similar to that in
HIV-associatcd HD and much higher than in spontaneous HD.
Although HD is rare after transplantation, its association with EBV and the severity
of the disease in these patients argues for a role of EBV infection and immunosuppression in
the development of the disease (Gamier et al, 1996), although the relation to underlying
immunosuppression may not be a strong one.
HD and Immunodeficiency diseases:
The risk of developing a malignant tumour is 4% in patients with genetic immune
deficiencies, which represents an incidence 1000 times greater than that recorded in the age-
matched general population (Curran et al, 1984; Fauci et al, 1984).
The majority of cancers developing in patients with congenital immunity are NHL.
However, HD has an increased incidence among certain immunodeficiency states, particularly
Ataxia Telangiectasia (AT), Wiskott-Aldrich Syndrome (WAS), and Bloom's syndrome
(Mueller et al, 1995). In an international series of 12 cases from the Immunodeficiency Cancer
Registry 9 (75%) were MC or LD subtype and only 1 (8%) NS (Robinson et al, 1987). Since
each immune deficiency syndrome has its own unique genetic basis it seems plausible that the
excess of HD is related to impaired immunity, with consequent enhanced susceptibility to
EBV. rather than to the diverse range of underlying defects (Stiller, 1998).
Tonsillectomy:
The common site of early stage HD is in the region of the lymph nodes that drain the
pharyngeal tonsil. It is well known that the tonsils can act as filter barriers to infective agents
or can even facilitate the passage of some diseases (Vianna ct al, 1971).
'Risk' of tonsillectomy is strongly related to childhood social class. Tonsillectomy is
performed more frequently on children from more affluent homes (Wolman, 1956) and
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medical practice. Using sibling controls or controlling for socio-economic factors e.g. place of
residence in the analysis can negate the effect of socio-economic status.
Four published English language studies have not taken account of social class
(Ruuskancn et al, 1971; Silingardi et al, 1982; Abramson et al, 1978; Bonclli et al, 1990).
Other studies of HD following tonsillectomy have taken account of social class (Table 1.13).
Of these, four found a statistically significant increase in risk of HD after tonsillectomy
(Johnson & Johnson, 1972; Vianna et al, 1971 & 1974; Kirschoff et al, 1980). (The first three
of these studies only analysed young adult cases.) Others found a non- significant increase in
risk (Gutensohn et al, 1975; Newell et al, 1973; Hardell & Bengtsson, 1983; Anderson &
Isager, 1978; Liaw et al. 1997). Mueller ct al (1987), Scrraino ct al (1991), and Zwitter et al
(1996) did not observe an increase at all.
Ablation of the tonsils may influence the development of HD in only a minority of
those affected. Bock et al (1994) investigated selected cellular and humoral immune system
parameters in 160 children who had undergone tonsillectomy and 302 age-matched controls
and concluded that any changes were clinically insignificant. The results of the studies
controlling for social class and the presence of a plausible biologic mechanism mean the role
of tonsillectomy cannot be discounted, even though its association with HD is not strong or
consistent.
Appendectomy;
The lymphoid tissue of the appendix, illium and colon may have a protective effect
against viral antigens (Burnet, 1959). Removal of the appendix may remove a barrier to
infection. Appendicitis may also be important because it could have an infectious aetiology
(Andersson et al, 1995). If this is true appendicitis and. following this, appendectomy could be
a proxy for late age at first infection, increasing risk of young adult HD. As with
tonsillectomy rates of appendectomy can be related to social class.
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Table 1.13. Summary of case-control studies investigating risk ofHD following tonsillectomy,
adjusted for SES.
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Many studies that have investigated the relationship between appendectomy and HD
have not taken account of social class (Hvams & Wynder, 1968; Bicrman. 1968; Ruuskanen
et al, 1971; Abramson et al, 1978; Silingardi et al, 1982). The results of studies that did
control for social class are in Table 1.14. None of these show a statistically significant
increase in risk of HD following appendectomy. If appendectomy docs relate to HD, it is not a
major factor.
HD and the immune system: conclusion:
The results of analyses of HIV-infected cohorts suggest that people with this vims
have a higher incidence ofHD but there is little evidence of an increase associated with organ
transplant or immuno-dcficicncy diseases. There is some evidence of an increased risk
following removal of the tonsils but not the appendix. Further epidemiological studies will be
needed to document a definite change in the incidence of HD among immunosuppressed
patients (Knopf & Locker, 1995).
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Table 1.14. Summary of studies investigating appendectomy & HD risk, adjusted for
SES.
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1.8 Hormonal factors and HP:
La Vecchia et al (1991) observed a steady rise in the mortality rate for males aged 30-
50 years compared with a flattening of the female mortality (and incidence) rates in the same
age group. Incidence data have shown the peak male: female incidence ratio to be at the time
when women have children (Muir et al, 1987). Alternatively the decline in female incidence
that develops in young adulthood and becomes gradually more pronounced by middle age may
be explained by sex differences in occupational exposures. However, for the few occupations
associated with HD the attributable risk would be too low to explain the observed sex
difference (Glaser, 1994).
As for HD and the immune system this section on hormonal factors and HD will be
quite detailed as it also forms part of the background to chapter 9 on physical activity and risk
ofHD.
Parity
Although endocrinologic factors have been observed in several cancers of non-
reproductive sites, the\' have not been considered for HD until recently (Glaser, 1994; Kravdal
& Hansen. 1993). Chen et al (1997a) investigated the Connecticut Tumour Registry 1935-92
and found that between 1970 and 1992 the trend in HD incidence differed in males and
females. In males HD incidence rose 2% ever)' 5 years, whereas in females it rose at 11% and
was expected to increase at this rate in the future. These authors obtained fertility data for
Connecticut women aged 20-44 years for 1940-84. More women born after 1940 were having
their first baby aged 30-39 years and fewer aged 20-24 years. Also the total number of births
per mother had fallen since 1960. These data support the hypothesis of an increased risk of
HD with lower parity and later age at first pregnancy. The results of studies looking at this
topic are in Table 1.15.
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Table 1.15. Summary of studies investigating parity and HD risk.
[~Study Numbers Comparison Risk Estimate Significance
Zwitter et al Matched c/c studv 2 vs. 0 children OR = 0.74 NS
(1996) 192 female cases (0.4-1.3)
(Slovenia) (aged 17-50) & 496
controls (age- &
residence-matched)
3 vs. 0 children OR = 0.83
(0.3-1.9)
NS
Abramson et al Matched c/c study 0 vs. 3 children RR= 1.9 p = 0.022




0 vs. 5 children RR = 4.7 p = 0.001
Olsson et al 38 cases (age 17-85) No. of cases with > 27% v. 23% Not given
(1990) & hospital controls pregnancy vs. no.
(Sweden) of controls
Franceschi et al C/C studv 152 cases 1-2 children vs. 0 OR = 1.04 NS
(1991) (age 15-77) & 613 (0.5-2.3)
(Italy) hospital controls 3+ children vs. 0 OR = 0.77
(0.3-1.9)
NS
Zahm et al (1995) C/C study 70 cases Women with .3+ OR = 0.4 NS
(USA) (35 m & 35 f) &
1432 popln control
children vs. 0 (0.1-1.3)
Tavani et al C/C studv 68 cases 3+ pregnancies vs. OR=0.6 NS
(1997) (age 17-79) & 448 0 (0.3-1.4)
(Italy) hospital controls
1+ abortion vs. 0







Lainbc el al Record linkage ever parous vs. ORf NS
(1998) studv cancer & never (number of
(Sweden) fertility registry.
917 HD born 1925-






Miller et al Cohort 11127 ever- Low vs. high parity RR = 1.32 p > 0.05
(1980) married women
(Canada)
Kravdal & 441 HD in cohort 1 child vs. 0 RI = 0.74 p < 0.05
Hansen (1993) 1.3 million (0 aged 2 children vs. 0 RI = 0.64 p < 0.05
(Norway) 15-56 3+ children vs. 0 RI = 0.46 p < 0.05
Kravdal & Nested c/c study. 1 child vs. 0 OR=0.74 p<0.05
Hansen (1996) 382 cases (age 15- 2 children vs. 0 OR=0.64 p<0.05
56) & controls 3+ children vs. 0 OR=0.46 p<0.05
(Norway) Nested c/c study. 39 1 child vs. 0 OR = 0.86 NS
cases (age 40-56) & 2 children vs. 0 OR = 0.59 NS
controls 3+ children vs. 0 OR = 0.53 NS
NS (not statistical y significant) = p>0.10
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Only two studies (Abrantson ct al, 1978; Kravdal & Hansen, 1993) found childbirth
to be statistically significantly protective but all the other studies in Table 1.15 are suggestive
of a protective effect. Abramson et al (1978) concluded that, "the male preponderance usually
seen in middle and late adult life may be partly due to the protection afforded to women by
their prior reproductive activities." This is supported by the fact that studies that have looked
at risk of HD in men by parity have found no relationship e.g. Men: RR 1 child vs. 0 1.06, 2
vs. 0 1.04, >3 vs. 0 1.03; Women 0.74, 0.64, 0.46 respectively (Kravdal & Hansen, 1993).
A pregnancy is characterised by a surge of sex hormone secretion; high and low
parity women have different histories of exposures to this hormonal environment. The
mother's immune system is also altered during pregnancy with cell mediated immunity
generally being depressed (Glaser, 1994). There is ample evidence that immune function is
responsive to sex hormones.
Effects of social class:
Parity may be associated with HD risk because it is a correlate of social class, a
demonstrated risk factor for HD. Fewer and later pregnancies would be predicted by the
elevated adult social status of the women at higher risk of HD. An increase in HD risk
associated with lower parity might reflect social class differences. Reported parity specific
OR's may not be adjusted for identified social class confounders.
Zahm ct al (1995) found the significant effect of childbirth was limited to women of
higher socio-economic status (high SES OR >3 children vs. none = 0.1 (0.002-0.9)).
However. Kravdal & Hansen (1996) adjusted for SES using either the case's or their father's
educational level and these did not modify the findings of a statistically significant decreased
risk of HD with increasing parity. Other studies (Franceshi et al, 1991; Zwitter et al, 1996;
Tavani ct al, 1997) have adjusted for SES variables and shown a non-significant protective
effect for parity.
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Age at first birth:
Observations of the data from the Connecticut cancer registry by Chen et al (1997a)
suggest that women with a later age at first pregnancy have a greater risk of HD. This has
been supported by the results of some case/control studies (Kravdal & Hansen, 1993. RR of
first birth >25 vs. <21 yrs 1.22; Miller ct al, 1980. RR of first birth >25 vs. <25 yrs 1.36
(p<0.05)). Lambe et al (1998) found some evidence of an increased risk of HD with late age
at first birth in women aged less than 45 years at diagnosis. However, other studies have not
detected this age effect (Franccschi et al, 1991; Zwitter et al. 1996).
Hormonal Factors and HD: Conclusion;
If parity were protective through a hormonal or immunologic process related to
pregnancy, it would seem likely to affect women, regardless of social class but not men. If
parity is protective for reasons of social class the effect should be seen in both genders. The
evidence is for greater parity to decrease the risk of HD in women only, although not all
results are statistically significant. Hormonal factors appear to be involved in the pathogenesis
ofHD, possibly operating through an effect on the immune system. The impact of the immune
system has been supported by Tavani et al (1997). These authors suggest that since the
pattern of risk ofHD was similar for full-term pregnancies and for abortions that events early
in pregnancy, including immuno-related events, rather than exposure to sex hormones (whose
levels arc higher at the end of pregnancy) are the likely mechanism.
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1.9 Familial HodgkiiTs Disease and inherited susceptibility:
There have been many reports of the multiple occurrence of HD within the same
family. This familial aggregation may be as the result of sharing a common environment in
childhood or of genetic factors (Higginson et al, 1992). Studies looking at familial aggregation
of HD have found a range of risks. However, the best evidence for a genetic basis for HD
comes from a study of twins by Mack ct al (1995).
Mack ct al (1995) investigated 432 sets of twins found through newspaper adverts.
The number of cases of HD observed aged <50 years in the healthy monozygotic and
dizygotic twins of patients with HD was compared with the number expected from national
age-specific incidence rates. They observed that 0 of 187 pairs of dizygotic twins became
concordant for HD, whereas 10 of 179 pairs of monozygotic twins did after 14 years follow
up. This result compared with 0.1 (monozygotic) and 0.1 (dizygotic) expected cases in
unaffected twins. Thus, monozygotic twins of patients with HD had a greatly increased risk
(99-fold), whereas no increase in risk for dizygotic twins was seen. This difference in risk
between monozygotic and dizygotic twins could be due to the effect of sharing the whole
genome of the twin with HD rather than just half of it. These results do not appear to be an
artefact of ascertainment or differential survival. The magnitude of the effect found in this
study suggests a fundamental genetic influence on pathophysiology.
Ferraris et al (1997) reviewed twenty-eight articles published 1972-95 on familial
HD. They also analysed 328 patients from 18 of the papers. The authors found a significant
difference between sporadic and familial HD in the age at diagnosis. Familial HD only had
evidence of one peak aged 15-34 years, whereas the sporadic HD had the characteristic
bimodal appearance. This suggests familial HD could be linked with certain forms of HD.
Mack et al (1995) observed that the majority of reported sibships with multiple cases of HD
consist solely, or include multiple cases of. NS subtype.
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To examine possible genetic markers of susceptibility to HD several authors have
looked at human leukocyte antigens (HLA) in patients with the disease. HLA genes are of
interest because resistance and susceptibility to infection arc under their potential control. An
association between HD and an HLA allele could be construed as providing support for an
infectious cause of HD (Taylor et al, 1996). Chakravarti ct al (1986) calculated that a
recessive susceptibility gene linked to the HLA complex was responsible for 60% of HD in
families. The remaining 40% could be due to other familial factors and/or environmental
factors. There have been many investigations of association between specific HLA types and
risk of HD e.g. Svejgaard et al (1975) found an increase in the frequency ofHLA-A1, B5, B8,
and B18 in an international scries of 1500 HD cases. More recently authors have found a
significant association between HD and HLA-DPB 1*0301 (Oza ct al, 1994; Taylor et al,
1996). The susceptibility might result from a particular DNA base sequence common to
several alleles (Mack et al, 1995). There appears to be an association between HLA class II
type and risk of HD but at present it is unlikely that any single allele or haplotype is
responsible for susceptibility to HD.
The risk of HD developing in a first degree relative of a case of HD is increased but
the precise risk is uncertain. Relative risks in a first degree relative range widely, from 2
(Abramson et al, 1977) to 17.1 (Gruffcrman et al, 1982; Bernard et al, 1987). Risk in
identical twins appears to be increased 100-fold. However, familial HD is relatively rare,
estimated at only 4.5% in published series (Ferraris et al, 1997). This may be due to the small
family size associated with upper socio-economic groups at higher risk of developing HD, in
part to the putative recessive pattern (Lcvine ct al, 1995). and also to low penetrance. HLA
association of HD and an increased risk in monozygotic twins constitute persuasive evidence
of the role of genetic susceptibility for HD.
55
1.10 Occupation:
Most investigations on occupational risk of HD have been performed in three broad
occupational categories: 1) employees in woodworking and wood related industries; 2)
agricultural workers; 3) occupational groups at risk of developing HD as an infectious disease
e.g. doctors, teachers. However, as occupational risk factors will not be investigated in later
chapters only a brief discussion of occupational risks of HD for doctors and teachers will be
given. A discussion of the findings for w oodworking and agricultural occupation risks for HD
can be found in Appendix A.
Doctors:
Vianna ct al (1974) were the first to suggest that, if HD is infectious, physicians
would be at an increased risk because they more frequently share a common environment with
HD cases. They identified male physicians aged >25 years who died from HD in New York
State 1960-72. The mortality rate in physicians was compared with that for Upstate New
York and the four counties with the highest median income. There was a significant difference
between the mortality rate in physicians and Upstate New York (p<0.01) and the four counties
(p<0.01). Physicians had a RR of 1.8 of dying from HD.
Few other studies have investigated this relationship and none have reproduced these
results (Smith ct al, 1974; Matanoski et al, 1975; Gruffcrman et al, 1976).
Teachers:
Vianna & Polan (1973) found an increased risk of HD mortality for school teachers
leading Milham (1974b) to look at the death records for all male residents of Washington
State aged over 20 years dying 1950-71. The PMR of HD for schoolteachers of all ages was
246 (100 = all occupations) and for ages 30-49 years it was 315. The observed and expected
number of deaths differed significantly (12 v. 4.9, p<0.005). However, schoolteachers may be
at less risk of death from other causes e.g. murder, accidents, than other occupational groups
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(Bahn, 1974). If the contribution of other causes of death to the all-cause death rate for
teachers were small, the proportion of deaths due to HD would be relatively large.
In contrast to Milham (1974b) Hoover (1974) found a RR for teachers of 1.5, which
is compatible with a social class effect. Also, no increased risk was observed in a 15 year
incidence survey conducted by Gruffcrman et al (1976) (30 cases observed vs. 27 expected,
RR=1.1, 0.7-1.6). The weight of evidence suggests that teachers as a group are unlikely to be
at an increased risk ofHD.
Occupational risks for HD: Conclusion:
Most investigations of HD occupational risk factors have been hindered by the rarity
of the disease and by the lack of detailed information on work exposures (Gruffcrman &
Dclzell, 1984). For the most part, occupational exposure is classified by death certificate,
medical records, or self-reported information obtained from questionnaires. There is little
epidemiological evidence that adults with potential occupational exposure to HD patients have
a significantly increased risk of the disease. If certain occupations are at a higher risk of HD
the best candidates are woodworking and agriculture (Appendix A), although a consistently
plausible agent has yet to be identified.
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1.11 Epidemiology of Hodgkin's Disease: summary:
A number of risk factors have been investigated in relation to HD, the majority of
these related to infection and immune function. However, few of these factors have a strong or
consistent relationship with HD (Table 1.16). A great deal of work has been performed on the
role of EBV in the aetiology of HD and it now appears that this virus plays a role in paediatric
and older adult HD as well as the MC subtype. However, in the age group (15-34 years) and
subtype (NS) with the most epidemiological evidence of an infectious origin EBV is least
frequently seen. Also there has been little work performed on the relationship of individual risk
factors to EBV status. The aetiology of HD remains elusive (Grufferman & Delzcll, 1984;
Glaser, 1994; Takvorian et al, 1993). HD is still the "enigmatic lymphoma" (Glascr et al,
1997).
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Table 1.16: Summary of risk factors for HD.






strong consistent age 0-14: low SES t risk
age 15-34: high SES t
risk
Proxy for no. &
timing of childhood
infections





Family history strong consistent age 15-34
NS subtype
Genetic susceptibility
Previous 1M moderate consistent age 15-34? Proxy for delayed
exposure to common
viruses
HIV moderate consistent MC & LD subtvpc Immune suppression.
Parity (low) moderate consistent None specified Pregnancy alters
female hormonal &
immune systems
Tonsillectomy moderate inconsistent None specified Removal of barrier to
infection





Transplantation weak consistent None specified Immune suppression
Appendicitis/
Appendectomy
weak inconsistent None specified Removal of barrier to
infection.
Appendicitis caused
by late exposure to
infection?
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2. Measurement of Physical Activity
2.1 Introduction:
Physical activity is defined as bodily movement due to skeletal muscle contractions
that result in quantifiable energy expenditure (Thompson, 1994). There are three primary
components of physical activity that can be varied and may have different effects on
carcinogenesis: intensity (work-rate); duration (length per activity bout); frequency (times
per week) of the activity (Thompson, 1994).
"The ability to relate physical activity to health depends on accurate, precise and
reproducible measures" (Wilson et al, 1986; National Center for Health Statistics, 1989).
However, no measurement methods are generally accepted so it has become the custom for
investigators to write their own - often with scant regard to validity, and still less to
comparability with other studies.
There is some evidence that the risk of HD is affected by physical activity (see
chapter 3). It was decided to include a section on physical activity in the questionnaire for
the Scotland and Newcastle study of Hodgkin's Disease (SNEHD). I wrote this section of
the SNEHD questionnaire after performing a literature review of methods that have been
used to measure physical activity. This chapter will summarise those methods found in the
literature. Chapter 3 will summarise the potential cancer health benefits/consequences of
physical activity.
2.2 Measurement of physical activity by direct monitoring:
Physical activity can be measured directly through behavioural observation,
mechanical or electronic devices, or physiologic instruments. These approaches alleviate
problems of poor memory and biased self-reporting but are limited by their high costs and
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burden on participants. Thus, these methods have only been used in small studies and not
for investigations into disease aetiology. However, they can potentially be used to validate
self-reports of physical activity (p.70).
2.3 Measurement of physical activity by self-report:
The most commonly used and practical method of estimating the prevalence of
physical activity in population studies has been by self-report (Washburn & Montoye,
1986). Respondents may be asked to recall leisure-time activities, occupational activities, or
both over a particular time frame. Information obtained from self-report instruments is then
converted into estimates of energy expenditure (kilocalories or kilojoules; metabolic
equivalents (METs)) or some other summary measure that can be used to classify or rank a
person by their activity level.
This chapter will focus on methods for assessing leisure time physical activity. This
is because the majority of present-day jobs require little physical activity and it is
questionable whether the kind of activity involved in one's occupation is comparable to that
during aerobic exercise (Bartram & Wynder, 1989). There are also problems of
misclassification inherent in using job titles for exposure assessment. For many women a
major component of their activity is household activity rather than occupation. However,
very few studies have attempted to include housework in their questionnaires (Freidenreich
et al, 1998).
Methods for measuring leisure time physical activity can be divided into three broad
groups: global surveys, recall surveys, and quantitative history surveys (Ainsworth et al,
1998). These three groupings are discussed below with examples that show there is great
variety within each group.
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1) Global Surveys:
Global surveys are the shortest type of physical activity questionnaire comprising of
only one to four items.
The majority of global surveys were developed to investigate risk factors for CHD
e.g. the New York Health Insurance Plan (NYHIP) questionnaire (Shapiro et al, 1965), the
Harvard Alumni Study questionnaire (Paffenbarger et al, 1978), Lipid Research Clinics
(Haskell et al, 1980), NHANES I questionnaire (Albanes et al, 1989). This kind of study
asks very simple questions about activity: "Do you regularly engage in strenuous exercise or
hard physical labour?" (Haskell et al, 1980).
Two of the above questionnaires have been used to investigate cancer risk as well as
CHD risk (Paffenbarger et al, 1978; Albanes et al, 1989). Simple global surveys have also
been developed specifically for cancer studies (Thune & Lund, 1996; Gerharrdson et al,
1988).
The simplest form of global survey refers simply to episodes of sweating. This
method derives from the work of Professor R.A.Bruce (cited in Paffenbarger et al, 1993)
who found that the best predictor of treadmill tested VO2 max in normal subjects was the
number of times they engaged in tasks long enough to work up a sweat. A sweating
frequency question is easily administered and scored and has been used by La Porte et al
(1985), Siconolfi et al (1985), Washburn et al (1990), Newcomb et al (1995), Booth et al
(1996), and Min-Lee et al (1997). However, no single question instruments have been
validated in a UK population.
The physical activity measures from global surveys provide a general impression of
physical activity. Global surveys published in the literature provide good surrogate
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measures of participation in vigorous physical activities (Kriska & Caspersen, 1997). Global
surveys have been successfully validated by correlation with direct measures of physical
fitness (NYHIP questionnaire) and physiological measures (Lipid Research Clinics
questionnaire results have been related to higher levels ofHDL cholesterol).
The majority of global surveys were developed for the investigation of CHD risk
and not cancer. The sensitivity of global survey sweat questions are not sufficiently detailed
to record changes in activity and the utility of self-reported sweating may be limited to
distinguishing active from inactive subjects in epidemiological surveys (Washburn et al,
1990). Therefore, global surveys may not be detailed enough and of great practical use in
cancer epidemiology.
2) Recall Surveys:
Recall surveys generally elicit more detailed information covering time periods of
one day to one year.
The original Framingham Study (Kannel et al, 1979) produced a summary physical
activity index based on the weighted sum of time the subject reported spending in five types
of activity over 24 hours: basal e.g. sleeping; sedentary e.g. sitting or standing; slight e.g.
walking; moderate e.g. gardening; heavy e.g. shovelling. Whittemore et al (1995) also used
a 24 hour recall of a typical day but divided time spent into only four categories: sleeping,
sitting, light or moderate activity, and vigorous activity.
The Tecumseh questionnaire was used to measure physical activity in the Tecumseh
Community Health Study (Montoye, 1975). A personal interview lasting 1 to 1 1/2 hours
was needed to complete the 36 occupation and 63 leisure time related questions on activity
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over the previous year. Each activity was scored based on duration, frequency and intensity
of activity. This instrument was later modified by Taylor et al (1978).
Baecke et al (1982) questioned subjects regarding work and leisure time activities in
the previous year, subjects responded to a five point scale with descriptions ranging from
never (point value 1) to always (point value 5). A sport activity index was then calculated
based on intensity, time engaged, and the proportion of the year participating in each
activity.
Sandler et al (1995) asked subjects to provide information on up to four sports that
they engaged in during the year before diagnosis or a reference date. The intensity of
specific activities was rated as low, medium, or high using codes based on a standard
reference. For each sport the number of hours per week (time), the number ofmonths of the
year (proportion) they engaged in this activity were coded on a five-point scale.
The results of Baecke et al (1982), Montoye (1975), and Taylor et al (1978)
questionnaires have all been significantly correlated with physiologic variables (lean body
mass in males but not females; lower body fat and blood pressure; HDL cholesterol levels,
BMI and heart rate, respectively). However, as with global surveys, recall surveys may not
be detailed enough to be of great practical use in cancer epidemiology.
3) Quantitative History Surveys:
The studies mentioned in the previous section have looked at periods of time of a
year or less and assumed the activity levels in this period are representative of lifetime
activity. However, the assessment of physical activity at a single time to evaluate its
association with cancer may be limited (Min-Lee et al, 1991). Such a measure may not
adequately reflect activity over the longer term and may be inadequate when changes over
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time are of primary interest (Schechtman et al, 1991). Studies are now attempting to
produce life-time histories of activity.
Quantitative history surveys have many items that identify the intensity, duration,
and frequency of activities performed over a lifetime or in specific periods of life where it is
postulated that physical activity may have the most effect.
Bernstein et al (1994) assessed participation (at least 2 hours/week) in physical
exercise of 545 female case/control pairs from menarche to breast cancer diagnosis date.
These activities included participation as a member of a sports team, including practice;
participation in individual sports; time spent at the gym and participation in exercise classes.
Gerharrdsson et al (1990) asked separate questions about physical activity during working
hours (day- time) and recreational hours (evenings and weekends) to gauge the level of
activity in 1950, 1955, and every five years to 1985. Sturgeon et al (1993) elicited
information on physical activity for each decade of life from the age of 20-29 to 70-79 yrs.
Alternatively questions pertaining to specific periods of life have been used,
especially for female hormonal cancers. McTiernan et al (1996), Chen et al (1997b), and
Gammon et al (1998) all emphasised activity around menarche in studies of breast cancer.
In studies of colon cancer lifetime questioning has been performed as it is unknown
.in which period physical activity may have the greatest effect. Slattery et al (1997) asked
study participants to recall their activity pattern two years prior to diagnosis and ten and
twenty years previously. White et al (1996) asked about physical activity in a ten year
reference period that ended two years prior to diagnosis in a study ofmale and female colon
cancer. Quantitative history surveys also allow the investigator to elicit changes in physical
activity over time.
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The studies described above probed for information about frequency and duration of
activity episodes and some, (Slattery et al, 1997; Gammon et al, 1998), divided activities by
intensity. Vigorous activities were "those that make you sweat or get out of breath", while
moderate activities are "those activities which are done at a more moderate pace" (Slattery
et al, 1997).
Although quantitative history surveys take longer to administer they can take
account of seasonal and lifestyle changes in physical activity. However, when quantitative
history surveys are validated the correlation between these surveys and direct measures of
physical activity are modest (Kriska & Caspersen, 1997). This is not surprising as the
activities could have been performed many years prior to direct measurements of physical
activity or fitness.
2.4 Classification of Data:
An all-inclusive coding system is crucial to facilitate accurate interpretation of
responses for analysis. The survey methods described previously use different methods of
classifying data. Physical activity measures in global surveys are generally expressed as
ordered category scores indicating higher or lower activity status e.g. sedentary, fairly
active, and very active (Gerhardsson et al, 1990). In recall surveys and quantitative history
surveys physical activity scores are based on ordinal scales, such as time spent exercising,
kilocalones (kcal) expended per day or week in all activities or selected activities, or in
other types of units that may reflect the time and intensity of activities (MET-hours).
The MET (metabolic equivalent) is usually the starting basis for calculating a
subject's physical activity index. Resting metabolic rate is approximately 1 kcal/kg/hour and
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is equivalent to 1 MET. The number ofMETs associated with a wide range of activities can
be estimated from aggregated laboratory and field research. Until recently there was no
'gold standard' list. People made their own MET lists based on previous work with their
own additions (Taylor et al, 1978; Wilson et al, 1986; Min-Lee et al, 1992).
Ainsworth et al (1993) derived the energy costs of specific activities from the best
available published and unpublished data to form a comprehensive list that most authors use
today. However, this classification is primarily based on previously published data and as
such may not reflect the exact average energy cost of all physical activities. The MET
values of some activities were not derived from actual measurements of oxygen
consumption; instead they were estimated from the energy cost of activities having similar
movement patterns
The process of ageing illustrates a more general problem with MET scores. As
people age their maximal oxygen uptake (a measure of cardiorespiratory fitness) decreases.
Activity of a given MET (absolute intensity) therefore requires a greater percentage of their
maximal oxygen uptake (relative intensity). A walk of 4 mph may be light exercise for a 20
year old, moderate for a 60 year old, and vigorous for an 80 year old although all would be
classed as 4 METs (US Dept Health, 1996, p32).
The use ofMETs allows different intensities of physical activity to be investigated
(bearing the above caveat in mind). For exa,nple, McTiernan et al (1996) looked specifically
at high intensity exercise (>7.0 METs) while White et al (1996) divided activities into low,
moderate, and high intensity (<4.5, 4.5-5.5, and >6.0 METs respectively). However, there
are problems of consistency as one author considered high intensity activity to be >7.0
METs and one >6.0 METs. These studies, therefore, would not be directly comparable.
There is no accepted MET definition of each activity level.
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Kilocalories of energy expended each week in a particular activity are calculated by
multiplying the MET score of that activity by the weight in kilograms of the person by the
number of hours the activity is performed. An index of total energy expended per week can
be calculated by adding the kilocalorie scores for all activities together. Subjects can then be
categorised into levels of kilocalorie expenditure. However, the investigator may not know a
subject's body weight, especially if the activity took place in the distant past. Therefore,
Min-Lee et al (1992) estimated energy expenditure without the weight parameter. Sports of
intensity of <4.5 METs were rated at 5 kcals per minute whilst those of >4.5 METs 10 kcals
per mmute. The energy expenditure thus calculated was very highly correlated with energy
expenditure calculated using weight and MET scores (Spearman rank correlation co¬
efficient 0.99). Errors can arise with methods that take account of body weight because
these estimates of energy expenditure may more closely reflect body weight rather than
energy expenditure (Amsworth et al, 1993).
At present the most frequent method of constructing summary scores is to use
MET-hours per day or week. These are calculated by multiplying the reported time spent on
each activity by its MET score. This method has the advantage of excluding body weight
and, thus, avoids confounding energy expenditure by body weight (Giovannucci et al,
1995).
The coding system developed can also allow analysis of changes in activity level
over time (if the questionnaire has been written to attempt this or has been administered
more than once). Min-Lee et al (1997) administered the same questionnaire 3 years apart
and created 4 categories of exercise defined as: 1) inactive at study entry and after 3 years;
2) inactive at entry and then active; 3) active at entry and then inactive; 4) active at both
measurements. Besides allowing for the evaluation of physical activity patterns over time a
joint assessment can also increase the precision of activity measurement i.e. people who
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provide more than one report of being active (or inactive) are likely to be those who are
truly active (or inactive). It is also possible that obtaining long-term activity patterns enable
the detection of the relevant time period when physical activity may be related to the
development of cancer (Ainsworth, 1998).
2.5 Problems with the recall of physical activity:
In the most general sense physical activity is defined by level of caloric
expenditure. While this has been useful in heart disease studies it is somewhat like defining
diet simply by calorie intake. Evidence is emerging that specific types and patterns of
physical activity, rather than absolute levels, may have differential associations for human
health (La Porte et al, 1985). Recall of these characteristics is, therefore, important.
Cognitive survey research has shown that individuals report usual patterns of events
more accurately than events that occur unusually since these patterns can be more readily
recalled from generic memory (Jobe et al, 1993). Thus, occupational activities are constant
over a longer period of time and are, therefore, easier to remember. Exercise or sporting
activities, which are more subject to variation, are more difficult to recall.
Jacobs et al (1993) evaluated the reliability and validity of 10 commonly used
physical activity questionnaires in 78 men and women aged 20-59 yrs. Most questionnaires,
even the very simple ones, were related to the performance of heavy intensity physical
activity. Few of them were related to light or moderate activities. Freidenreich et al (1998)
found heavy activity was more easily remembered and reported. Light activities appear to
be the most difficult to recall. Unfortunately they are also the most common. Most existing
simple questionnaires probe predominantly for heavy intensity activities (Jacobs et al,
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1993). This makes linguistic sense since most people asked about performance of regular
exercise seem to think about vigorous or organised activities, not routine activities.
The stability and timeframe of behaviour involved link in with the intensity of the
activity. For highly stable activities like sleep, heavy intensity leisure activities and
household chores the timeframe of the question and the details of the scope of the activity
seem to be of little importance. For highly variable activities, like light or moderate, the
issue of recent vs. habitual looms large (Jacobs et al, 1993).
2.6 Validation of Measurement:
To be valid an instrument must measure what it is intended to measure (LaPorte et
al, 1985). Physical activity is very difficult to measure. Therefore, it is of great concern how
well self-reported physical activity accurately represents a person's habitual activity status.
The principle difficulty in establishing the validity of a physical activity measure is the lack
of an accepted 'gold standard' criterion measure for comparison. Investigators have,
therefore, resorted to indirect validation approaches. Most commonly, questionnaires have
been compared with direct monitoring of physical activity e.g. cardiorespiratory fitness.
Given the uncertainty over methods of validation field tests of repeatability at least
are highly desirable and essential good practice.
2.7 Reliability of Measurement:
Testing the reliability of activity questionnaires is problematic. It is difficult with
repeated measures of physical activity to determine whether you are measuring the
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unreliability of the measuring instrument or true variation in the physical activity of an
individual. Information regarding the stability of physical activity patterns in the population
is scarce. Booth et al (1996) assessed repeatability on 115 participants recall of activity over
2 different time periods and a repeat measure of the same time period. The results of this
study suggest that variations in repeatability coefficients between recall of the same 2 week
period and activity recalled over different 2 week periods was due to actual variation in
physical activity participation over different time periods, not poor recall or poor
measurement characteristics.
The mam problem with using repeatability as a criterion for the quality of a physical
activity assessment is that a large proportion of the study population might report no
participation at both test and retest measurements (Booth et al, 1996). These respondents
would have identical zero values for both measurements, potentially inflating the measure
of reliability. An assessment of the reliability of any measure, therefore, should consider the
statistics derived from both the whole study sample and from the subset of respondents who
reported participating in the activity of interest on at least one occasion.
2.8 Measurement of physical activity: Conclusion:
As with other complex behaviours, an accurate assessment of lifetime patterns of
physical activity is difficult to achieve. Few people have stable activity patterns throughout
their lives. Instead most people have activity patterns that vary daily, seasonally, or during
different periods of their life. Also it is difficult to assess activity during the aetiological
window of time when the activity is most important because the time period of exposure
that influences cancer risk is not known. The optimal approach for cancer epidemiology is
to use multiple assessments over many years to help combat this problem and increase the
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precision of the measurement (Oliveria & Christos, 1997). Alternatively a quantitative
history survey covering lifetime physical activity could be used. Case-control studies more
completely assess lifetime activity levels, or levels at different periods of life; cohort studies
are not usually appropriate as they generally rely on activity levels recorded at baseline.
The methods of measuring and classifying physical activity in epidemiological
studies are not standardised. The methods can be divided into broad categories but there is
still great variety within each category. Currently there is no accepted 'gold standard'. No
one method ofphysical activity measurement is valid, reliable, practical, and non-interfering
(LaPorte et al, 1985). Techniques that are the most valid and reliable (direct monitoring) are
not practical or can actually alter the behaviour of the subject and influence the activity
being measured. Conversely, those techniques that are practical and/or do not interfere with
normal activity e.g. global, recall, or quantitative history surveys, are likely to be less valid
and reliable. These surveys rely heavily on recall processes to obtain information about
physical activity at some point in the past. A weakness of all surveys is recall bias
(Amsworth, 1998).
A physical activity questionnaire should attempt to cover lifetime activity of all
types (occupational, household, and recreational) and focus on the intensity, duration, and
frequency of each activity. The section of the SNEHD questionnaire that records physical
activity was written to take account of the above points. It covers a long period of time and
records the intensity, duration and frequency of each activity. Analysis of data from these
questions is presented in chapter 9.
It is only with the development of quantitative history survey methods that detailed
records of physical activity are being collected. These methods should be used for cancer
epidemiology in the future.
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3. Health Consequences of Physical Activity
3.1 Introduction:
"Physical activity reduces the risk of premature mortality in general, and of CHD,
hypertension and diabetes mellitus in particular. Physical activity also improves mental health
and is important for the health of muscles, bone, and joints" (US Dept Health, 1996, p4). The
influence of physical activity on cancer risk is less clear. This may be because cancer is "a
matrix of diseases differing in aetiology, site, timing, symptoms and course" (Paffenbarger et
al, 1987).
Cherry (1922) was first to propose that increased physical activity protected against
the development of cancer. He observed that primitive societies had lower cancer rates than
more civilised cultures and that the amount of occupational activity was inversely associated
with cancer mortality.
The effect of physical activity on cancer risk could act through an immune or a
hormonal pathway or both. This chapter will discuss the impact of physical activity on the
immune and hormonal systems and the results of studies investigating cancer risk.
3.2 Physical activity and cancer:
Study search methods:
The next section will focus on studies that have investigated the effect of physical
activity on cancer risk. MEDLINE and BIDS were searched back to 1990 to find English
language studies with the following key words: exercise, physical activity, cancer, aetiology,
colon, breast, prostate, endometrium, ovarian, testicular, lung, Hodgkin's disease. Once these
were found citations of these were followed up, as were the references in each study to get as
full a picture as possible of the effect of physical activity on cancer risk. Although an attempt
was made to find all studies those investigating leisure time activity or total activity will be
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emphasised. Those relating to occupational activity will not be discussed in detail for reasons
given in Chapter 2.
Physical activity and all-site cancer:
Eight cohort studies have been published in the literature. Of these one was based on
occupational physical activity alone and this found no significant effect of activity levels
(Paffenbarger et ah 1978). Three of the remaining seven have looked at fitness (Blair et al,
1989; Wannamethee ct al, 1993; Steenland et al, 1995) while the remaining four have focused
on recreational or total activity. Details of these studies are shown in Table 3.1.
Three of four studies looking at activity levels found a statistically significantly lower
risk of cancer in those undertaking more activity (Paffenbarger et ah 1986; Albanes et al,
1989; Wannamethee et al, 1993). These results were significant for males only. Three others
showed a non-significant decreased risk of cancer (Garfmkel & Stellman, 1988 (males only);
Blair ct ah 1989 (males only); Stccnland et ah 1995 (both sexes combined)). Garfinkel &
Stellman (1988) found an increased risk of cancer in women with increasing activity level.
Leon et al (1991) found a non-significant increase in risk of cancer in males but suggest that
the predominance of cigarette smokers in the MRFIT cohort may have negated any possible
protective effect of leisure time physical activity against cancer. Linsted et al (1991) and
Arraiz ct al (1992) found no relationship between physical activity and risk of cancer.
Three studies investigated risk of all site cancer with fitness level. These all showed a
decreased risk of cancer with higher level of fitness, but this effect was only statistically
significant in one (Stecnland et al, 1995).
All of these studies arc prospective cohorts and are in the form of global surveys (see
Chapter 2), based on a single simple activity question at baseline e.g. "How much exercise do
you get (at work or play)?" (Garfinkcl & Stellman, 1988). These studies take no
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Table 3.1: Physical activity and all-site cancer.
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account of changes in activity levels or ask for detailed activity information. Studies of all-
site cancer also combine cancers that may be influenced by physical activity with those that
arc not. These problems may account for essentially null results.
Physical Activity and Colon Cancer:
Colon cancer is the malignancy for which most data is available relating to physical
activity. Animal studies have shown that chemically induced colon cancer is reduced by
physical activity, including both forced strenuous activity which led to weight loss (Klurfield
et al, 1987), and moderate voluntary activity which did not result in weight loss
(Andrianpoulos et al. 1987; Rcddy et al, 1988).
A literature search produced 35 studies that investigated the risk of colon cancer by
activity level. Ten of these studies used only measures of occupational activity (Milhanr et,
1983; Vena et al, 1985; Fredriksson et al, 1989; Brownson et al, 1989; Peters et al, 1989;
Brownson et al, 1991; Dosemeci et al, 1992; Arbman et al. 1993; Vineis et al, 1993; Chow et
al, 1994). All of these showed an increased risk of colon cancer with lower activity levels and
five of the results were statistically significant (Milham et al, 1983; Vena et al, 1985;
Fredriksson et al, 1989; Brownson et al. 1991; Chow et al, 1994). The effect was generally
stronger in males if the sexes were analysed separately. The results of occupation based
studies are remarkably consistent, especially when few have evaluated confounders.
The remaining studies in the literature investigated recreational or total activity. Of
these thirteen attempted to adjust for at least one of the crucial confounding effects of diet or
body size. The results of these studies arc shown in Table 3.2.
Again the results are consistent. Ten of the studies had a statistically significant
reduction in risk of colon cancer with increasing activity levels. The only exception to this
reduction was Marcus ct als' (1994) finding that risk of colon cancer was increased in women
76
Table 3.2: Physical activity and Colon cancer
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Table 3.2: Physical activity and Colon cancer (continued).
"
Slattcry et al Matched C/C llpa OR male=1.63 p>0.05
(1997) study 2073 cases lowest amount (1.26-2.12)
(USA) (age 30-79) & of activity vs. OR female=T.59 p<0.05
2466 controls highest (1.21-2.10)
(age- & sex-
matched)
Longnecker ct al C/C study of vigorous ltpa OR=0.57 p for trend 0.06
(1995) 163 cases (age >2 hrs/wk vs. 0 (0.33-0.97)
(USA) >32)& 703
controls
Thune & Lund Cohort 53242 total activity RR male= p for trend 0.04
(1996) males & 28274 active vs.








p for trend 0.04
Tluin et al Nested C/C ltpa RR male=0.60 NS
(1992) study of 1150 heavy exercise (0.28-1.27)





vs. none RR female=0.90
(0.41-1.96)
NS
Gerharrdsson et C/C study of total & ltpa OR=1.8 p=0.05
al (1990) 452 cases (age activity (1.0-3.4)





NS (not statistically significant) = p>0.10
HR = heart rate. EE = energy expenditure, ltpa = leisure time physical activity.
* 90% confidence intervals.
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with increasing activity level. In the studies that looked at the sexes separately the protective
effect was generally stronger in males than females. This could be due to the narrower range
of activity exhibited by women. Of the studies that tested for a dose-response, six found a
statistically significant decrease in colon cancer risk as activity levels increased (Slattery et al,
1988; Severscn et al, 1989; Gcrhardsson ct al, 1990; Giovannucci et al, 1995; Longnecker et
al, 1995; Thune & Lund, 1996).
There arc several mechanisms by which physical activity could reduce the risk of
colon cancer. The most widely held hypothesis is that physical activity stimulates colon
peristalsis thereby decreasing the time that dietary factors, endogenous secretions such as bile
acids, and carcinogens reside in the bowel (Burkitt. 1971; Burkitt et al, 1972). It is a well-
known clinical observation that physical inactivity, particularly bed rest, is associated with
constipation. At the other extreme long distance runners have been reported to develop
diarrhoea and even faecal incontinence (Sullivan & Wong, 1992). Several studies have shown
that exercise does decrease transit time (Holdstock et al, 1970; Cordain et al, 1986; Oettle et
al, 1991; Koffler et al, 1992). However, others have not (Bingham & Cummings, 1989;
Lanipe et al. 1991. Cocnen et al, 1992). Also transit time is not a well-established risk factor
for colon neoplasia.
Exercise may affect prostaglandin synthesis, specifically a type of prostaglandin
called F; alpha. Animal studies have demonstrated that F2 alpha inhibits tumour growth in the
colon, and strenuous physical activity appears to increase the levels of prostaglandin F2 alpha
(Bennett & Del Tacca, 1975; Tutton & Barkla, 1980). Prostaglandin E2 is svnthesised in
greater quantities in human cancer cells (Bennett & Del Tacca, 1975). Inhibitors of
prostaglandin synthesis are known to suppress colon cancer development and observations
have revealed that exercise may reduce prostaglandin E2 levels.
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Alternatively, the decrease in risk could be due to associated beneficial lifestyle
changes, such as a low fat diet (Sandler et al, 1995).
Together the research on physical activity and colon cancer strongly suggests that
activity has a protective effect against the risk of developing this cancer.
Physical activity and cancers associated with the hormonal system:
Prostate Cancer One of the main aetiologic hypotheses for prostate cancer is
prolonged androgenic stimulation (Le Marchand et al, 1991). Since physical training lowers
testosterone levels (see p.94) physical activity may protect against the development of
prostatic disease through a favourable effect on hormone profiles (Hartman et al, 1998).
However, in most studies possible confounding by diet, body size, race or socio-economic
status have not been considered.
Seven published studies have investigated only occupational activity. Three studies
described a statistically significantly increased risk of prostate cancer with lower activity
levels (Milham et al. 1983; Vena ct al, 1987; Brownson et al, 1991). Three more described an
increase in risk with low levels of occupational activity, but the results were not significant
(Paffcnbarger et al, 1987: Doscmcci et al, 1993; Hsing et al. 1994).
The eighteen studies of recreational or total physical activity, or cardiorespiratory
fitness, have also produced inconsistent results. Only eight of these studies made any attempt
to control for confounding by diet or body mass. These can be considered the best studies and
their results arc presented in Table 3.3 (although diet has only been adjusted for in one study:
Ilic et al, 1996). One study (Albancs et al. 1989) found leisure time physical activity to be
statistically significantly protective for prostate cancer. Two studies found an inverse
relationship (Olivcria & Blair. 1993; Thune & Lund, 1994) but the results were not
significant. In the study by Thune & Lund (1994) the relationship was limited to those men
aged over 60 years. Two studies found no effect of recreational activity or recreational and
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Table 3.3: Physical activity and prostate cancer
Study Numbers Comparison Risk Estimate Significance
Albanes ct al Cohort NHANES 1 ltpa. RR= 1.80 p for trend




Ilic ct al Matched C/C study lifetime ltpa. Not given NS




Tluine & Lund Cohort 53242 (age total activity at RR=0.61 p for trend
(1994) 19-50 at entry), av. baseline. (0.36-1.01) 0.03
(Norway) follow-up 15 yrs walking at work & RR=0.45
(220 cases) moderate ltpa vs.
sedentary




Oliveria et al Cohort 12975 men fitness quartile i. RR= 1.1 p for trend
(1996) (age 20-80) 1982. (0.63-1.77) <0.004
(USA) examined 1970-89 i. 2 vs. 1 ii. RR=0.73
(94 cases) ii. 3 vs. 1




Gann et al (1995) Cohort 22380 men heart rate at (i) RR= 1.00 p for trend
(USA) enrolled 1967-73. baseline. (ref) 0.006
av. follow-up 19.2 quintiles of heart (ii) RR=1.55





Cerhan ct al Cohort 1050 men physical activity RR=1.9 p for trend





Severson et al Cohort 8006 total & i. RR=1.05 i. NS
(1989) Japanese men living recreational (0.75-1.47)
(USA) in Hawaii 1965, activity. ii. RR=1.05 ii. NS
followed 20yrs i. highest total (0.73-1.51)
(206 cases) tcrtile vs. lowest
ii. as above ltpa
NS (not statistically significant) = p>0.10
ltpa = leisure time physical activity.
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occupational activity combined (Severscn et al, 1989; Ilic et al. 1996) and one found that
greater activity levels to be associated with an increased risk (Ccrhan et al, 1997).
Studies of the association with cardiorespiratory fitness are more consistent. Both
Gann ct al (1995) and Oliveria et al (1996) observed a statistically significantly protective
effect for higher fitness level. Both of these studies had a statistically significant dose-
response. However, in contrast to the results of Thunc & Lund (1994), the effect of fitness in
the Oliveria et al (1996) was limited to men aged <60 years.
The prostate is primarily an androgen dependent gland controlled essentially by levels
of plasma testosterone, of which 90-95% of the body's production is svnthesised in the testes.
Physical activity may protect against the development of prostate cancer through reductions in
the resting levels of endogenous sex hormones, particularly testosterone (Ross et al, 1988;
Gittes, 1991). The prostate gland is dependent on these hormones for growth and development
and is affected by hormonal stimulation. A recent case-control study conducted within the
Physician's Health Study (Gann et al, 1996) found that high levels of circulating testosterone
was associated with an increased risk of prostate cancer. Men with prostate cancer have
higher levels of endogenous testosterone than non-canccrous men, and cancerous tissues have
been reported to have higher levels of testosterone than healthy tissue (Ahluwahia et al, 1981).
If exercise docs decrease the risk of prostate cancer, a chronic decrease in testosterone levels
would be important in influencing risk as compared with transient change, suggesting that
long-term exercise may be necessary for decreased prostate cancer risk.
The body of evidence to date shows no consistent relationship between prostate cancer
and physical activity. Further studies are needed to investigate the frequency, intensity, and
duration of activity, as well as the type and period of life during which activity might be
beneficial. However, it is reasonable that exercise may be a potential factor that can be
modified to protect from prostate cancer.
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Breast Cancer The intensity and duration of exercise has been found to affect the
development of experimentally induced breast cancer in rats (Thompson, 1994). Several
mechanisms for this effect have been hypothesised by Kramer & Wells (1996). The
relationship could be due to: 1) the maintenance of low body fat and modulation of extra-
glandular oestrogen; 2) a reduction in the number of ovulatory cycles and subsequent
diminuition of lifetime exposure to endogenous oestrogen; 3) enhancement of natural immune
function; 4) association with other healthy lifestyle habits.
Most aetiologic theories have focused on oestrogen because of the numerous
menstrual and reproductive risk factors for breast cancer e.g. women who have an early
menarchc. late menopause, and low parity are at increased risk. Physical training has been
shown to decrease oestrogen levels (sec p.91). Many breast cancer risk factors that are
believed to operate through an oestrogen pathway are culturally or personally determined by a
woman's lifestyle. In an effort to reduce risk, however, few of these factors are easily
modifiable, with the exception of physical activity (Gammon et al, 1996).
27 studies on the relationship of physical activity to breast cancer risk have been
published. Seven of these have focused on only occupational activity (Milham et al, 1983;
Vihko et al, 1992; Doscmcci et al, 1993; Pukkala et al, 1993; Zheng ct al, 1993; Coogan et al,
1997; Mezzctti et al, 1998). Of these seven studies four (Milham et al, 1983; Pukkala et al,
1993; Zheng ct al, 1993; Mezzctti et al, 1998) found a statistically significant increase in risk
of breast cancer with low levels of occupational activity. The others also found the same
pattern of risk but the results were not significant.
The remaining 21 studies have investigated total or recreational activity. The majority
of these have made an effort to control for confounding by SES. reproductive history, body
mass, and diet. Eighteen controlled for female reproductive history, 16 for body mass, and 14
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adjusting for dietary factors (of these 14 5 only considered alcohol intake). The results from
these studies are shown in Table 3.4.
Six studies analysed all women together. Two studies found a statistically
significantly increased risk of breast cancer with lower levels of activity (Frisch et al, 1985;
Fraser et al, 1997), two found a non-significant protective effect (Dorgan et al, 1994;
Frcidcnreich ct al, 1995; D'Avonzo ct al, 1996), one found no effect (Albanes et al, 1989),
and one found activity to increase risk (Dorgan et al, 1994). Nine studies presented results by
menopausal status. Nine studies had results for pre-menopausal women with three having a
significant inverse relationship (Bernstein et al, 1994; Flirose et al, 1995; Thune et al, 1997).
In two studies there was no effect (Chen ct al, 1997b; Gammon ct al, 1998) while two studies
revealed that a lower level of activity w as associated w ith a lower risk of breast cancer in pre¬
menopausal women (Albancs et al, 1989; Hu et al. 1997). The pattern of risk for post¬
menopausal women is rather more consistent with seven of the nine studies having an inverse
risk. Of these studies four were statistically significant (Hirose ct al, 1995; McTieman et al,
1996; Cerhan ct al, 1996; Carpenter et al. 1996) and three were not (Albanes et al, 1989;
Freidcnreich et al. 1995; Hu et al, 1997). In the remaining two studies activity level had no
effect on breast cancer risk (Taoli et al, 1995; Thune et al. 1997).
It is possible that physical activity during adolescence and young adulthood may
protect against the later development of breast cancer. Eight of the studies in Table 3.4
examined this possibility. Among the eight studies, two found a strong and statistically
significant reduction in risk (Frisch et al, 1985; Mittcndorf ct al. 1995), one found a non¬
significant reduction in risk (D'Avonzo et al, 1996), and four no association (McTiernan et al,
1996; Chen et al. 1997b; Rockhill ct al, 1998; Gammon et al, 1998). However, it is not
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Table 3.4: Physical activity and Breast cancer.
Study Numbers Comparison Risk Estimate Significance
Frisch et al Cohort 5398 former college sport. RR=1.86 p=0.05
(1985) college students non-athletes vs. (1.00-3.47)





Rockhill ct al Cohort Nurses strenuous llpa age i. RR= 1.1 i. NS
(1998) Health Study II (age 18-22 & no. hours (0.8-1.6)
(USA) 25-42) enrolled ltpa at baseline. ii. RR= 1.1 ii. NS
1989, 6 years i. age 18-22 2/wk (0.8-1.5)
follow-up 10-12 months p.a.
(372 cases) vs. none
ii. 1989 ltpa >7
hrs/wk vs. <1 ln-
McTiernan et al C/C study 537 cases lt pa 2yrs i. OR=0.6 i. p for trend
(1996) (age 50-64) & 492 <interview. (0.4-1.0) 0.07
(USA) controls high intensity
exercise 3hrs/wk
vs. 0
Albanes et al Cohort NHANES I ltpa. RR=1.0 NS
(1989) 7407 women (age all women (0.6-1.6)






Bernstein ct al C/C studv 545 cases lifetime Itpa. OR=0.42 p for trend
(1994) (age <40) & 545 >3.8 hr/wk (0.27-0.64) <0.05
(USA) controls exercise vs. 0
Fricdenreich et al C/C study 444 cases ltpa. OR=0.73 NS




Cerhan et al Cohort 1825 (age activity at baseline. i. RR=0.5 p for trend
(1996) 65-102 at entry) i. moderate activity (0.2-1.0) 0.007
(USA) followed 1982-93 vs. none ii. RR=0.2
(46 cases) ii. high activity vs.
none
(0.1-0.9)
Thune et al Cohort 25614 (age ltpa. RR=0.63 p for trend
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NS (not statistically significant) = p>0.10
ltpa = leisure time physical activity.
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easy to compare the results of these studies as they all looked at slightly different age groups,
from 12-13 years (Gammon ct al, 1998) to college athletes (Frisch ct al, 1985).
Breast cancer has a poorly understood aetiology. Because the effect of physical
activity on breast cancer is likely to be modest, or van' throughout lifetime, measurement of
physical activity needs to be very accurate to minimise the possibility that an effect is missed
because of measurement error (Freidenreich et al, 1998). Non-significant results may be due
to the low levels of physical activity reported by women who did exercise and the low
prevalence of reported physical activity. Future studies should include the entire period from
childhood to diagnosis and include measurement of recreational, household and occupational
activity. Although the evidence is not conclusive that physical activity has a protective effect
on breast cancer there is sufficient evidence to warrant more research on this topic.
Ovarian cancer Three studies have investigated an effect of activity on ovarian cancer risk
(Table 3.5). Of these two looked only at occupational activity with both finding a slightly
elevated risk of ovarian cancer with inactive occupations (Pukkala et al, 1993; Zheng ct al,
1993). Mink et al (1995) found a positive association of ovarian cancer with high levels of
physical activity. This is inconsistent with existing theories of ovarian cancer pathogenesis.
Endometrial Cancer There arc five studies in the literature investigating endometrial
cancer risk. One of these was based on occupational activity only (Kalandidi et al, 1996). This
study found a decreased risk of endometrial cancer in jobs requiring manual labour (p=0.03).
The remaining four investigated both leisure time activity and occupational activity and
adjusted for the major potential identified confounding factors. The results of these studies are
given in Table 3.5. None of the results for leisure time activity were statistically significant
except for a moderate amount of vigorous exercise in young adulthood and 20 years before
interview in the study by Olson ct al (1997). However, the
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Table 3.5: Physical activity and other female hormonal cancers.





C/C study 405 cases
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NS (not statistically significant) = p>0.10
ltpa = leisure time physical activity.
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results all point in the same direction, a protective effect of recreational activity on endometrial
cancer risk. Of the two studies that looked for a dose-response (Levi et al, 1993; Olson et al,
1997) only one found a statistically significant relationship (Levi et al, 1993).
Many observations implicate oestrogen as having a role in cancers of the reproductive
tissues: the breast; endometrium; cervix; and ovary. This evidence includes observations that
the cancer risks are modified in association with age at menarche, number of ovulatory cycles,
and age at menopause. There is some evidence that suggests that physical activity can
influence at least some of these aspects of menstrual history.
Strenuous exercise has been found to delay menarche in many cases (Warren, 1980;
Frisch et al, 1981) and cause oligomenorrhea and secondary amenorrhea (Dale et al, 1979;
Frisch et al. 1981). These disturbances to the menstrual cycle may result in a reduced lifetime
exposure to ovarian hormones. Flowever, even participation in moderate levels of activity can
have discernible effects on the frequency of ovulatory cycles. Bernstein et al (1987) found
moderate physical activity (as defined by >600 kcal energy expenditure per week) was
associated with a three-fold increase in risk of anovulatory cycles.
More active women have low er levels of oestrogen (see p.91) or increased metabolism
of oestrogen to less potent forms.
The life period during which activity could effect breast cancer risk is also not known.
Thus, while exercise does have an effect on female sex steroid hormones it is unclear whether
this is responsible for the lower risk of female reproductive cancers seen in some studies.
The body of work on ovarian and endometrial cancer does not show a consistent
statistically significant relationship between other hormone dependent cancers in women and
physical activity.
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Physical activity and Other Cancers:
Testicular cancer Forrnan et al (1994) and the United Kingdom Testicular Cancer
Study Group (UKTCSG) (1994) found exercise to be moderately protective for testicular
cancer. Thun & Lund (1994) found no such effect. Coldman ct al (1982) and Haughey et al
(1989) have found increased risk of testicular cancer associated with cycling and horse riding,
but (UKTCSG) found no evidence of such an effect.
Lung Cancer Exercise has been found to protect against lung cancer in 6 studies (Garfinkel
& Stellman, 1988; Albanes ct al, 1989; Paffenbargcr et al, 1987; Paffenbarger et al, 1978;
Paffenbarger et al, 1986; Severson ct al, 1989). However, only one of these (Albanes et al,
1989) was statistically significant and adjusted for smoking status and cigarette pack year
history.
3.3 Physical activity and the endocrine system:
The effects of physical activity on the endocrine system can be divided by sex and
also the effects produced by a single episode of activity versus the effect of more long-term
training.
Female: Single episode:
Most interest has been on the effect of exercise on the levels of progesterone and
oestrogen but most studies have looked at the chronic (p.91), rather than the acute, effects.
Jurkowski (1978), Boncn ct al (1979), and Fahey ct al (1997) have found significantly
elevated levels of oestradiol and progesterone after a single activity episode. Jurkowski (1978)
investigated three activity levels and found the increase in progesterone was related to exercise
intensity as did Fahey ct al (1997) with the significant increase in progesterone only seen after
high intensity exercise. Jurkowski (1978) also found that ocstradiol levels were only
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statistically significantly increased after heavy or exhaustive exercise and not light activity. In
contrast, Fahey ct al (1997) found ocstradiol to be significantly increased after 1 hour of low
and 1 hour of high intensity activity. Bonen et al (1979) found heavy exercise in untrained
subjects produced significant increments in ovarian hormones; no such increments were
observed in trained subjects at the same absolute exercise workload.
Several studies have shown a statistically significant increase in the level of female
testosterone (Sutton ct al, 1973: Shangold ct al, 1981; Obminski et al, 1997). However, the
level of testosterone remained well within the normal range for women. Sutton et al (1973)
found that only maximal exercise had a statistically significant effect on testosterone levels
and not sub-maximal effort. Kraemer et al (1993) found no relationship between a single
episode of activity and testosterone.
Studies investigating the pituitary hormones lutenizing hormone and follicle
stimulating hormone have found essentially no change (Sutton ct al, 1973; Jurkowski et al,
1978; Bonen et al. 1979; Bonen ct al, 1981).
Cortisol (Obminski et al, 1997; Kraemcr et al, 1998a), prolactin (Shangold et al,
1981; Bullcn ct al. 1982). and growth hormone (Hakkinen & Pakarinen, 1995; Kraemer et al,
1998a) levels are increased after acute exercise.
Female: Traininu:
Most investigations again focused on the long term exercise effects on the levels of the
ovarian hormones oestrogen and progesterone. The majority of studies find a lower level of
oestradial. oestrogen, or ocstronc in regular exercisers (Dale et al, 1979; Boyden et al, 1983;
Bullcn ct al. 1985; Nelson et al, 1988; Cauley ct al, 1989; Newcomb ct al, 1995; Nagata et al,
1997; Dc Souza et al, 1998). This effect is seen in both pre- and post-menopausal women
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(McTiernan et al, 1996). However, not all studies have found a decreased level of oestrogen in
trained women (Bonen et al, 1979; Schwartz et al, 1981; Bullen ct al, 1982). Bullen and
colleagues (1982) looked only at moderate activity and found no effect whereas De Souza et al
(1998) found moderate physical activity statistically significantly decreased oestrone levels.
Boyden et al (1983) suggested that it is particularly endurance running that lowers the
circulating concentration of oestrogen.
The majority of evidence points to regular exercise lowering the concentration of
progesterone with most (Dale et al, 1979; Bonen et al, 1981; Ellison & Lager, 1986), but not
all (Bonen et al, 1979) reductions being statistically significant.
The majority of studies have found no effect of training on testosterone levels in
women (Baker et al, 1981; Schwartz ct al, 1981; Boyden ct al, 1983; Weiss et al, 1983;
Hakkinen et al, 1990; Kracmer et al, 1991). Only one study suggested that testosterone levels
are statistically significantly elevated in established female runners (Dale et al, 1979) but the
testosterone levels were still well within normal levels for women.
As with single episodes of exercise little work has been performed on Cortisol and
prolactin levels. Biillcn et al (1982) suggest that moderate activity may increase the levels of
circulating Cortisol but have no effect on prolactin. More studies are needed to investigate
these relationships.
Male: Single episode:
The focus of an exercise effect on the endocrine system in men has been testosterone.
The majority of studies have found that acute exercise increases testosterone levels in men
(Sutton et al, 1973; Hakkinen & Pakarinen, 1995; Volck ct al, 1997; Obminski et al, 1997;
Fahrner & Hackney, 1998; Kraemer et al, 1998a). This relationship has been found in old
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men as well as young (Kracmcr ct al, 1998b; Hakkinen & Pakarinen, 1995) and for more
moderate (Fahrner & Hackney, 1998) and high intensity activity (Sutton et al, 1973;
Obminski et al, 1997; Volck et al, 1997). In contrast, Foumicr et al (1997) found testosterone
levels to significantly fall over the course of a 110km ultra-marathon, possibly due to the very
long duration of intense exercise. Kuoppasalmi ct al (1980) found maximal short term running
to have little effect on testosterone levels but a moderate intensity run of 90 minutes led to a
decreased level. Short-term intense exercise appears to increase testosterone levels but
prolonged exercise of at least 90 minutes typically results in a reduced level, regardless of
intensity. These levels tend to return to normal within 24 hours. More investigation is needed
into the effect of sub-maximal exercise on endogenous testosterone levels as such a
relationship is still to be fully described.
The mode of exercise can also affect the exercise-induced change in testosterone. In
contrast to the literature on running (Kuoppasalmi et al, 1976), cycling (Cumming et al,
1986), and resistance exercise (Kraemcr, 1988) Cumming ct al (1987) observed a decrease in
testosterone levels following intense swimming exercises. Jensen et al (1991) observed no
difference in testosterone levels following intense endurance exercise compared to strength
exercise.
Growth hormone rises during short-term exercise after an initial delay of about 10
minutes but plateaus after 30 minutes (Sutton et al, 1973; Felsing et al, 1992; Richter ct al,
1994; Hakkinen & Pakarinen, 1995). This change in hormone level is not statistically
significant if physical activity is performed at a reduced level. However, Fukatsu et al (1996)
did not observe an increase in GH, even after prolonged intense exercise.
Cortisol is consistently elevated following acute exercise (Hartley ct al, 1972; Sutton
et al, 1973; Hakkinen & Pakarinen, 1995; Fukatsu et al, 1996; Farmer et al, 1997; Obminski
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et al, 1997; Kraemer et al, 1998a; Kracmcr ct al, 1998; Fahrner & Hackney, 1998). In studies
that compared maximal and sub-maximal activity the effect was limited to the former (Sutton
et al, 1973; Hakkinen & Pakarincn, 1995).
Male: Training:
The focus of studies of the effect of long-term exercise on resting hormone levels has
again been testosterone. In general, if sedentary people undergo a training programme or
athletes increase their training level, the resting blood level of testosterone falls (Webb et al,
1984; Wheeler et al, 1984; Urhausen ct al, 1987; Flynn ct al, 1994; Duclos et al, 1996;
Gullcdge & Hackney, 1996; Flvnn ct al, 1997; Hackney et al, 1998). Other authors have not
found a difference in resting testosterone levels between trained athletes and sedentary controls
(Lucia et al, 1996) or no change in testosterone levels over the course of 8-12 weeks of
training (Lucia ct al. 1996). Sutton ct al (1973) and Kraemer et al (1998a) found an increased
level of testosterone.
Flynn ct al (1997) has found a greater decrease in levels of free testosterone than total
testosterone after a doubling of mileage in male distance runners. A finding confirmed by
Wheeler et al (1984), Flynn et al (1994), and Hackney et al (1998). The greater effect on
circulating levels of free testosterone is important. Free testosterone more accurately reflects
the biologic activity of circulating testosterone and suggests a more notable decrease in
androgen bioavailability than would be apparent from the measurement of total testosterone
alone.
There is no agreement if these changes in testosterone mean that those who train
regularly have testosterone levels outside of the physiological range. Although the mean level
of total and non-specifically bound testosterone was statistically significantly lower in runners
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it was still within the physiologic range in studies by Wheeler ct al (1984) and Hackney ct al
(1998).
Although trained athletes appear to have lower serum levels of testosterone at rest, a
relationship between physical activity and testosterone level has not been confirmed in older
men and the effect of moderate and light activity on hormonal status has not been evaluated.
Very little work has been performed on the long-term effect of physical activity on
other hormones in men. Little effect of activity has been seen on resting levels of Cortisol
(Wheeler et al, 1984; Gulladge & Hackney, 1996; Mujika et al, 1996; Flvnn ct al, 1997), or
prolactin (Gulladge & Hackney, 1996; Mujika et al, 1996; Hackney et al, 1998).
Physical activity and the endocrine svstcm: Conclusion:
Improvements in laboratory techniques have allowed research related to exercise and
endocrinology to flourish. The emerging literature, however, is often inconsistent or
contradictory. Exercise intensity, duration, mode, frequency, and volume may each have
specific effects on the endocrine changes seen with exercise and training. Furthermore,
hormonal responses to exercise arc dependent on initial training status and fitness level.
Careful considerations should be given to the biological relevance of any statistically
significant result.
Physical activity has not been strongly related to hormone concentrations. The only
consistent relationship of training is with decreases in resting levels of oestrogen and
progesterone in women and testosterone in men. It is not clear if these decreases are clinically
important as the levels reported arc usually within the physiologic range. It is also not clear
whether all absolute levels of exercise have the same impact. However, the sympathetic and
medullary responses to exercise arc directly proportional to the relative intensity of the
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exercise (Deustcr et al, 1989). In general if individuals perform exercise bouts at an absolute
intensity untrained individuals will elicit a more profound endocrine change than their trained
counterparts (Lugcr ct al, 1987). A blunted hormone response is particularly evident in
endurance trained athletes (Vasankari ct al .1993).
3.4 Physical activity and the immune system:
It has long been known that the immune system plays an important role in recognising
and killing tumour cells (Roitt ct al, 1991). Any change in immune function could affect the
body's ability to defend itself against the initiation and promotion of a tumour. During the last
95 years 629 papers (60% in the 1990s) dealing specifically with exercise and immunology
have been published (Nieman, 1997).
Published papers can be divided into those that have looked at the effect of a single
bout of exercise; those that have compared trained people with sedentary controls; and
changing immune parameters over the course of a training programme. For the following
section moderate amounts of physical activity are defined as 3-5 times per week, 15-60
minutes per session at 40-60% VO; max. High intensity activity is performed above 60% V02
max and may take place more frequently for longer periods.
Single Episode:
Acute exercise is the most frequently studied area of exercise immunology and has
revealed that a rapid interchange of immune cells between peripheral lymphoid cells and the
lymphoid organs occurs. The response depends on many factors including the intensity,
duration and mode of exercise. Of cells involved in immune response Natural Killer (NK)
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cells, neutrophils, and macrophages (of the innate immune system) appear to be the most
responsive to the effects of acute exercise, both in terms of numbers and function.
NK cells NK cells possess the ability to initiate spontaneous cytolytic activity against
virally infected cells and malignant cells (O'Shea & Ortaldo, 1992; Welsh & Vargas-Cortes,
1993; Strasncr et al, 1997). Animal studies have shown that natural cytotoxicity is important
in the immune surveillance against cancer (Garclick ct al, 1982).
Despite convincing evidence from animal studies, the role ofNK cells in immunologic
surveillance against cancer in humans is poorly defined. Circumstantial evidence for the
importance of natural cytotoxicity in humans is provided by studying NK deficiency states
such as Chediak-Higashi syndrome (Rodcr ct al, 1980), X-linkcd proliferative syndrome
(Sullivan ct al, 1980), or people who have had a renal transplant (Gui et al, 1983) and are
pharmacologically immunosuppresscd. These individuals have reduced NK cell activity and
an increased risk of cancer.
A consistent biphasic NK cell response to acute exercise has emerged from the
literature. There is a transient increase in the absolute and relative function of blood
mononuclear cells expressing characteristic NK cell markers immediately after exercise,
immediately followed by a drop below baseline levels within 2 hours of recovery (Brahmi et
al, 1985; Pcderscn et al. 1988; Nieman et al. 1991; Nicman et al, 1992; Shinkai et al, 1992).
The magnitude of both phases of response seems to correlate with exercise intensity (Strasner
et al, 1997). The temporary enhancement ofNK activity occurs whether the exerciser is young
or old, male or female, trained or untrained, fit or unfit.
There is debate as to whether the delayed decrease in total NK cell cytotoxic activity
after prolonged intense exercise represents a true suppression of killing activity or is due to the
redistribution of circulating lymphocyte subsets during exercise (Mackinnon ct al, 1988; Berk
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et al, 1990; Mackinnon, 1992; Nicman ct al, 1993a). Again this effect is related to the relative
exercise intensity.
The changing number ofNK cells and their changing activity level could be brought
about through a hormonal mechanism. NK cell activity is negatively correlated with serum
Cortisol levels (Nicman & Nchlson-Cannarella, 1991) so that the exercise-induced surge in
Cortisol secretion could contribute to the late suppression of NK cell activity. The precise
physiologic role of steroid hormones on NK activity requires further clarification. Pross &
Bainen (1982), Thvss et al (1984), and Holbrook ct al (1983) showed that NK cell activity did
not vary within the menstrual cycle and was not affected by the menstrual status of women
implying no effect of female steroid hormones (Holbrook ct al. 1983). In contrast Sulke et al
(1985) measured suspected NK cell activity in 18 healthy women and showed a significant fall
in activity in the peri-ovulatory period. However, NK cell activity was not related to oestradiol
concentrations in the individual women, and oestradiol at physiologic concentrations may not
directly affect the function ofNK cells (Sulke et al, 1985).
Two main, and clinically relevant, questions remain to be answered: 1) Do the small
exercise-induced modulations of immune cell function reach clinical relevance; 2) what
amount of exercise can improve immunity without impairing it?
Neutrophils In general high intensity exercise suppresses most neutrophil functions, both
acutely and chronically, while the results of moderate exercise have been conflicting. Despite
the limitations of studies conducted in this field so far, there is no doubt that exercise triggers
functional responses in neutrophils. The effect of duration or type of activity at a fixed
intensity have received little attention. The physiological implications of exercise-induced
changes in neutrophil function remains unclear but the overall trend fits in with the
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epidemiological evidence that intense exercise increases vulnerability to infection while
moderate exercise may be immuno-potentiating (Smith, 1997).
Conclusion In general acute exercise bouts of moderate duration (<60 minutes) and
intensity (<60% vo2max) are associated with fewer perturbations and less stress to the immune
system and appear to transiently improve immunity. Prolonged high intensity exercise appears
to put general stress on the immune system and depress immunity.
Training:
Studies of training effects on the immune system can be divided into two kinds:
studies which focus on the different immune parameters in athletes and non-athletes at one
point in time (cross-sectional studies); and those which follow a group of people over the
course of a training programme (longitudinal studies).
Natural killer cells: The majority of cross-sectional studies support enhanced resting NK cell
activity in athletes compared to non-athletes, in both younger and older age groups (Pedersen
et al, 1989; Tvede et al, 1991; Nieman et al, 1993b; Nieman et al, 1995). Nieman et al (1995)
found NK cell activity was 57% higher in experienced marathon runners than sedentary
controls. Tvcdc et al (1991) found higher levels of NK cell activity in elite cyclists during the
summer months (intensive training period) when compared to winter (low training).
Longitudinal studies have given inconsistent results. The paucity of longitudinal data
likely reflects the confounding of training and fitness with acute exercise effects and various
compliance issues inherent in longitudinal training studies. Several prospective studies
utilising moderate endurance training regimes of 8-15 weeks have reported enhanced NK cell
activity relative to sedentary controls (Fiatrone ct al, 1989; Crist et al, 1989; Hoffman-Goetz
et al. 1990; Nicman et al, 1990a; Pedcrscn et al, 1990). Other authors have not reported this
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enhanced NK cell activity with training (Baslund ct al, 1993; Nicman et al, 1993b). Indeed,
Gleeson et al (1995) reported NK cell numbers to be decreased over an 8-month training
season in elite swimmers. It may be that exercise has to be performed for a prolonged period
of time (i.e. years) before NK cell activity is affected and this may explain the lack of an effect
in studies with short training periods.
Neutrophils During periods of high intensity training neutrophil function is suppressed in
athletes (Green et al. 1981; Lewicki et al, 1987; Hack et al. 1992; Hack et al, 1994; Baj et al,
1994; Pyne ct al, 1995). Hack ct al (1994) and Baj ct al (1994) observed neutrophil function
in athletes was similar to controls during periods of low training workloads, but significantly
suppressed during the summer months of intensive training. As neutrophils have phagocytic
activity, suppression of neutrophil function during periods of heavy training is probably a
significant factor explaining increased upper respiratory tract infection (URTI) risk among
athletes (Nicman. 1997).
Exercise, immune svstcm. and URTI Two models have been put forward to explain the
relation ship between infection and exercise. They are not necessarily mutually exclusive.
Nieman & Nehlsen-Cannarella (1992) proposed a j-shaped curve to describe the relationship
between amount of exercise and URTI. This model suggests that individual's who exercise
moderately exhibit a lower incidence of URTI compared to the sedentary population; in
contrast, athletes undertaking strenuous training would exhibit an increased risk. However, the
precise shape and activity levels involved in this model arc not known.
Pcdcrscn & Ullum (1994) suggested an "open window' hypothesis to describe the time
period after intensive training during which the athlete had an increased risk of infection.
Moderate exercise stimulates immune function during and for a short time following exercise.
In contrast intensive exercise causes an initial stimulation followed by a longer lasting (i.e.
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hours) suppression. It is during this open window that the athlete is at an increased risk of
contracting an infection. Some elite athletes train intensively at least once a day and, thus, may
spend a significant amount of time within this "open window".
Data from epidemiological studies on long-distance runners arc consistent with a
relationship between excessive training and susceptibility to URTI. Compared with non-
athletes the risk of URTI is higher in athletes training for competition and competing in long
distance events such as marathons or ultra-marathons (Peters & Batcman, 1983; Nieman et al,
1990a; Peters ct al, 1993). The risk of URTI appears to be related to training volumes and
possibly intensity.
Conclusion In response to long-term exercise training, the only finding to date reported
with consistency between investigators is a significant elevation ofNK cell activity. There is
some evidence that neutrophil function is suppressed during periods of heavy training. Limited
data suggest that unusually heavy chronic exercise may increase risk of URTI. Again, this is
relatively heavy exercise i.e. an unfit person undertaking heavy exercise will be more affected
than a fit person exercising at the same absolute level. However, a threshold of activity seems
to be needed to cause a breakdown in immune function. The optimal level of exercise that
enhances but does not suppress immune function is not yet known.
Physical activity and the immune svstem: Conclusion:
The immune response to exercise varies with exercise mode, intensity, and duration.
Moderate amounts of exercise training has little, if any, chronic effect on immune function at
rest (Nieman ct al, 1990b; Nehlscn-Cannarclla et al, 1991a). Thus, any protective effect of
immuno-surveillance that comes from moderate exercise training is probably the result of
changes during each exercise episode (Nieman et al. 1991: Nehlscn-Cannarclla ct al, 1991b).
Moderate training reduces the amount of effect of a given bout of exercise at a relative
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intensity and this decreases the likelihood of an adverse immune response (Shepherd & Shek,
1994). Athletes reveal positive chronic effects of exercise training with an enhanced NK cell
activity. However, they also have a suppression of neutrophil function. Problems occur when
training becomes over-training. This causes adverse immune responses and may be
responsible for an increased risk of URT1.
Ideally to test the effect of regular physical activity on immune function a large group
of individuals, randomised to sedentary control groups and exercise groups, should be
followed for at least one year with multiple immune measures being taken before, during and
after the study (Nieman, 1997). This study has not yet been performed and would require a
great deal of money. At present only a few small longitudinal and cross-sectional studies are
available.
On the basis of these Shepherd & Shek (1995) concluded that exercise can induce
changes in the activity of the cells of the immune system. This could be relevant to HD and
other cancers of the immune system.
3.5 Physical activity and Hodgkin's disease:
There has been very little work performed on the impact of physical activity on HD.
Two studies have been found in the literature (Table 3.6) that suggest there may be some
inverse relationship. However, these are both cohort studies with very few cases of HD. This
relationship will be investigated in chapter 9 using data from the Scotland and Newcastle
study of Hodgkins Disease (SNEHD). There is a possibility that moderate
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Table 3.6: Hodgkin's Disease
Study Numbers Comparison Risk Estimate Significance f





























NS (not statistically significant) = p>0.10
ltpa = leisure time physical activity.
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levels of physical activity may be associated with a lower risk ofHD through its impact on the
endocrine and immune systems while strenuous activity could increase risk.
3.6 Health Consequences of Physical Activity: Conclusion:
Physical activity has been found to confer beneficial effects on the immune system as
long as activity is not performed at too high an intensity for too long. Physical activity also
has an impact on the endocrine system changing the levels of various hormones, particularly
lowering the resting levels of oestrogen and progesterone in women and testosterone in men. In
contrast to the effect on the immune system physical activity appears to need to be quite
intense for these hormonal effects to be seen. In theory these effects could have an impact on
cancer risk.
Calabrase (1990) concluded that data supporting the hypothesis that exercise protects
against cancer through an immune pathway was lacking, and that several lines of reasoning
argue against such a relationship. Chief among these is the observation that the cancers found
in immuno-suppressed individuals such as AIDS patients (lymphorcticular origin) are not the
same as those affected by physical activity (colon, female reproductive, prostate). However,
Hoffman-Goetz & Hustcd (1995) have proposed that although various exercise induced
mechanical and hormonal changes best explain the change in risk of colon, breast, and
prostate cancer in the physically active, several potential immunological effects may be
contributing factors.
At present physical activity appears to be protective for colon cancer, although there
is no agreement on how this protective effect is conferred. Data regarding a relationship
between physical activity and breast, endometrial, ovarian, prostate, testicular cancers, and
Hodgkin's disease are too limited and inconsistent to support any firm conclusions.
104
4. Data for Analysis
The results presented in the following five chapters arc based on data from three
separate sources.
4.1 Scandinavian Cancer Registry:
The analysis of the seasonal presentation of HD in Chapter 6 is based on data from
four Scandinavian cancer registries (Denmark, Finland. Norway, and Sweden). The data
consisted of over 2000 cases of HD aged 0-34 years with details of age, sex, and month and
year ofHD registration provided. I had no role in the collection of these data.
4.2 Young Adult Hodgkins Disease Case-Control Study (YHHCCS):
YHHCCS is a matched case-control study of HD in young adults residing in the
counties of West Yorkshire, Avon, Cornwall, Cumbria, Devon, Dorset, Gloucestershire,
Humber, Lancashire, North Yorkshire, and Somerset. Eligible cases were those aged 16-24
years, diagnosed 1/10/1991 to 31/5/1995, living in the parts of the counties listed above
included in the Leukaemia Research Fund (LRF) Data Collection Study (DCS) area
(Cartwright et al, 1990). Controls were matched on age, sex, and administrative area (FHSA)
of residence with the aim of having two controls per case. The matching criteria was fulfilled
in most cases, the only exceptions being one set with only one control and two sets with
three controls. Controls that did not give consent or who could not be traced were replaced
with further random selections based on the same matching criteria.
The fieldwork for this study was the responsibility of the LRF centre and I had no
role in the data collection. Reports ofmy data analysis are presented in Chapter 7.
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4.3 Scotland and Newcastle Study of Hodgkins Disease (SNEHD):
SNEHD is a study of HD in adults residing in the Northern health region of England
and all of Scotland with the exception of the Western Isles and Dumfries and Galloway.
Eligible cases were those aged 16-74 years on 1/1/1993 with HD diagnosed 1/1/1993 to
31/3/1997 living in Newcastle/North Tyneside, Gateshead/South Tyneside, Cumbria,
Northumberland, Durham, Sunderland, and Cleveland FHSAs and Lothian, Greater
Glasgow, Argyll & Clyde, Borders, Fife, Forth Valley, Grampian, Highland, Tayside,
Lanarkshire, and Ayrshire & Arran health boards. Controls in 10 year age groups were
selected randomly from FHSA and health board lists (for more details of control selection
see Chapter 5). Controls that did not give consent or who could not be traced were replaced
with further random selections from the same GP practice based on the same sex and age-
group criteria.
The aim of the SNEHD study was to identify risk factor profiles for HD in total and
also for HD subgroups classified by age group at diagnosis and EBV in the tumour cells. The
fieldwork for this study was the responsibility of Dr. Freda Alexander in Edinburgh and a
team of six interviewers (of which I was one) and support staff. I was involved in the writing
of the sport and athletics section of the questionnaire (based on the research presented in
Chapter 2) and the piloting of the total questionnaire. I was responsible for the calculation of
control numbers and the administrative work involved in control selection and contact. I
analysed the results of general and family health sections with advice from Dr Alexander
(Chapter 8) and also the section on sport and athletics without advice from Dr Alexander
(Chapter 9).
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5 SNEHD Control Selection
5.1 SNEHD Control Number Calculation:
The age distribution of HD cases is bimodal (see Chapter 1) whereas the age
distribution of the general population is closer to a normal curve. Therefore, in order to take
account of this difference the number of controls required for SNEHD was to be frequency
matched with the number of cases by area (FHSA)/Health board), age group, and sex. To
estimate expected numbers 1 combined the data for HD registration for the last year data were
available by age and sex (1989 for England & Wales, 1990 for Scotland) with the populations
for the same years. This allowed the calculation of an approximate HD rate per 105for the UK
by age and sex (Table 5.1).
These rates were then applied to the most up-to-date population estimates available
for the SNEHD region (estimates for England provided by the Office Population Censuses and
Surveys, for Scotland by the General Registry Office for Scotland). Approximate expected
number of cases arising in the SNEHD region each year were calculated (Table 5.2).
Multiplying this annual number of cases by four (the planned number of years of the study)
gives a figure of around 630 expected HD cases. Thus, 630 controls would be required for
SNEHD.
The expected age distribution of the cases is shown in Table 5.3 and reveals evidence
of the bimodalitv of the distribution of HD and the greater frequency of males over female
cases. The expected age distribution of controls based on a standard calculation (630/N where
N is the number of people in each age/sex/area group) are also in Table 5.3. There are too
many female controls in all age groups over 24 years and not enough male controls to allow a
fine level of analysis. Thus, the aim of
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Table 5.1. Approximate rates ofHodgkiirs Disease in England & Wales and Scotland by 10-
year age group.
Age Group
Sex 15-24 25-34 35-44 45-54 55-64 65-74 TOTAL
Male 3.83 3.83 3.58 2.98 2.79 4.07 2.88
Female 3.53 2.29 1.66 1.12 1.69 2.35 1.88
Table 5.2. Approximate expected number of cases per year in the SNEHD study region by
10-year age group.
Age Group
Sex 16-24 25-34 35-44 45-54 55-64 65-74 TOTAL
Male 18.1 23.5 18.8 13.9 10.7 12.5 97.5
Female 15.9 13.9 8.7 5.3 7.0 9.1 59.9
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Table 5.3. Expected numbers of cases in the SNEHD region and the number of controls using
the original formula by 10-year age group.
Age Group
16-24 25-34 35-44
Sex Cases Controls Cases Controls Cases Controls
Male 72.4 58.4 94 76.5 75.2 64.9
Female 63.6 55.9 55.6 75.1 34.4 65.5
Age Group
45-54 55-64 65-74
Sex Cases Controls Cases Controls Cases Controls
Male 55.6 58 42.8 47.8 50 38.3
Female 21.2 58.7 28 51.6 36.4 48.4
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frequency matching the cases to the controls is not met by this basic calculation. The
distribution of controls, therefore, was adjusted to make sure that the frequency of controls in
each age/sex group was as close as possible. Once this adjustment was made the number of
controls required was very close to the expected number of cases.
However, a few further adjustments to the control numbers were made. Only 12
controls for Orkney and Shetland combined were required and these were randomly allocated
to Orkney or Shetland and to age/sex groups. It was decided that the number of selected
controls was too similar to the number of expected cases and to avoid the risk of having too
few controls recruited in any age/sex group due to refusals the number of controls in Scotland
was inflated by 15%. One year into the study Ayrshire and Arran was included. Therefore,
control numbers for Ayrshire and Arran were calculated by the same method as before. The
final number of controls required in each age/sex group after all the adjustments are shown in
Tables 5.4 (Scotland) and 5.5 (England).
Overall, the total number of controls needed for SNEHD was calculated to be 750.
5.2 Patient details:
Control information for England and Scotland came in different forms.
England:
Each Family Health Service Authority (FHSA) covered by the study (Cleveland,
Cumbria, Newcastle/North Tyneside, Gateshead/South Tyneside, Sunderland,
Northumberland and Durham) sent a tape with a 1 in a 100 random sample of patients from
their lists. Random numbers were then generated and controls were picked from the sample
until the required numbers in each age/ sex group had been filled. Random numbers also used
to generate a year of pseudo-diagnosis (1993-1996) for each control.
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Table 5.4. Total control numbers required for Scotland including 15% increase and Ayrshire
& Arran.
Age Group
I Sex 16-24 25-34 35-44 45-54 55-64 65-74 TOTAL
Male 57 75 60 44 32 37 305
J Female 53 42 28 20 24 25 192
Table 5.5. Total control numbers required for the North of England.
Age Group
Sex 16-24 25-34 35-44 45-54 55-64 65-74 TOTAL
Male 26 38 31 22 18 20 155
Female 24 20 14 12 12 16 98
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Scotland:
The method of extracting patient details in Scotland was different to that for England.
Random numbers were then used to calculate a date of pseudo-diagnosis (1993-1996). These
pseudo-diagnosis dates were applied to the overall control numbers giving the required
controls for each year of pseudo-diagnosis in each age/sex group in each health board. A
computer programme written by the Common Services Agency of the NHS in Dundee selected
patients at random from each health board list with specific details supplied from the study
centre (Edinburgh). Requests for controls were sent to each individual health board in
Scotland (Borders, Lothian, Lanarkshire, Argyll & Clyde, Greater Glasgow Health Board,
Fife, Forth Valley, Tayside, Grampian, Highland, Orkney, Shetland and later Ayrshire and
Arran) approximately every 3 months from March 1996 until the complement of controls was
filled. Control details were sent to Edinburgh and then mounted onto Excel.
Control Approaches:
The stages of contacting a potential control are shown in Figure 5.1. No control was
contacted without the permission of their GP. If the GP refused permission to contact the
control was replaced with a control of the same age/sex group from the same GP practice to
avoid geographical SES bias. (It was only possible to replace control refusals from the same
GP practice in Scotland as the format of the English data prevented this.) If the GP provided
information that the potential control was ineligible (dead, not aged 16-74 years, not born in
the UK, not mentally competent to perform the interview) the control was replaced with
another from the same age/sex group. If GPs did not reply in 2-3 weeks a reminder letter was
sent with a further letter 2-3 weeks after that if a reply had still not been received. GPs were
also contacted by telephone.
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Figure 5.1. Flow diagram of contact route for potential controls.
For definitions of bold text see Table 5.6
113
Once the GP had consented one of two types of letter were sent out to the potential
control. The SNEHD study compared two methods of approaching controls. One method was
more formal and was signed by Dr. Alexander (office contact), and the other was slightly
more friendly and informal and signed by the interviewer for that control's region (interviewer
contact). The two methods were assigned randomly. The design and conduct of this
randomised study was my responsibility. Simple randomisation could have been used, but by
chance this may lead to long runs of the same contact type. To avoid this and to ensure that
the number of controls in each contact group was fairly similar at all times block
randomisation was used with a block size of four. This ensures that of every four controls,
two would be contacted using the office letter and two with the interviewer letter. With two
possible letters (I interviewer contact; O office contact) and a block size of four there are six
possible combinations: OOII, OIOI, OIIO, IIOO, IOIO, and IOOI. The order of the block was
assigned using random numbers.
A potential control was given 2-3 weeks to reply to our letter, after which their
address was checked by telephoning or faxing the health board/FHSA in which they were
registered. If a telephone number was available an attempt was made by a research
interviewer to contact them by telephone. This was a quick method for getting a response
(positive or negative) from the potential control.
If the address was correct and telephone details were not available, a reminder letter
was sent (again from the interviewer or the office). If the potential control again did not reply
after a further 2-3 weeks a second reminder letter was sent out. After three letters in total most
people had replied. For those people who had not replied the interviewer for their area, where
feasible, made a visit in person (cold calling). If cold calling was unsuccessful the control was
coded 'No Response" on our database and treated as a refusal for replacement purposes.
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Every- effort was made to contact the potential control but controls could only be
traced if they were registered with a GP. If the patient had moved and not re-registered there
was no other way of contacting that person and they were entered on the database as 'No
Contact'.
5.3 Control Response Rate Methods:
Controls were contacted using the methods described above and assigned a code
depending on their response (Table 5.6). At the end of the study period characteristics of the
controls who agreed to take part (DONE) were compared with those who did not (all other
codes except INELIGIBLE). The first step was to analyse the proportion of positive responses
for first choice controls only and the total series (including replacements). As mentioned above
two methods of control contact were used to see if either had a better effect on control
response. Control response is also likely to affected by demographic variables (age, sex,
Carstairs index of address at contact, and country). The proportion of positive responses were
calculated with and without the inclusion of controls considered to be 'No Contact', as it
could not be confirmed that these controls were eligible. The proportions of positive case
responses are also given including and excluding 'No Contact'.
Once the proportion of positive responses had been calculated in subgroups based on
demographic variables and contact type more formal statistical methods were used to compare
those who agreed to take part with those who did not. Logistic regression analyses were
performed on the dependent variable YES/NO (i.e. control agreed to take part or not) using
the following explanatory variables: sex, area (England or Scotland), contact (Interviewer or
Office) (all dichotomous variables), age group (both as a trend and as 6 10 year categories),
Carstairs index (both as a trend and 7 categories). Univariate logistic
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GP CONTACT One or more letters sent to GP
GP CONSENT GP consents
GP DEAD GP reports control dead (INELIGIBLE)
GP REFUSAL GP refuses permission to contact
CTRL CONTACT Control approached 1
CTRL CONSENT Control consents, interview pending
CTRL DEAD Control found to be dead (INELIGIBLE)
CTRL REFUSAL Control refuses
DONE Interview done
INELIGIBLE Control dead, wrong age, not competent
NO CONTACT Not possible to find the potential control
NO RESPONSE Control address correct, no reply
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regression analyses were performed first. Those variables that were statistically significant
were then put in multivariate models.
5.4 Results:
The overall proportion of positive responses for cases and controls are shown in Table
5.7. It can be seen that they differ, with approximately 75% of eligible cases taking part
compared with less than 50% of first choice controls. Table 5.7 also makes it clear that the
number of cases and controls considered to be 'NO CONTACT" was different. Only 8 cases
(1.2%) were so categorised compared with 57 controls (7.7%). The proportion of male and
female cases that could not be contacted was approximately the same (7.7% and 7.4%
respectively). However, the proportion did vary by the age of the control. The majority of
controls who could not be contacted were in the younger age groups (age 16-24 and 25-34).
By age group the 'NO CONTACT" rates were: age 16-24 11.1%, age 25-34 10.1%, age 35-
44 6.8%, age 45-54 5.3%, age 55-64 3.1%, and age 65-74 yrs 4.0%. The youngest age
groups are more mobile and may be less likely to re-register with GPs.
The control positive response varied by sex, with women more likely to agree than
men (55.6% vs. 45.9%). This was not the case for cases with approximately equal proportions
of males and females agreeing to participate. When looking at positive responses by age the
youngest (age 16-24 years) and oldest (age 65-74 years) age groups were less likely to agree
to take part with the other age groups having similar rates. The cases had a smooth falling off
of proportion of positive responses with age. In the controls an interesting pattern is revealed.
The youngest males and the oldest females are the least likely to agree to take part (27.8% and
37.9% respectively). Indeed, the oldest age group is the only one in which the proportion of
positive female responses is lower then the male. This pattern was not seen for the cases.
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Table 5.7. Response rates for cases and first choice controls by demographic variables and
contact type.
Comparison Case (inc. 'No Case (not inc. Control (inc. Control (no inc
Contact) 'No Contact') 'No Contact') 'No Contact')
Total 493/666 (74.0) 493/658 (74.9) 340/739 (46.0) 340/682 (49.9)
Female 208/277 (75.1) 208/274 (75.9) 153/297 (51.5) 153/275 (55.6)
Male 285/389 (73.3) 285/384 (74.4) 187/442 (42.3) 187/407 (45.9)
Age 16-24 115/145 (79.3) 115/143 (80.4) 79/208 (38.0) 79/185 (42.7)
25-34 123/158 (77.8) 123/156(78.8) 76/149 (51.1) 76/134 (56.7)
35-44 71/87 (81.6) 71/85 (83.5) 49/118 (41.5) 49/110(44.5)
45-54 64/80 (80.0) 64/79 (81.0) 53/93 (57.0) 53/88 (60.2)
55-64 59/87 (67.8) 59/87 (67.8) 53/96 (55.2) 53/93 (57.0)
65-74 54/90 (60.0) 54/90 (60.0) 30/75 (40.0) 30/72 (41.7)
Male 16-24 64/8 1 (79.0) 64/79 (81.0) 27/107 (20.6) 27/97 (27.8)
25-34 69/90 (76.7) 69/90 (76.7) 48/95 (50.5) 48/83 (57.8)
35-44 45/57 (78.9) 45/55 (81.8) 31/81 (38.3) 31/74 (41.9)
45-54 41/53 (77.4) 41/52 (78.8) 33/61 (54.1) 33/56 (58.9)
55-64 42/55 (76.4) 42/55 (76.4) 29/54 (53.7) 29/54 (53.7)
65-74 21/40 (52.5) 21/40 (52.5) 19/44 (43.2) 19/43 (44.2)
Female 16-24 51/64 (79.7) 51/64 (79.7) 52/101 (51.5) 52/88 (59.1)
25-34 54/68 (79.4) 54/66 (81.8) 28/54 (51.9) 28/51 (54.9)
35-44 26/30 (86.7) 26/30 (86.7) 18/37 (48.6) 18/36 (50.0)
45-54 23/27 (85.2) 23/27 (85.2) 20/32 (62.5) 20/32 (62.5)
55-64 17/32 (53.1) 17/32 (53.1) 24/42 (57.1) 24/39 (61.5)
65-74 33/50 (66.0) 33/50 (66.0) 11/31 (35.5) 11/29 (37.9)
England 170/219 (77.6) 170/217 (78.3) 113/241 (46.9) 113/229 (49.3)
Scotland 323/447 (72.3) 323/441 (73.2) 227/498 (45.6) 227/453 (50.1)
Office letter NA NA 172/369 (46.6) 172/342 (50.3)
Intrviewr letter NA NA 168/370 (45.4) 168/340 (49.4)
Carstair's 1 NA NA 23/38 (60.5) 23/35 (65.7)
2 NA NA 34/68 (50.0) 34/58 (58.6)
3 NA NA 70/140 (50.0) 70/130 (53.8)
4 NA NA 68/133 (51.1) 68/124 (54.8)
5 NA NA 67/146 (45.9) 67/138 (48.6)
6 NA NA 42/106 (39.6) 42/96 (43.8)
7 NA NA 22/61 (36.1) 22/55 (40.0)
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There was little difference in the proportion of positive responses for cases or controls
by country (78.3% versus 73.2% and 49.3% versus 50.1% in England and Scotland
respectively). There was also little difference in the response generated by the two approach
letters. 50.3% of first choice controls w ho received the formal letter from Edinburgh agreed
to take part compared with 49.4% of controls who received the letter signed by an interviewer.
There was a decreasing likelihood of potential controls agreeing to take part with
lower socio-economic status (as assessed by Carstair's index of address from health board).
(Response by Carstair's index was not calculated for cases as postcode was missing for 379
(56.9%) of them.) The most affluent (Carstair's index 1) were the most likely to agree to take
part (65.7%) and the least affluent (Carstair's index 7) were the least likely (40.0%). This
socio-economic pattern was consistent across sexes and also for the type of contact letter
received. It was not consistent across countries. In Scotland the most and least affluent groups
were the most likely to agree to take part with the lowest response rates in the middle groups.
In England there was no consistent socio-economic pattern but the numbers in the
denominators were very small. It was not possible to say much about the effect of socio¬
economic status by age as. again, the denominator numbers were very small.
The results of the logistic regression analyses to find variables that predict a control's
willingness to take part are shown in Tables 5.8 (first choice controls) and 5.9 (total controls).
These results tend to support the observations of the response rates. When first choice controls
only are examined the significant predictors in univariate analysis were: Carstair's index (as a
trend, p=0.004), age group (as a categorical variable, p=0.005), and sex (p=0.014). The same
variables are also significant predictors for the total control scries. However, in this analysis
the area variable was also significant. This is not surprising
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Table 5.8. Results of regression models for variables affecting positive response (1st choice
only).
Model | -2Iogl diff dev df p
Univariate models
constant 1019.76 — — —
constant + SEX 1013.70 6.06 1 0.01
constant + CONTACT 1019.65 0.11 1 0.74
constant + AREA 1019.65 0.11 I 0.74
constant + AGRGROUP (trend) 1016.68 3.08 1 0.08
constant + AGRGROUP (categorical) 1002.98 16.78 5 0.005
constant + CARSTAIRS (trend)'1 948.82 8.18 1 0.004
constant + CARSTAIRS (categorical)3 947.163 9.839 6 0.13
Multivariate models
constant + AGE GROUP (cat) +
CARSTAIRS (trend)b
934.56 14.26 5 0.01
constant + AGE GROUP (cat) +
CARSTAIRS (trend) + AGE
GRP*CARSTAIRS interaction0
928.65 5.91 0 0.32
constant + AGE GROUP (cat) +
CARSTAIRS (trend) + SEXC
924.39 10.17 1 0.001
constant + AGE GROUP (cat) +
CARSTAIRS (trend) + SEX + AGE
GRP*SEX interaction*1
914.08 10.31 5 0.07
constant + AGE GROUP (cat) +
CARSTAIRS (trend) + SEX +
CARSTAIRS*SEX interaction*1
923.55 0.84 1 0.33
a. Compared with model of constant only for those not missing Carstair's index base
equals 957.00. Differences are from this base rather than 1019.76.
b. Compared with model of constant + CARSTAIRS (trend) base of 948.82.
c. Compared with model of constant + AGE GRP (cat) + CARSTAIRS (trend).
d. Compared with model of constant + AGE GRP (cat) + CARSTAIRS (trend) + SEX.
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Table 5.9. Results of regression models for variables affecting positive response (Total series)
Model -21ogl difif df P
Univariate models
constant 1713.673 — — —
constant + SEX 1702.442 11.231 1 0.0008
constant + CONTACT 1713.668 0.005 1 0.94
constant + AREAb 1708.913 4.759 1 0.03
constant + AGRGRP (trend) 1712.390 1.282 1 0.26
constant + AGRGRP (categorical) 1700.150 13.522 5 0.02
constant + CARSTAIRS (trend)'1 1590.512 7.733 1 0.005
constant + CARSTAIRS (categorical)1 1589.165 9.079 6 0.17
Multivariate models
constant + AREA + AGE GRP (cat) + 1569.54 9.11 5 0.11
CARSTAIRS (trend)b
constant + AREA + AGE GRP (cat) + 1563.96 5.59 5 0.35
CARSTAIRS (trend) + AGE
GRP*CARSTAIRS interaction0
constant + AREA + AGE GRP (cat) + 1551.94 17.61 1 <0.0001
CARSTAIRS (trend) + SEXC
constant + AREA + AGE GRP (cat) + 1535.34 16.60 5 0.005
CARSTAIRS (trend) + SEX + AGE
GRP*SEX interaction'1
constant + AREA + AGE GRP (cat) + 1551.60 0.33 1 0.56
CARSTAIRS (trend) + SEX +
CARSTAIRS*SEX interaction11
a. Compared with model of constant only for those not missing Carstair's index base
equals 1598.24. Differences are from this base rather than 1713.67.
b. Compared with model of constant + CARSTA1RS (trend) base of 1590.51.
c. Compared with model of constant + AGE GRP (cat) + CARSTA1RS (trend).
d. Compared with model of constant + AGE GRP (cat) + CARSTA1RS (trend) + SEX.
121
as there were many more controls selected for Scotland. (Area was kept in the multivariate
models as it had been statistically significant, although meaningless in terms of prediction). In
the total series age group does not result in a statistically significantly better fitting model
when added to a model including Carstair's index and area. However, sex does have a
statistically significant result. Of the statistically significant individual variables the only
statistically significant interactions were for age group and sex in the total series (p=0.0053).
The interaction of age group and sex was almost statistically significant when looking at the
first choice controls alone (p=0.07).
5.5 Discussion:
The term response rate is generally used to show the proportion of people agreeing to
take part in a study, although this is not strictly speaking a rate. However, the proportion of
positive responses will be referred to as a response rate for this discussion. The calculation of
response rates is important as they provide an estimate of the proportion of the targeted
population who participate (Groves & Lyberg, 1988). The success of any survey depends on
achieving a high response rate. Thus, the biggest threat to the validity of a case-control study
is non-participation of subjects and the resulting potential for selection bias (Austin et al,
1994). Although the cases have the condition of interest, it is the controls that constitute the
key methodological part of the case-control method (Janerech et al, 1979).
Cases and controls should be "representative of the same base experience"
(Meittenen, 1985). The base is the set of people in which diseased subjects become cases.
Typically in chronic disease epidemiology membership of the base is dynamic, in the sense
that the subject may be in the base at certain times and out of it at other times (Wacholder et
al, 1992). The simplest way to satisfy this principle is to choose a random sample of
individuals from the same source as the cases. In simple random sampling controls are
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selected randomly from the base. Therefore, each eligible member has the same probability of
selection as a control, and the sampling is independent i.e. the presence of a specific subject in
the sample does not make the presence of any other more or less likely. This was the original
method used for SNEHD but it did not result in a frequency-matched distribution of cases and
controls. SNEHD control numbers were calculated using stratified sampling and frequency
matching, the base being sub-divided up into strata determined by age, sex, and area with the
sampling fraction allowed to vary across strata.
Participation rates in case-control studies are frequently low with the different results
for cases and controls, as is the case for SNEHD. Low participation rates will create selection
bias if participants and non-participants have a different exposure distribution and if
participation rates differ for cases and controls (Austin et al, 1994). The potential for such
bias increases in relation to the proportion of non-participants. This can be a great problem
when, as in SNEHD, population controls are used. However, bias can occur even if the case
and control rates are similar, since the reasons that cases and controls agree to take part, or
refuse to, may differ and may relate to the exposure of interest (Austin et al, 1994).
Hartgc et al (1984) reported the control response rate for four case-control studies in
the United States that used random digit dialling (RDD). The household screening response
rates were 80%, 86%, 88%, and 89%. The corresponding subject interview response rates
were 78%, 72%, 84%, and 78%. The overall response rate is the product of these two values
and ranged from 62-74%. These overall response rates are quite low. Stech (1981) has
documented a considerable increase in refusal rates 1952-79 in survey research. Several
studies conducted in the mid-1980s have reported even lower response rates. The Male Breast
Cancer Study (Thomas et al, 1992) reported a 65% response rate for RDD screening and a
69% response rate for the field phase, giving an overall response rate of 45%. In the Oral and
Pharyngeal Study (Blot et al, 1988) the response rate for the screening phase of RDD was
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79% and the response rate for the field phase was 73%, giving an overall response rate of
57%.
Slattery et al (1995) surveyed 102 epidemiologists and biostatisticians involved in
cancer epidemiology research. 61% replied to queries about response rates. Despite the
method of response rate calculation, use of incentives, and the length of the interview, over
60% of the researchers who replied believed that it was more difficult to obtain high response
rates in 1993 compared to 5 years previously.
Low control participation rates are a particularly serious threat to validity. The
reasons for which controls agree to participate are unclear, but may differ to those of cases.
Some may be motivated by an increased sense of altruism. Some studies have shown that non-
respondents are less healthy than respondents are (Doll & Hill, 1964; Criqui et al, 1978), and
smoke more (Criqui et al, 1978). Another study has found that respondents were more likely
to have a history of screening procedures (Olsen ct al, 1992). Non-respondents in telephone
surveys are frequently less educated, lower in social class and older than respondents (O'Neil,
1979). Austin et al (1981), as part of a heart disease risk factor program, collected
information from subjects who refused to participate as well as those who did. They
demonstrated that the most common response pattern was that subjects with risk factors
tended to participate more often than those without risk factors, and subjects with disease
tended to participate less often than those without.
There arc not only problems associated with people who refuse to participate but also
with those who cannot be contacted for any reason (labelled as 'NO CONTACT' in SNEHD).
Thus, some of the non-response may be due to letters that never reach study subjects rather
than non-participation. To maximise response rates it is important to try as hard as possible to
find subjects. In general, there is a clear danger of bias resulting from less successfully tracing
migrant subjects, because migration and health are related. In British mortality data it has
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been shown that those who move longer distances have lower mortality, suggesting a 'healthy
migrant' effect not unlike the 'healthy worker' effect (Fox & Goldblatt, 1982). When accurate
addresses arc available for each study subject investigators can be reasonably confidant that
letters that are not returned are due to non-response on the part of study subjects (Sandler &
Holland, 1990). However, if an address list is no longer current the investigator has no
assurance that the letter has reached the intended subject, unless it is returned. High rates of
mobility, divorce, unemployment, and inaccurate data sources can combine to render follow-
up costly and uncertain (Alderman, 1996).The people who are lost may or may not be eligible
to take part in the study. In SNEHD everything possible was done to trace non-responders
including telephoning, if possible, checking addresses with health boards and checking health
board registrations. However, if a potential control had moved and failed to re-register with a
new GP there was no further way of contacting them.
To have a response rate that reflects a representative sample of the population it is
necessary to include individuals who require more effort to locate as well as those who are
easily located. However, in general those with unknown eligibility are often excluded from the
denominator of any calculations, leaving what Slatterv et al (1995) have described as a 'co¬
operation rate' rather than a response rate. This was the main reason for calculating the
SNEHD response rates twice, once including 'NO CONTACT' and once without.
Attention has focused on methods for encouraging potential controls to agree to take
part. A potential mechanism to improve study response is the use of incentives. Holt et al
(1991) found that 134 of 177 women who had originally refused to take part in a study agreed
to do so after re-contact and the offer of $10 for their time. However, the use of incentives
would hugely increase the cost of studies and is not frequently used in the UK and has
possible ethical problems.
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The conduct of population-based case-control studies requires special care to make
sure that response rates are high and comparable for cases and controls (West et al, 1984).
The need to assess comparability and to minimise misclassification, non-response and
observation bias is clear, but the techniques for doing so are not. The problem is unresolvable
short of obtaining information on the exposure distribution of the non-participants, an
impossible task in most situations. Only a few variables were available for the SNEHD
controls to compare those that did agree to take part with those that did not. Response rate
differed by age, sex, and socio-economic status (based on the Carstair's index). These factors
can be adjusted for in the analysis, but these are only basic things. In the case of SNEHD
some ethical committees requested the removal from control literature of anything which might
'put pressure' on the potential. The study did as much as possible to get people to take part
and trace those who had moved but even so had quite poor control response rates.
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6 Seasonality ofHodgkin's Disease.
6.1 Introduction:
Speculation about the possible infectious nature of Hodgkin's Disease (HD) began
soon after its original description by Thomas Hodgkin in 1832. There is a variety of
evidence that HD could have an infectious origin including clustering investigations, HD's
relationship with EBV, and the seasonal presentation of HD. The majority of these were
discussed in detail in chapter 1.
If the aetiology of HD involves recent exposure to an infectious agent or allergens
one might expect a seasonal variation in onset, depending on the length and variability of
the latent period and the method of transmission. However, little attention has been paid to
the observation first made by Cridland in 1961 that there is seasonal variation in the
incidence of HD. Although, some investigators have reported fluctuations in onset by
month, the peak being in the northern hemisphere late winter/ early spring (Cridland, 1961;
Innes & Newell, 1961; Fraumeni & Li, 1962; Newell et al, 1985; Neilly et al, 1995a & b:
Douglas et al, 1996; Westerbeek et al, 1998; Douglas et al, 1998), others have not confirmed
this (Bjelke, 1969; Modan et al, 1969; Newell, 1972).
This study uses data from the Danish, Finnish, Norwegian and Swedish cancer
registries in order to search for seasonal patterns in the occurrence ofHD over 1, 2, 3, and 4
years. This is the first study to look at seasonal effects over a period greater than a year.
This may be important because several viruses have epidemic patterns repeating over
periods of several years.
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6.2 Methods:
Source of cases Incident HD case data for Denmark, Finland, Norway, and Sweden
were supplied by the national cancer registries. For each case of HD the month and year of
birth and the month and year of diagnosis was provided; from these the age at diagnosis
could be calculated. The dates of diagnosis varied by country: Denmark provided high
quality data for 1978-92; Finland 1953-93; Norway 1980-92; and Sweden 1980-91.
For each country cases aged 0-34 years were used as a single series and in later
analyses divided into two (0-14, 15-34 years) or three (0-9, 10-19, 20-34 years) age groups.
This second method was used because some authors have found that the difference between
paediatric and young adult HD in terms of EBV-association focuses on children under age
10 (Razzouk et al, 1997).
Statistical and Computational Analysis A separate Excel spreadsheet was
constructed for each country to record the distribution of observed HD cases by month of
diagnosis. Standard age-specific reference rates were computed using rates taken from
Parkin et al (1992); these were the average of the rates for each of the four countries in each
of seven age groups: 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34 years. Expected numbers
of cases for each month in each country were calculated by applying the reference rates to
person-years at risk derived from census data (Denmark, Norway, Sweden) or annual
population estimates for the whole period (Finland). The spreadsheet was completed with
values for the calendar year and sine and cosine values corresponding to 1, 2, 3, and 4 year
cycles i.e. one year = 360°/n (n=l, 2, 3, 4). Each month is then assigned an angular value
e.g. for a one year cycle January=0°, February=30° ... December=330°. Three separate
spreadsheets were constructed: one with the total observed and expected cases of HD; one
with the cases divided into two age groups (0-14, 15-34 years); and one with the cases
divided into three age groups (0-9, 10-19, 20-34 years). A total series was also constructed
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with the records from Denmark, Finland, Norway, and Sweden combined and aligned across
calendar year.
The statistical model for the cyclic pattern over n years was log (O/E) = (sin + cos)n
+ s where 8 is the random error. Seasonal analysis of monthly frequencies of disease
diagnosis was performed using Poisson regression with the link function = log. The
dependent variable was the observed number of cases of FID, the explanatory variables were
annual trend, sex, age group and the sine and cosine values for 1, 2, 3, and 4 year cycles (sin
+ cos)n (n=l,2,3,4)- (F°r example, (sin + cos)i is shorthand for entering sine and cosine
values for a one year cycle into the regression model.) The offset was the expected number
of cases. This was implemented using SAS 6.11 PROC GENMOD. Univariate analyses
were used to find the model that best explained the distribution of observed cases using
analysis of deviance with asymptotic chi-square distribution applied to the difference in
deviances in nested models. The comparison involved the addition of (sin + cos)n to the null
model of trend+sex. The differences in deviance were always tested on 2 degrees of
freedom. (Sin + cos)n were always included in the models as a pair rather than individually
since no prior hypothesis specified the zero of the cycle. Once the best model was found the
sine and cosine coefficients could be used to calculate where the series peak lay (the
acrophase) and also the magnitude of the seasonal fluctuation, the amplitude (Figure 6.1).
The effect age group was then investigated as well as the interaction of sex and age
group with (sin + cos)n for all four countries individually and the total series.
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Figure 6.1: Example seasonal curve showing the amplitude A and the position of the peak of





Between 1978-92 there were 802 registrations of HD in Denmark, 773 registrations
1980-91 in Sweden, 1733 registrations 1953-93 in Finland, and 487 1980-92 in Norway.
These data can be seen in Tables 6.1 to 6.4. Data from each country has the young adult
peak seen usually in HD and the rates are similar to those found in Parkin et al (1992).
The results of the step up models for the four countries and the total series can be
seen in Tables 6.5 to 6.9. For Denmark the best model was that with (sin + cos)j included;
indeed this was the only seasonal effect. In Finland, (sin + cos)j was again statistically
significant, as were (sin + cos)2- (Sin + cos)4 was statistically significant in Norway while
Sweden was the only country not to show any evidence of seasonality. When the four
countries were analysed together there was statistically significant evidence of a one-year
cycle but not a two, three or four year effect.
More detailed results of the Poisson regressions for the one year cycle are in Table
6.10. In both Denmark and Finland (sin + cos)] variables made a statistically significant
improvement to the model. For Denmark the peak incidence was 0 = 27.9° and for Finland
at 0 = 25.7° i.e. in late January for both. Neither Norway nor Sweden showed a statistically
significant result for (sin + cos)i. However, the total series did, the likelihood ratio test
being highly statistically significant (p<0.001) with peak towards the end of January (0 =
29.0°). The country-seasonality figure shows the result of adding country*(sin + cos)j
interaction terms to the total model. There was no statistically significant interaction,
therefore the data are consistent with patterns in all the countries being the same. (No
interaction test was performed for (sin + cos)2i3?4 as these main effects were not
statistically significant in the total series). The amplitude (extent of seasonal
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Table 6.1. Hodgkin's Disease - Denmark 1978-92
Nos. Rates per 10^ population
Age Male Female Total % total Male Female Total M/F
0-4 4 0 4 0.50 0.16 0.00 0.08 oo
5-9 8 4 12 1.50 0.31 0.16 0.24 1.94
10-14 28 20 48 6.00 1.01 0.75 0.88 1.35
15-19 81 44 125 15.6 2.80 1.60 2.20 1.75
20-24 118 93 211 26.3 3.86 3.21 3.54 1.20
25-29 117 97 214 26.7 4.00 3.49 3.75 1.15
30-34 123 65 188 23.4 4.41 2.44 3.43 1.81
Total 479 323 802 100.0 2.36 1.66 2.02 1.42
Table 6.2. Hodgkin's Disease - Sweden 1980-91
Nos. Rates perlO^5 population
Age Male Female Total % total Male Female Total M/F
0-4 4 0 4 0.50 0.13 0.00 0.08 oo
5-9 16 8 24 3.10 0.51 0.27 0.39 1.89
10-14 33 27 60 7.80 1.00 0.85 0.93 1.18
15-19 87 69 156 20.2 2.47 2.05 2.26 1.20
20-24 83 101 184 23.8 2.33 2.97 2.65 0.78
25-29 106 74 180 23.3 2.95 2.16 2.56 1.36
30-34 99 66 165 21.3 2.66 1.86 2.26 1.44
Total 428 345 773 100.0 1.72 1.45 1.59 1.21
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Table 6.3. Hodgkin's Disease - Finland 1953-93
Nos. Rates per 105 population
Age Male Female Total % total Male Female Total M/F
0-4 11 3 14 0.81 0.15 0.04 0.10 3.75
5-9 44 19 63 3.64 0.58 0.26 0.42 2.23
10-14 62 50 112 6.46 0.78 0.65 0.72 1.20
15-19 147 141 288 16.6 1.85 1.84 1.85 1.01
20-24 243 163 406 23.4 3.11 2.18 2.65 1.43
25-29 266 164 430 24.8 3.58 2.29 2.94 1.56
30-34 248 172 420 24.2 3.46 2.48 2.97 1.40
Total 1021 712 1733 100.0 1.93 1.39 1.66 1.39
Table 6.4. Hodgkin's Disease - Norway 1980-92
Nos. Rates per 10^ population
Age Male Female Total % total Male Female Total M/F
0-4 1 1 2 0.40 0.06 0.06 0.06 1.00
5-9 5 3 8 1.60 0.28 0.17 0.23 1.65
10-14 17 16 33 6.80 0.86 0.84 0.85 1.02
15-19 41 39 80 16.4 1.91 1.91 1.91 1.00
20-24 81 57 138 28.3 3.76 2.78 3.27 1.35
25-29 71 49 120 24.6 3.37 2.45 2.91 1.38
30-34 69 37 106 21.8 3.30 1.87 2.59 1.76
Total 285 202 487 100.0 1.93 1.44 1.69 1.34
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Table 6.5. Univariate analysis of cyclic pattern: Denmark.
Model no. Factors add. Compared Diff in dev. Diff in df P ~~1
1 (sin + cos)j trend, sex 7.27 2 0.026
2 (sin + cos)2 trend, sex 4.03 2 0.133
3 (sin + cos)3 trend, sex 1.26 2 0.533
4 (sin + cos)4 trend, sex 4.02 2 0.134
Table 6.6. Univariate analysis of cyclic pattern: Finland.
Model no. Factors add. Compared Diff in dev. Diff in df P
1 (sin + cos)i trend, sex 27.01 2 p<0.001
2 (sin + cos)2 trend, sex 9.12 2 0.011
3 (sin + cos)3 trend, sex 2.04 2 0.361
4 (sin + cos)4 trend, sex 1.57 2 0.456
Table 6.7. Univariate analysis of cyclic pattern: Norway.
Model no. Factors add. Compared Diff in dev. Diff in df P n
1 (sm + cos)] trend, sex 3.34 2 0.188
2 (sin + cos)2 trend, sex 3.92 2 0.141
3 (sin + cos)3 trend, sex 3.11 2 0.211
4 (sin + cos)4 trend, sex 14.81 2 p<0.001
Table 6.8. Univariate analysis of cyclic pattern: Sweden.
Model no. Factors add. Compared Diff in dev. Diff in df P
1 (sm + cos)i trend, sex 1.32 2 0.517
2 (sin + cos)2 trend, sex 1.10 2 0.577
3 (sin + cos)3 trend, sex 2.03 2 0.362
4 (sin + cos)4 trend, sex 0.28 2 0.869
Table 6.9. Univariate analysis of cyclic pattern: Total series.
Model no. Factors add. Compared Diff in dev. Diff in df P+
1 (sin + cos)j country,
trend, sex
27.47 2 p<0.001
2 (sin + cos)2 country,
trend, sex
3.51 2 0.173
3 (sin + cos)3 country,
trend, sex
4.35 2 0.114




Table 6.10. Results of one-year seasonality analysis.
Regression coefficient (95% CI) Statistical testing Interpretation

























27.47 p<0.001 29° 12.1%
Country*seasonality interaction 0.10>p>0.05
a. dev = difference in deviance v. trend+sex model, except for total = v. country+trend+sex.
b. on 2 degrees of freedom (= difference in degrees of freedom v. trend+sex model, except
for total = v. country+trend+sex.)
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variation) for Denmark, Finland, and the total series were 13.5%, 17.7% and 12.1%
respectively (Figures 6.2-6.5). Thus, while there is statistically significant evidence of
seasonal presentation of FID, the curve is quite shallow.
Due to the statistical significance of the results of the one year cycle for
presentation ofHD in the total dataset, without statistically significant evidence of between-
country heterogeneity, patterns of 2, 3, and 4 year cycles were calculated again adjusted for
one year (Tables 6.11-6.13). Finland was the only country to show statistically significant
evidence of a two-year cycle. (Sin + cos)3 was not statistically significant in any of the
countries studied or the total series. Norway showed statistically significant evidence of a
four-year cycle ofHD presentation persisting after adjustment.
A step-down model process was applied to make more parsimonious models
containing (sin + cos)n adjusted for age, trend and sex with results in Table 6.14. The
process of finding the best model for Finland was the most complicated, as the data showed
independent evidence of both one and two year seasonality. The best model consisted of
both trend and sex, (sin + cos)12 and an interaction term of trend and sex. Once the
seasonal pattern of HD presentation had been analysed an attempt was made to find out if
the seasonal/cyclical pattern was different by sex or age group. Results are in Tables 6.15-
6.20. Analyses were performed for Sweden because of the significant seasonality results
observed for the other countries. The Swedish data showed the only significant interaction
with age group and the seasonal effect was limited to those cases aged 10-19 years. This
significant result may only be occurring by chance as there was no statistically significant
evidence of seasonality in the original Swedish data.
While the seasonal effect did not interact significantly with age group, the seasonal
effects could more easily be ascribed to separate age groups. In Denmark,
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Figure 6.2: Hodgkin's Disease in Denmark 1978-92. On the vertical axis the monthly data















Figure 6.3: Hodgkin's Disease in Finland 1953-93. On the vertical axis the monthly data
given as a percentage above and below the mean. The horizontal axis is in months.
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Figure 6.4: Hodgkin's Disease in Norway 1980-92. On the vertical axis the monthly data are
given as a percentage above and below the mean. The horizontal axis is in months.
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Figure 6.5: Hodgkin's Disease in Sweden 1980-91. On the vertical axis the monthly data are
given as a percentage above and below the mean. The horizontal axis is in months.
oSbjuoojoj
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Table 6.11. Results of two-year seasonality analysis (after adjustment for one year).
Regression coefficient (95% CI) Statistical testing


























a. dev = difference in deviance trend+sex +sinl+cosl+sin2+cos2 v. trend+sex+sinl+cosl
model, except for total = v. country+trend+sex+sinl+cosl.
b. on 2 degrees of freedom ( = difference in degrees of freedom trend+sex
+sinl+cosl+sin2+cos2 v. trend+sex+sinl+cosl model, except for total = v.
country+trend+sex+sinl+cosl.)
Table 6.12. Results of three-year seasonality analysis (after adjustment for one year).
Regression coefficient (95% CI) Statistical testing


























a. dev = difference in deviance trend+sex +sml+cosl+sm3+cos3 v. trend+sex+sinl+cosl
model, except for total = v. country+trend+sex+sml+cosl.
b. on 2 degrees of freedom (= difference in degrees of freedom trend+sex
+sinl+cosl+sm3+cos3 v. trend+sex+sinl+cosl model, except for total = v.
country+trend+sex+sin 1+cos 1.)
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Table 6.13. Results of four-year seasonality analysis (after adjustment for one year).
Regression coefficient (95% CI) Statistical testing


























a. dev = difference in deviance trend+sex +sinl+cosl+sin4+cos4 v. trend+sex+sinl+cosl
model, except for total = v. country+trend+sex+sml+cosl.
b. on 2 degrees of freedom (= difference in degrees of freedom trend+sex
+sinl+cosl+sin4+cos4 v. trend+sex+sinl+cosl model, except for total = v.
country+trend+sex+sin 1+cos 1.)
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Table 6.14. Univariate analysis to test for the significance of sex and trend.
Country Model no. Factors add. Compared Diff in dev Diff in df P
Denmark 1 trend, (sin + cos)] 0.27 1 NS
2 sex, (sin + cos)] 0.02 2 NS
3 trend, sex (sin + cos)] 1.46 3 NS
Finland 1 trend (sin + cos)] 3.51 1 0.061
2 sex (sin + cos)] 0.11 2 NS







6 trend*sex trend, sex,
(sin + cos)]
9.61 1 0.002
Norway 1 trend, (sin + cos)4 0.004 1 NS
2 sex, (sin + cos)4 0.18 2 NS
3 trend, sex (sin + cos)4 0.50 3 NS
Swedena 1 sex trend 6.84 1 0.009
2 trend sex 9.47 2 0.009
3 (sin + cos)] trend, sex 1.32 2 NS
Total 1 sex country 0.00 1 NS











NS (not statistically significant) = p>0.10
a. No effect of (sin + cos),, in Sweden.
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Table 6.15. Multivariate analysis: main effect of sex and interaction of sex with cyclic
patterns.
Country Factors add. Compared Diff in dev Diff in df P
Denmark sex (sin + cos)i 0.02 2 NS
*sex (sin + cos)j,
sex
0.12 2 NS





Norway sex (sin + cos)4 0.18 2 NS
*sex (sin + cos)4,
sex
0.14 2 NS
Sweden 1) *sex 1) trend,sex,
(sin + cos)i
0.5 2 NS
2) *sex 2) trend,sex,
(sin + cos)2
0.66 2 NS











NS (not statistically significant) = p>0.10
*sex = interaction of cyclic pattern with sex.
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Table 6.16. One-year seasonality by sex.
Regression coefficient (95% CI) Interpretation
Country sex sin cos peak amp%
Denmark Male 0.052 (-0.08-0.18) 0.111 (-0.02-0.24) 25.70 12.3
Female 0.081 (-0.07-0.24) 0.132 (-0.02-0.29) 31.50 15.5
Finland"1" Male 0.117 (0.03-0.20) 0.149 (0.06-0.24) 38.10 18.9
Female 0.029 (-0.08-0.13) 0.180 (0.08-0.29) 8.80 18.2
Norway Male -0.012 (-0.18-0.15) 0.126 (-0.04-0.29) 275.40 12.7
Female 0.037 (-0.16-0.23) 0.104 (-0.09-0.30) 19.3° 11.0
Sweden Male 0.031 (-0.10-0.17) -0.008 (-0.14-0.13) 104.40 3.2
Female 0.062 (-0.09-0.21) -0.074 (-0.22-0.08) 140.00 9.7
Total Male 0.068 (0.01-0.13) 0.607 (0.55-0.67) 6.30 61.1
Female 0.045 (-0.02-0.11) 0.103 (0.03-0.17) 23.50 11.2
(none of the interactions of seasonality with sex are significant on 2 df, see Table 15)
+ trend included in model
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Table 6.17. Multivariate analysis: age as mam effect and interaction of age in two groups (0-
14, 15-34 years) with cyclic pattern (*age).
Country Factors add. Compared Diff in dev Diff in df P
Denmark age (sin + cos)j 0.02 1 NS
*age (sin + cos)j,
age
0.68 2 NS











Norway age (sin + cos)4 0.19 1 NS
*age (sin + cos)4,
age
0.65 2 NS
Sweden 1) age 1) trend,sex,
stnl, cosl
0.002 1 NS
1) *age 1) trend,sex,
(sin + cos) j,
age
0.9 2 NS
2) age 2) trend,sex,
(sin + cos)2
0.002 1 NS




3) age 3) trend,sex,
(sin + cos)4
0.002 1 NS












NS (not statistically significant) = p>0.10
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Table 6.18. Multivariate analysis: age as main effect and interaction of age in three groups
(0-9, 10-19, 20-34 years) with cyclic pattern (*age).
Country Factors add. Compared Diff in dev Diff in df P
Denmark age (sin + cos)] 0 2 NS
*age (sin + cos)],
age
3.24 4 NS











Norway age (sin + cos)4 0.18 2 NS
*age (sin + cos)4,
age
2.91 4 NS
Sweden 1) age 1) trend,sex,
(sin + cos)]
0.002 2 NS




2) age 2) trend,sex,
(sin + cos)2
0.22 2 NS




3) age 3) trend, sex,
(sin + cos)4
0.002 2 NS













NS (not statistically significant) = p>0.10
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Table 6.19. One-year seasonality by age group at two levels.
Regression coefficient (95% CI) Interpretation



















































(none of the interactions of seasonality with age group are significant on 2 df, see Table
6.17)
148
Table 6.20. Main effect of age in three groups and interaction of age group with one-year
seasonality.
Regression coefficient (95% CI) Interpretation












































































(none of the interactions of seasonality with age group are significant on 2 df, see Table
6.18)
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Finland, and the total series the effects of (sm + cos)i are limited to the older age group (age
15-34 years). In these countries, as well as Norway, the peak of the curves in the older age
group are all within January (0-3()0) while peaks for the 0-14 years age group are at totally
different times of the year (April for Denmark and the total series, May for Finland).
Norway and Sweden show no evidence for any seasonal effect being limited to a particular
age group. When the data is divided into three age groups there is again some evidence that
the seasonal effect is limited to the young adults in Denmark, Finland, and the total series.
In these countries the peak in the 20-34 years age group is again January.
6.4 Discussion:
As with many other epidemiological data at a national level covering many years,
involving many reporting centres there may be weaknesses in the quality of the data used in
the analyses presented here. The figures on HD for the four countries were collected over
different time periods and reporting and diagnostic criteria may have changed during this
time, especially in Finland as the data from this country covers a longer time period (40
years) tnan the other countries (10 years). Alexander et al (1989) reported the results of
cross-checking 1986 notifications of haematopoetic cancers from Yorkshire, Trent and
South West regional cancer registries received by the Leukaemia Research Fund (LRF) in
October 1987 against LRF registrations for 1986. The cancer registry only contained 56.8%
of the total HD registrations within 9 months. Since an important source of data for the
registries is death certificates it is likely that their ascertainment will be less good for
cancers with low mortality rates e.g. HD. However, in the context of cancer registration
Alexander et als' time period of 9 months is a short one. The Office of Population, Censuses
and Surveys (OPCS) did not publish data on 1971 registrations until 1978; more recently
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this time gap has been reduced to 3 years. The data for this study goes back to 1993 and,
therefore, should be reasonably complete.
The data used here are for children and young adults (age 0-34 years) and not the
older cases (age 50+ years). Therefore, changes in diagnosis over time which mean that
cases that may previously been classified as HD may now be classified as NHL in the 50+
age group could not affect these data.
Month of histologic confirmation should be considered the most objective indicator
of disease onset and this is the data used in the analysis presented here and the majority of
studies. Onset of symptoms can vary according to the individual symptoms and, therefore,
have a large subjective component involving recall and other factors. The date of first
symptom is much weaker (Douglas et al, 1998). In the analysis in this chapter the date used
was that of HD registration which would normally approximate closely to histologic
confirmation.
The seasonal presentation of HD cases from the Scandinavian cancer registries has
been analysed using formal statistical methodologies. However, this is not always the case
for studies of this question. Seven of thirteen studies published (Table 6.21) have only
described the pattern of presentation of HD. More recent studies have made use of two
methods of analysis: Edward's (1961) and cosinor analysis.
Edward's (1961) method used a square root transformation of the monthly
frequencies of disease incidence to quantify the degree of cyclic variation. The degree of
cyclic trend is based on the ratio of the peak annual frequency to the lowest annual
frequency, estimated from a fitted sine curve. The time of year that the peak occurs can be
estimated as well.
151
Table 6.21. Studies investigating the seasonal presentation of Hodgkin's Disease.
Author Cases Test Age Peak P
Cridland (1961) 106 None NA Dec NA
(England)
Innes & 104 None NA Jan NA
Newell (1961)
(Scotland)
Fraumeni & Li 314 None <15 Nov/Dec NA
(1962) Dec/Jan NA
(USA)
Bjelke (1969) 820 None All NA NA
(Norway)
Modan et al 204 No All Jun <0.01
(1969) details
(Israel)
Newell (1972) 282 None <40 Feb/Apr/Oct NA
(USA) 276 >40 Sep NA
Bogger-Goren et 21 None 2.5-14.5 NA NA
al (1983)
(Israel)
Alderson 737 Edwards 1961 All May/Jun 0.005>p>
& Nayak (1971) 0.001
(England)
Newell et al 117 Edwards 1961 0-14m Mar NS
(1985)
(USA) 83 0-14f Oct NS
981 15-39m Feb 0.002
702 15-39f Feb NS
1057 >40m Mar NS
767 >40f Oct NS






Table 6.21 (cont.). Studies investigating the seasonal presentation ofHodgkin's Disease.
Author Cases Test Age Peak P
Neilly et al 446 Costnor analysis <40m Feb <0.05
(1995a &b)
(UK) 350 <40f Mar <0.05
327 >40m Feb NS
216 >40f Apr NS
Douglas et al 1580 Cosinor analysis <40tot Feb/Mar <0.05
(1996)
(ScoTand) 882 <40m Jan/Feb <0.05
697 <40f Mar/Apr <0.05
1864 >40tot May NS
983 >40m Apr NS
881 >40f Jun NS
Douglas et al 2959 Cosinor analysis 0-79 Apr 0.063
(1998)
(England) 1260 0-79 NS Mar 0.009
1894 0-44tot Mar NS
1098 0-44m Feb NS
796 0-44f Mar NS
1066 45-79tot May NS
654 45-79m Mar NS
410 45-79f Apr NS
NS (not statistically significant) = p>0.10
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For cosinor analysis the year length is considered to be 360° and the mid-point of
each month of the year is assigned an angular value t, for January (15°) through to
December (345°). In order to establish the presence of a seasonal presentation in the data a
cosinor model of the form Y = Po + Pjsin(t) + P2Cos(t) + s is fitted, where s is random
error. Cosinor analysis also gives the angular position in the year (converted to the nearest
month) where the fitted regression line has its highest value. The methods used in the
analysis presented here is very similar to cosinor analysis in that both fit a function for (sm
+ cos) in the regression model.
The earliest reports of a seasonal presentation of HD go back to 1961 and generally
just described the seasonal pattern of presentation of HD. In 1961 Cridland looked for a
seasonal pattern in the clinical onset of HD. In 106 out of 269 case histories seen at the
Royal Marsden Hospital 1945-69 there was reason to suppose that the clinical onset was
closely related to the time of apparent onset (precise criteria given). Of the 106 patients
Cridland studied 23 (21.7%) had a clinical onset in December. Innes & Newell (1961) used
the same method to look at a series of patients in Edinburgh. Using this methodology meant
that only 104 out of a possible 440 patients were used in the analysis. Of these 104, 43
(41.3%) had a clinical onset in January-March (18% in January). The methodology in both
of these studies can be criticised.
Cridland (1961) and Innes & Newell (1961) found, for a highly selected group of
HD cases, constituting only 40% and 24% of their entire series respectively, that a
'significant' number had clinical onset in the winter. However, these results are entirely
dependent on the ability of patients to recall the month in which they first noticed large
lymph nodes (taken to be month of onset). As mentioned previously specification of the
month of onset is difficult and involves many uncertainties. The month of diagnosis on the
other hand, can usually be fixed objectively. If there were marked seasonal variation in the
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clinical onset of HD, one might expect these to be reflected in the distribution of cases by
month of diagnosis (Bjelke, 1969).
Fraumeni et al (1962) observed diagnosis to be more common in December and
January (64/285 = 22.5%) in a study of children aged under 15 years in the USA. This study
also suggested that the clinical onset of HD peaked in December and January. Bogger-
Goren et al (1983), again looking at children, found 13/21 (61.9%) cases ofHD experienced
onset of symptoms in the cold season (October-March). These cases diagnosed in the cold
season had more acute symptoms and were generally stage III or IV.
In contrast to studies which have found a seasonal presentation of HD Modan et al
(1969), Bjelke et al (1969), and Newell (1972) found no evidence of a seasonal presentation.
"As a whole, variation in the distribution of cases by month of diagnosis could easily be
ascribed to chance" (Bjelke, 1969). Bjelke (1969) also made special mention of the fact that,
in particular, no seasonal pattern was observed for the cases aged 15-34 years.
Alderson & Nayak (1971) used Edwards' method and showed the peak number of
diagnoses of HD in England took place in May/June. This 'spring peak', as they described
it, was seen especially in males and, more surprisingly, in those cases aged over 50 years.
Newell et al (1985) using the same method investigated the occurrence of HD by month of
diagnosis and sex for 1969-71 and 1973-75 in seven regions of the United States and Puerto
Rico. These authors found that seasonal variation was not statistically significant for boys or
girls aged under 14 for either time period. There was also little monthly fluctuation in adults
over 40. However, in males aged 15-39 years diagnosis peaked in February (spring) in four
of the six years and in an adjacent month in the other two. For females the diagnosis peaked
in January or February for three of the six years. The results for all six years combined can
be seen in Table 6.20. More recently Westerbeek et al (1998) investigated the seasonal
presentation of various haematological malignancies, including HD, in children aged 0-14
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years in England. These authors investigated the data for evidence of seasonality in the date
of first symptoms and date of diagnosis. Westerbeek et al (1998) found a striking seasonal
variation in the date of first symptom for HD, with a highly statistically significant peak in
December, with an amplitude of 41.0%. There was no significant seasonal variation in the
date of diagnosis of HD. Westerbeek et al (1998) suggested that the date of first symptoms
more closely reflects the event that precipitates the clinical onset of disease than date of
diagnosis. However, the majority of studies have used date of diagnosis as the variable of
interest and many have found statistically significant seasonal diagnosis ofHD.
Edwards' method was used to check for seasonal presentation of HD in the total
combined series for Scandinavia presented in this chapter. The results of the Edwards'
method and the Poisson regression method used here produce almost identical results (both
giving a statistically significant one-year seasonality with peaks of 28.6° and 29.0°
respectively).
Neilly et al (1995a & b) analysed 1359 cases of HD from the Scotland and
Newcastle Lymphoma Group (SNLG) registry 1979-92 by cosinor analysis. A March peak
was evident when all cases were analysed (p<0.01). When analysed separately NS and MC
HD showed the March peak (p<0.05) while LP and LD HD had no demonstrable seasonal
variation. However, there were far fewer LP and LD cases (13 and 6.7% of the total series
respectively) and, therefore, the lack of observed seasonality for LP and LD could be due to
low power. In a breakdown by age and sex there was evidence of seasonality in both sexes
but only in those under 40 years of age. High grade NHL analysed in the same way did not
demonstrate seasonality of presentation.
Douglas et (1996) also used cosinor analysis to investigate the seasonality of 3444
cases of HD (including the cases used by Neilly et al, 1995 a & b) taken from the cancer
registry for Scotland. They found significant seasonality in the total data and in both sexes
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and the sexes combined and in cases diagnosed under 40 years. The peak in males was about
a month earlier than in females (Jan/Feb v. Mar/Apr) (both p<0.05). Above the age of 40
years the seasonality in each sex was no longer significant.
Douglas et al (1998) analysed population-based data from parts of England and
Wales over 10 years. These authors examined 2959 cases by age (0-44 and 45-79 years) and
sex groups and also by Rye type. Patients with NS HD had a highly statistically significant
seasonal presentation of HD with a low amplitude and a peak in March. A significant
seasonal peak was also seen for LP HD except this had a high amplitude and a peak in
August. There were no statistically significant results for any individual age and sex group
analyses.
The findings of the analysis presented here agree with those of previous work in that
diagnosis appears to peak in spring in the Northern hemisphere. Seasonality is a feature of
infectious illness but at present there is not any conclusive evidence that HD is caused by an
infection, although there is a great deal of circumstantial evidence. It is possible that
tumours caused by an infection could have a relatively constant incubation period giving a
seasonal rhythm for tumour presentation.
However, there are alternative explanations for a seasonal presentation of HD; it
need not be related to infection. The human immune response also has seasonal features
(Abo et al, 1978; Canon et al, 1986; Levi et al, 1988). Presentation of HD appears to
coincide with an increased period of T cell activity in normal adults which may be related to
viral exposure (Neilly et al, 1995b). Seasonal variation in HD could be due to the attention
of patients being drawn to previously unrecognised enlarged nodes by a coincidental
infection of the upper respiratory tract. However, Cridland (1961) found only 10.4% of HD
patients presented with coincidental or recent upper respiratory tract infection and that these
were not most prevalent in the month of highest incidence ofHD.
157
If an infectious agent is involved in the aetiology of HD a seasonal variation might
be expected depending on the behaviour of the agent, the length and variability of the latent
period and method of spread. A lack of seasonal onset or diagnosis does not rule out the
possibility of an infectious origin, as low incidence in infected people combined with a very
long and/or variable latent period could blur its episodic appearance. Alternatively a
causative agent might not vary seasonally. Conversely, a significant seasonal presentation is
not conclusive proof of an infectious origin.
In agreement with Newell et al (1985), Neilly et al (1995a & b), and Douglas et al
(1996) this analysis found statistically significant evidence of seasonality in the presentation
of HD. The effect of age group and the interaction of age group with seasonality did not
reach statistical significance but the effect was most evident in the young adults. No
significant interaction with sex was found. The peak month in this study was slightly earlier
in the individual countries and the total series (January) than in other reports
(February/March) (Newell et al, 1985; Neilly et al, 1995a & b; Douglas et al, 1996). The
findings are consistent with the hypothesis chat clinical HD is the rare sequellae of exposure
to a very prevalent but seasonal environmental agent e.g. a virus of low pathogenecity to
which infection is most frequent at the beginning of the year.
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7 Results ofYHHCCS General & Family Health Analyses
7.1 Introduction:
The aetiology of HD remains unclear. There is a body of evidence relating to past own
medical history and its effect on risk of HD. The effect of infections are especially of interest
because evidence has amassed for the 'late-host-response' model of HD in young adults, under
which the disease is a (rare) sequella to late first infection by one or more unknown infectious
agents. Evidence includes studies showing a positive association between HD in young adults
and proxies for risk for late first exposure to infection and the relationship of IM to HD (see
Chapter 1). General support for an infectious aetiology of HD is provided by reports linking
specific HLA class II alleles (Bodmer et al, 1989; Klitz et al, 1994). The best documented
association is a positive one with HLA DPB1*0301 phenotype (Taylor et al, 1996). It would be
expected that people who had more infections would have a lower risk of young adult HD,
especially if these occurred early in life. If infection was delayed risk of young adult HD may be
increased. Although there have been studies looking at specific infections (Vianna et al, 1971;
Newell et al, 1973; Paffenbarger et al, 1977; Andersson & Isager, 1978; Kirschoff et al, 1980;
Gutensohn & Cole, 1981; Evans & Gutensohn, 1984) none have considered the total number of
childhood infectious illnesses.
Own medical history factors including childhood infectious illnesses (chicken pox,
German measles, measles, mumps, and whooping cough) individually and in total at specific
ages are tested here on data from the YHHCCS study for their effect on HD risk in young adults.
These infectious illnesses are being interpreted as proxies for increased probability of exposure
to a wide spectrum of agents with and without clinical symptoms.
EBV has now been found in around 35% of HD cases in the developed world (see
Chapter 1) and its role is generally agreed to be causal. Sub-classification of cases by the
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presence of EBV (EBV +ve) or absence (EBV -ve) of EBY in the HRS cells provides a
classification which may identify aetiological subgroups. (EBV +ve is analogous to EBV-
associatea, used in Chapter 1.) Only one case series has attempted to compare epidemiological
risk factors by EBV status (Sleckman et al, 1998). Risk factors for HD are considered separately
for subgroups based on EBV status, histological status, and HLA DPB1 type.
There is also evidence that certain aspects of family history are risk factors for HD.
These variables will be tested on data from the YHHCCS study. In addition an attempt was
made to develop a basic scoring system for cancer risk and infectious mononucleosis (IM) risk
in family members. Many studies of family history define exposure by the number of affected
relatives without taking account of the age of family members.
7.2 Materials and Methods:
The YHHCCS study is described in Chapter 4.
Inter-view Data:
Trained interviewers conducted face-to-face interviews. The period of interest was from
birth up to a reference date which was the date of diagnosis of the case in each matched set.
Information was requested on proxies for exposure to infection, past history of infectious illness,
past medical history of the index and their family, and a limited history of infectious illness in
friends and family.
Categories of interest.
Index General Health analyses-. The effect of appendicitis at any age, at age younger than the
mean of controls (aged <12 yrs), and older than the mean age of controls (>12 yrs) was
investigated. Removal of Tonsils/adenoids was analysed in the same way (mean age of controls
5.5 yrs). Thyroid disease and previous transplant were also recorded. The questionnaire included
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questions on previous malignancies and auto-immune diseases, but these could not be analysed
as there were no positive responses.
Infectious illness analyses: The presence of specific childhood infectious illnesses (chicken
pox, German measles, measles, mumps, whooping cough) were recorded on the questionnaire.
These infectious illnesses were analysed as a simple yes/no variable at any age and as yes/no in
age groups: 0-4, 5-9, >10 years. These data were then combined to give a total number of
childhood infections at all ages and at ages 0-4, 5-9 and >10 years. A blind assessment (to
case/control status) of the distribution of frequencies of childhood infections in the total series
led to sensible strata for the number of episodes for analysis (Table 7.1). The total number of
infections at all ages, and aged 0-4 and 5-9 years were also analysed as dichotomies in which the
lowest level (generally none) is taken as a reference group and the rest are combined. If no age
was given the data was considered to be missing in the analysis by age of individual infections.
For total infectious illness, missing values were treated as zeros in the sums, unless the data were
missing for all individual infections, then the total was set to missing. To check if this
assumption was correct the analyses were repeated using data from people who answered yes/no
for 5 infections, for 4, for 3, for 2, and for 1 only. The results for all of these were compared.
There was very little difference in the magnitude of the odds ratios produced and the directions
were constant. Therefore, only the results treadng missing values as zeros will be presented.
The presence of IM in the index was elicited from the questionnaire, however,
laboratory confirmation was not obtained. The question on IM had three possible answers: no,
suspected, and yes. IM was analysed in four ways. Separate analyses were performed treating
suspected IM as yes and suspected IM as no. To remove the possible confusion arising from IM
in the year prior to diagnosis (symptoms of IM can arise as a preliminary indication ofHD) IM
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Table 7.1: Categories for analysis of number of all childhood infections combined.
Age group Number of levels Definition
All ages 4 1 (0 or 1), 2 (2), 3 (3), 4 (>4)
Aged <5 years 3 0 (0), 1 (1), 2 (>2)
Aged 5-9 years 4 0 (0), 1 (1), 2 (2), 3 (>3)
Aged >10 years 2 0 (0), 1 (>1)
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up to one year prior to diagnosis was analysed separately (also twice once treating suspected IM
as yes and one as no).
Family health analyses'. Presence of malignancy in a first-degree relative was recorded on the
questionnaire. For analysis malignancies were divided into three groups: haematological
malignancy (ICD 9 200-204); any haematological or young onset (aged <50 years) malignancy;
any malignancy. The number of relatives with the condition of interest was analysed as either
two levels (>lv.O) or three levels (0, 1, >2). In the literature, most analyses of cancer in a first-
degree relative adjust for the number of relatives. However, this may not be enough due to the
differing risk of cancer by age and sex. Therefore, in the analysis presented here the risk of
cancer in a family member was weighted by age. Incidence rates of all the cancers affecting
YHHCCS first degree relatives were taken from Cancer Incidence in 5 Continents (Parkin et al,
1992) allowing the construction of an approximate ratio of cancer cases aged 0-24: 25-49: >50
years for the UK. As age increases there are more cases of cancer in an approximate ratio of
1:8:47. Weighted sums of relatives at risk equal Zwi across relatives where w( = 1 for relatives
age 0-24, 8 for relatives age 25-49, and 47 for relatives age >50 years. The weighted sum of
relatives at risk was then divided into quartiles. Those with larger, but especially older families
had a greater risk of cancer and, therefore, larger scores.
The presence in the family of multiple sclerosis (MS), pernicious anaemia (PA),
rheumatoid arthritis (RA), and thyroid disease were investigated. The answers to these questions
were then combined to give a total auto-immune disease variable. Again, if possible the number
of relatives with the particular disease were analysed with two (>1, 0) or three levels (>2, 1, 0).
Although there was probably a lack of ascertainment of IM in first degree relatives IM
in these relatives was analysed twice as for index IM, once considering suspected as yes and
once as no. As for cancer the number of relatives were weighted by risk of IM by age. Douglas
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et al (1996) investigated reports of IM and found it to be diagnosed most frequently aged 15-24
years (GP reports 48% of IM diagnosed aged 15-24 years, laboratory data 51.6%). Only 2.3%
IM was diagnosed in 0-4 year olds by GP reports, 3.4% from laboratory data; 20.5% and 14.0%
respectively in 5-14 year olds. Therefore, children aged 0-4 years are 2.3/48 or 3.4/51.6
(mean=0.06) times as likely to get IM as those aged 15-24 years, children aged 5-14 years are
20/48 or 14/51.6 (mean 0.35) times as likely. The weighted sum of relatives at risk equalled Ewj
across relatives where W| = 0.06 for children age 0-4 years, 0.35 for children age 5-14 years and
1 for all other relatives. IM was considered as a continuous variable: number of episodes of IM
in first degree relative / weighted sum of first degree relatives at risk. Thus IM in a family
member was always adjusted for the number of 'at risk' relatives.
IM in someone who shared a house and IM in a close friend were also considered as
exposure categories. Finally, a category of EBV illness/contact which was positive for subjects
who had had previous IM and/or had a close friend with IM. Again IM was considered in two
ways, one taking suspected as yes and one as no.
Factors controlled for in the analysis'.
Carstairs index is a measure of socio-economic status (SES) based on residence at
diagnosis (cases) or pseudo-diagnosis (controls) and is used in the analysis of YHHCCS because
participation between cases and controls was biased re current SES. The address has been used
to give the Carstairs index (Jarman et al, 1991) as an indicator at 5 levels of SES using data
derived from the 1991 census. However, Carstair's index was unavailable for a number of cases
and controls and, therefore, all analyses that adjusted for this variable involved the exclusion of a
small amount of data.
Additionally risk of HD is associated with SES, young adults of higher SES have a
higher risk ofHD possibly related to delayed exposure to infection (see Chapter 1). Many of the
risk factors analysed e.g. tonsillectomy, appendectomy, are also associated with SES.
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Analyses were also performed adjusted for potential confounding factors that reflect
childhood social class: parental education, sibship size, and birth order (Table 7.2).
Family health analyses were additionally adjusted for the number of first degree
relatives or the weighted sum of relatives at risk.
EBVStatus andHistopatholosy.
Paraffin embedded biopsy material was retrieved from cases and histopathological
review was performed by the staff at the LRF Virus centre in Glasgow under the leadership of
Professor Ruth Jarrett. EBV status was available for 103 cases and histological review for 105
cases, including all but one of those with EBV status known. Cases are described as EBV +ve if
the HRS cells scored positive for either EBER ISH or LMP-1 immunohistochemistry.
HLA DPB1 twins'.
Dr Malcolm Taylor in Manchester carried out typing of DPB1 alleles. Type is known for
81 cases and 73 controls but for the case and at least one matched control in only 46 matched
sets. In the analysis reported here the subjects have been classified as to whether HLA
DPB1*0301 was present or absent (0301yes or 0301no respectively).
Statistical methods:
Conditional logistic regression was used for all analyses on SAS 6.11 using PROC
PHREG using the specification TIES=DISCRETE for N:M matched data. The results are
reported as Odds Ratios (OR) with 95% Confidence Intervals (95% CI). Analyses were applied
to the total series of all subjects, the subset for which EBV status was known (EBV +ve vs. EBV
-ve), the subset with histological status known (NS vs. AOS (all other subtypes)), and the subset
with HLA DPB1 type known (030lyes vs. 030lno). Formal tests of interaction were performed
to see if any of the sub-groups were statistically significantly different from one another i.e. if
EBV +ve and -ve groups had different results.
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Table 7.2: Potential social class confounders related to socio-economic status.
1) Birth order: 1st, 2nd, 3rd or later
2) Number of full- and half-siblings: 0, 1, 2 or more (higher SES => smaller families).
3) Siborder: combination of number of siblings and birth order, 0 (1st bom with no siblings), 1
(lsl bom with siblings), 2 (later bom with or without siblings)
4) Housing density: number of people living in each home before aged 16 years/ number of
rooms in each home averaged for each home lived in under age 16 years and divided into
quartiles 1 (lowest number of people per room and, therefore, highest SES)...4 (highest
number of people per room and, therefore, lowest SES)
5) Age father and mother left school: <15, 16, >17 years for biological parents only, higher age
left school, higher SES in childhood
6) Educational level reached by mother and father: 1 ('O' level or lower), 2 (A level or
equivalent - university diploma/certificate, HNC/HND, City and Guilds full technology
certificate, BEC/TEC/BTEC/SCOTBEC/SCOTTECH higher, nursing qualification (not
degree), non-degree qualification, qualification from college of technology or professional
institution, BTEC foundation), 3 (degree). Higher level, higher SES in childhood.
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For the total series all analyses were performed unadjusted, adjusted for Carstairs index,
and then with adjustment for Carstairs index and each of the eight other potential social class
confounders. To reduce the total number of tests performed only those childhood social class
variables that resulted in a statistically significantly better fitting model and changed the odds
ratio (OR) by more than 10% were included in the subgroup analyses. For ease of presentation
results will only be given for the unadjusted and adjusted for Carstairs index analyses.
The number of positive responses for some of the variables of interest were small, with
some variables having no cases or controls exposed. In these cases SAS 6.11 returns ORs of
infinity and could not calculate confidence intervals. Exact methods are needed to calculate these
confidence intervals.
All testing of statistical significance for conditional logistic regression modelling has
examined the deviance difference against its asymptomatic chi-square distribution under the null
hypothesis (Clayton & Hills, 1993). When a main effect was examined the chi-square
distribution had one degree of freedom and the chi-square for the interaction (e.g. with EBV
status) has a further 1 degree of freedom. This procedure is appropriate if the hierarchy of
hypotheses to be considered is: no association, association common to both subgroups,
association different by case subgroups. The data were also examined for the statistical
significance of association of each risk factor with the cases in at least one subgroup (e.g. the
deviance difference when terms for the (possibly different) effects in EBV +ve and EBV -ve HD
were added to the model were tested against the chi-square distribution with 2 degrees of
freedom). This is appropriate if the prior hypothesis was that the association with the exposure
would be specific to EBV +ve or EBV -ve HD.
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7.3 Results:
The main characteristics of cases and controls are shown in Table 7.3. Cases are
predominantly ofNS subtype and EBV -ve. There are slightly more male cases than female.
The results of the general health variables for the total series are in Table 7.4 and by
subgroups in Tables 7.5-7.7. None of the variables analysed give rise to any significant results.
The EBV +ve, AOS, and 030 lyes subgroups are small and, therefore, the ORs have very wide
confidence intervals. The case that had received a transplant was EBV +ve and ofAOS subtype.
The results for infectious illness analyses for the total series are in Table 7.8. Combined
infections (at any age) were associated with a statistically significant reduction in risk of HD
when considered as a dichotomy. However, the trends across levels were not statistically
significantly different from the null for combined infectious illness at any age (results not
shown). Of the individual infections only measles had any statistically significant results. The
results for the other individual infections were very unimpressive and are not presented. Measles
was associated with a statistically significant reduction in risk of HD if occurring at any age and
age 5-9 years .
The results for childhood infection within subgroups are in Tables 7.9-7.11. The total
number of infections at any age were associated with a statistically significant lower risk ofEBV
+ve and EBV -ve HD. None of the trends across levels were statistically significant. When split
by age group more infections aged >5 were associated with an increased risk of EBV +ve HD
but in the opposite direction for EBV -ve HD. Statistical testing of the interaction by EBV status
confirm that the association between EBV +ve and EBV -ve cases differ significantly. When
divided by histological subtype the risk of NS HD was statistically significantly lower with more
childhood infections at any age. None of the effects remained significant when split by age. The
interaction by histological status was statistically significant for childhood infection at any age,
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Table 7.3: YHHCCS cases and controls for analysis with selected characteristics.
Category Cases Controls
Total 118 235
Age (mean) 16-25 (20.8) 16-25 (20.8)
Sex Male 62 (52.5) 125 (52.7)
Female 56 (47.5) 112 (47.3)
Histology LP 14(11.9) NA
MC 14(11.9) NA
LD 1(1.7) NA
NS 81 (68.6) NA
NOS* 4(3.4) NA
EBV status +ve 19(16.1) NA
-ve 84 (71.2) NA
not done/missing 15 (12.7) NA
0301 Allele yes 21 (17.8) NA
no 60 (50.8) NA
missing 37 (31.4) NA
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even though the ORs for NS and AOS HD were both in the same direction. Measles was again
associated with a lower risk of HD in both subgroups but the OR was only statistically
significant for NS HD. Due to the small number of cases with HLA DPB1 type known none of
the results were statistically significant.
The impact of IM on risk of HD in the total series is shown in Table 7.12. IM in the
index was associated with an increased risk of HD whether suspected IM was treated as yes or
no or if IM in the year prior to diagnosis was included or not. However, the only result that was
statistically significant was that for IM at any time with suspected IM treated as no. IM in a
family member, in a member of the household, or in a close friend was also associated with an
elevated risk ofHD but none of the results were statistically significant.
The results for IM by subgroup are in Tables 7.13-7.15. IM is associated with a
statistically significantly elevated risk of EBV +ve HD but has little association with EBV -ve
HD. Statistical testing of the interaction by EBV status confirms that the associations with EBV
+ve and EBV -ve cases differ significantly. The effects of IM in a family member were in the
opposite direction with a decreased risk of EBV +ve HD and an increased risk of EBV -ve but
the interaction by EBV status was not significant. Risk of both EBV +ve and EBV -ve HD was
increased following IM in a household member or a close friend. There was a statistically
significant increase in risk of EBV +ve HD following EBV illness/contact (OR 5.80, 95% CI
1.20-28.17) but not for EBV -ve HD. None of the results for IM by histological subtype were
statistically significant. IM in the index, in a family member, or the household were all
associated with an increased risk of 0301yes HD. However, the results were only statistically
significant when treating suspected IM in the index as yes. EBV exposure was statistically
significantly associated with an increased risk of 0301yes HD. There was little effect of any of
the IM variables on risk ofHD when *0301 was not present. The interaction for the EBV contact
with allele subgroups was statistically significant.
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Family health results for the total series are in Table 7.16. None of the results are
statistically significant. Results of the family health variables by subgroup are in Tables 7.17-
7.19. Due to the small number of EBV +ve cases the results for EBV -ve HD are very similar to
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7.4 Discussion:
Many different a priori hypotheses related to past medical history have been investigated
by YHHCCS. Very few of these have given results that were statistically significant. In part this
is due to the age of the cases and controls, there has not been enough time to develop the
condition of interest e.g. previous cancer. Also, the small numbers in some of the calculations,
especially within sub-groups, mean that many of the comparisons lack statistical power. In these
instances the absence of statistically significant effects does not necessarily reflect the absence
of a causal relationship. Certain aspects of the results should be interpreted with care, especially
those which are non-significant and have very large or small point estimates for the odds ratio.
While bearing these caveats in mind the results from YHHCCS can be compared with published
work. Of the variables studied four are most often reported in the literature: IM, appendectomy,
removal of tonsils/adenoids, and family history of cancer.
Previous IM has been implicated as a risk factor for HD for a variety of reasons (see
Chapter 1). YHHCCS data confirmed the statistically significant increased risk of HD following
IM in the total series, with and without adjustment for Carstairs index. If IM in the year prior to
diagnosis was excluded the results for the total series were no longer statistically significant.
When analysed as separate HD subtypes the effect of prior IM was seen for all groups after
adjustment, but the results for EBV -ve HD were weakest. When IM in the year prior to
diagnosis was removed associations were only seen for EBV +ve HD and AOS HD. Household
exposure to IM significantly elevated the risk ofHD in the total series and greatly so in the EBV
+ve subgroup, but risk of EBV -ve HD was not significantly elevated. The association of IM
was not completely restricted to EBV +ve HD, but the results are strongest in this subgroup.
This is in contrast to the results of a case series comparison by Sleckman et al (1998) which
found no association between prior IM and EBV status. This study analysed similar numbers to
YHHCCS but with a much broader age range at diagnosis (16-55 years). The results from
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YHHCCS suggest a specific causal association of recent EBV exposure with EBV +ve HD. The
data are also consistent with a weak positive association of EBV -ve HD with previous IM; this
could be interpreted in terms of lifestyles and environments predisposing to late exposure to
EBV and agents with similar transmission routes.
The possible effect of appendectomy on risk ofHD is discussed in Chapter 1. However,
no studies have found statistically significant results. YHHCCS analyses are based on reports of
appendicitis and also show no evidence of an effect of appendicitis on HD risk in the total series.
Six published studies have investigated risk of HD following tonsillectomy in young
adults after adjusting for SES. Of these four have found a statistically significant increase in risk
of HD (see Chapter 1). The tonsils can act as filter barriers to infective agents (Vianna et al,
1971). Data from YHHCCS showed a very slight non-significant increased risk ofHD following
tonsillectomy at any age after controlling for SES. Some authors have suggested that the role of
tonsilar tissue in immune function is most important in childhood and decreases with age
(Brandzaeg, 1987; Andersson et al, 1994; Liaw et al, 1997) but the YHHCCS total series
produced the opposite pattern, with a non-statistically significant increase in risk following late
removal. YHHCCS data does contribute further infonnation on HD risk following tonsillectomy.
The results of studies controlling for social class and the presence of a plausible biologic
mechanism mean the risk of tonsillectomy can still not be discounted, even thought the
association is not strong.
It is interesting to note that the only person to receive a transplant was a case that was
EBV +ve and of AOS subtype. This concurs with the case reports of HD following
transplantation (see Chapter 1).
Very few studies have attempted to assess risk ofHD by number of childhood infections
and none have attempted to form composites of infections in total or at specific age groups.
Paffenbarger et al (1977) found risk of HD to be decreased following several childhood
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infections but the only statistically significant result was for whooping cough. The combined
variable for childhood infections at any age and in the 3 age groups of interest (0-4, 5-9, 10+
years) is protective in the total YHHCCS series. The same pattern is seen for measles alone and
it is possible that measles is driving the result for the combined infections. There are not many
differences in the effect of childhood infections by subgroup apart from the finding that EBV
+ve HD is associated with more infections aged >5 years and EBV -ve HD is associated with
fewer infections in the same age group. This finding could, however, be due to chance as a large
number of statistical tests were performed.
The presence ofHD in a first degree relative is relatively rare, estimated at only 4.5% in
published series (Ferraris et al, 1997) but it is usually found to be a statistically significant risk
factor in epidemiological studies. The presence of a haematological malignancy in a first degree
relative conferred increased risk of HD in the total YHHCCS series. It is interesting to note that
the subtype most associated with an increased risk following a haematological or young onset
malignancy or any malignancy at all is NS HD. Thus, YHHCCS results agree with observations
by Ferraris et al (1997) and Mack et al (1995) who thought familial HD could be linked to
certain kinds ofHD, especially NS HD.
Most studies of family history of cancer have used the number of affected relatives in
the family to calculate relative risk but they have not considered the heterogeneity of the familial
risk of cancer in a systematic way. Yang et al (1998) compared a simple classification of family
history of breast cancer (yes/no) to the method of using a quantitative family history score (FHS)
based on a comparison of the observed number of cases in a family compared with the expected
number during the observation period, taking into account some of the co-variates of the family,
in this cases age, sex, race, birth cohort, as predictors of breast cancer mortality. With the use of
the FHS, about one third of the women with a positive family history of breast cancer were at no
higher risk for breast cancer mortality than those without a family history of the disease. As a
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quantitative relative risk for each family history, FHS gave a better fit to the data, and it
provided an incremental improvement in the predictive accuracy of developing fatal breast
cancer. In YHHCCS a FHS was constructed based only on the age of family members. This
score allowed the production of better fitting models compared with adjusting only for the total
number of close relatives. In the total series adjusting for the total number of close relatives did
not significantly improve the fit of any of the models of family history of cancer after adjustment
for Carstairs index. However, adjusting for the risk of cancer in the family, weighted by age
only, statistically significantly improved the model's fit in every case (0.0l<p<0.001). Thus,
even a simple attempt at creating a FHS can be effective.
Case-control studies can both test and generate hypotheses. YHHCCS data support a
role for IM in increasing risk of HD. YHHCCS results suggest a specific causal association of
recent EBV exposure (IM) with EBV +ve HD. Another new finding is the protective effect of
childhood infectious illness. YHHCCS data to a lesser extent agrees with previous work on
family history of cancer as a risk factor for HD. The role of appendectomy, tonsillectomy and
auto-immune diseases could not be adequately analysed due to small numbers of positive
responses. Larger studies of a wider range of ages are needed to make more conclusive
statements about these variables.
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8 Results of SNEHD General & Family Health Analyses
8.1 Introduction:
There is a body of evidence relating to past own and family medical history and their
effect on HD risk. Own and family medical history factors are tested here on data from the
Scotland and Newcastle study of Hodgkin's Disease (SNEHD). The analysis of SNEHD data
has the ability to test hypotheses generated by YHHCCS. Investigations were performed for
the same childhood infectious illnesses (chicken pox, German measles, measles, mumps, and
whooping cough) individually and in total at specific ages of occurrence. SNEHD data also
included a much larger number of infections which allowed a more comprehensive analysis
of the impact of infectious illness on HD risk. The importance of infectious illness on risk of
HD is discussed in Chapter 1. Several studies have looked at specific infections (Vianna et
al, 1971; Newell et al, 1973; Paffenbarger et al, 1977; Andersson & Isager, 1978; Kirchoff et
al, 1980; Gutensohn & Cole, 1981; Evans & Gutensohn, 1984). However, prior to the
YHHCCS analysis none assessed a combined number of infectious illnesses.
SNEHD covers a wide range of ages (16-74 years) compared with YHHCCS (16-24
years) (see chapter 7) and allows the investigation of risk factors in subgroups based on age
at diagnosis. A causal role for EBV has now been found in around 35% of HD cases in the
developed world (see Chapter 1). As for YHHCCS, SNEHD analysis will compare the
epidemiological risk factors by EBV status. Risk factors for HD will be analysed in the total
series and sub-groups based on age group (16-34 and 50+ years being the main groups of
interest) and EBV status. Age group 16-24 years was also analysed as a direct comparison
for YHHCCS but the results will not be presented in detail. A basic family history score
(FHS) for cancer risk in family members based on age was calculated for the YHHCCS
analysis. For SNEHD a more complicated FHS was developed based on age and sex to see if
this resulted in better fitting regression models.
192
8.2 Materials and Methods:
The SNEHD study is described in Chapter 4.
Inter-view Data:
Trained interviewers conducted face-to-face interviews. The period of interest was
from birth up to the date of diagnosis of cases and a date of pseudo-diagnosis for controls.
Information was requested on proxies for exposure to infection, past history of infectious
illness, past medical history of the index and family, a limited history of infectious illness in
friends and family, and sporting activities.
Categories of interest.
The sections of the questionnaire used to record details of general health, family
health, and infectious illnesses are in Appendix B. All analyses are based on reports of
illness at interview, without confirmation from medical records.
Index General Health analyses'. Information on previous malignancy in the index was
recorded at interview. These reports were divided into any previous malignancy and previous
haematological malignancy and analysed as dichotomous variables (yes/no). The
questionnaire allowed the reporting of several auto-immune diseases using closed questions
on insuhn dependent diabetes, thyroid disease, rheumatoid arthritis, pernicious anaemia,
multiple sclerosis, systemic lupus and Sjogrens syndrome. These variables were analysed as
dichotomous responses (yes/no) but due to the small number of positive responses the results
are not presented. A combined auto-immune disease variable was constructed from a
combination of the answers to all the above closed questions and an open question on
'immune disorders'. The answers to closed questions on eczema and asthma were analysed
individually and also combined with other allergies (taken from the answers to open
questions on 'serious or unusual illness') to form a variable called atopic.
The effect of appendicitis and removal of the appendix were analysed separately at
any age, at age younger than the mean of controls (aged <16 yrs), and older than the mean
age of controls (>16 yrs). Removal of Tonsils/adenoids was analysed at any age, age <5.5,
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age 5.5-10, and >11 years. Three categories were used because of difficulties in splitting
cases and controls by age as some people reported a school stage e.g. when at primary
school, rather than as a year or an age. Receiving a blood transfusion was analysed as a
dichotomy (yes/no). An open question on chronic infections was asked with responses
analysed as dichotomies (yes/no) at any age, age 0-4, 5-10, >11 or >5 years. The numbers of
specific chronic infections were small, however, answers were divided into general groups
for analysis: lower respiratory tract infection (lrti), upper respiratory tract infection (urti),
chronic tonsillitis/throat infection, chronic tonsillitis/throat infection/lymph glands, urti plus
these, or 'other' chronic infections.
Infections illness analyses-. Childhood infectious illnesses (chicken pox, German
measles, measles, mumps and whooping cough) were recorded as a simple yes/no variable
in the questionnaire. Data were then analysed as dichotomies at any age and in age groups:
0-4, 5-10, >11, and >5 years. The answers to questions on these infectious illnesses were
combined to give a total number of childhood infections at all ages and at ages 0-4, 5-10,
>11, and >5 years. The numbers of childhood infections were split into levels the same as
those for YHHCCS. The total number of infections at all ages, and aged 0-4, 5-10, >11, and
>5 years were also analysed as dichotomies in which the lowest level (generally none) is
taken as a reference group with the rest combined. In addition reports of other individual
infectious illness were recorded in closed questions on the questionnaire: HSV-1, HSV-2,
shingles, and pneumonia. These were analysed in the same way as the childhood infections.
There was also an open question on 'other serious infectious disease', however only scarlet
fever was recorded with any frequency. For the herpes viruses (including chicken pox) the
effect of very late exposure (in this case meaning first exposure after leaving school) was
also investigated. The herpes viruses were combined to give a total number of herpes virus
infections at any age and in the age groups described previously. A variable of 'additional'
infections was constructed as a combination of several infections reported more frequently in
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response to the open question on 'Any other serious infectious disease'. 'Additional'
infections included: tuberculosis, diphtheria, meningitis, malaria, scarlet fever, rheumatic
fever and the closed question on pneumonia. 'Additional' and childhood infections were also
combined for analysis. Finally a variable combining childhood infections, herpes viruses,
'additional' infections, and all chronic infections was constructed (based on a summation of
the answers for individual infectious illnesses to prevent double counting e.g. for chicken
pox). Blind (to the case/control status) assessment of the distribution of frequencies of
infectious illness led to sensible strata for the number of episodes for analysis.
To allow for any confusion in reporting close to diagnosis or pseudo-diagnosis all
infectious illnesses, separately or in combination, were analysed including or excluding the
year prior to the date of interest. However, the results for both analyses were very similar
and therefore the results including the last year are the only ones presented. If no age was
given the data were considered to be missing when analysed by age of illness. For total
infectious illnesses missing values were treated as zeros in the sums, unless the data were
missing for all individual infections, when the total was set to missing.
Interviewees could respond to the question on IM in three ways: yes, no, not sure. If
the interviewee answered positively a further question was asked to elicit if the IM had been
confirmed by a blood test. IM was analysed in 3 separate ways. Definite IM was IM
confirmed by a blood test i.e. the interviewee had to respond yes to having IM and yes to it
being confirmed by a blood test, all other responses were considered as no. Suspected IM
allowed IM that had not been confirmed by a blood test or if the index was not sure to be yes
with only interviewees responding specifically no being considered as no. IM in levels was
also analysed with 1 equal to definitely no, 2 IM not sure or not confirmed by a blood test, 3
equal to IM confirmed by a blood test.
Family health analyses', the presence of malignancy in first degree relatives was elicited
from the questionnaire. Responses to this question were divided into HD, haematological
malignancy, any young onset cancer (aged <50 yrs), any haematological or young onset
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malignancy, breast, uterine, ovarian or any female cancers combined, or any malignancy for
analysis. If numbers permitted the number of relatives with the condition of interest was
tested as either two (>lv.O) or three levels (0, 1, >2). However, the number of people with >2
relatives was very small and, therefore, only the results for the dichotomy are presented. In
the literature most analyses of cancer in a first degree relative adjust for the number of
relatives. However, as described in the YHHCCS chapter, this may not be enough due to the
differing risk of cancer by age and sex. The cancer variables were adjusted for number of
first degree relatives and for risk of cancer m a first degree relative adjusted for age in 3 age
groups (0-24, 25-49, >50 yrs) (as for YHHCCS). In addition a finer weighting was
constructed using 10 year age groups and sex by the method outlined in Chapter 7.
The questionnaire asked for information on presence in the family of insulin
dependent diabetes (IDDM), multiple sclerosis (MS), pernicious anaemia (PA), rheumatoid
arthritis (RA) (at any age and age <50 yrs), and thyroid disease. The answers to these closed
questions on auto-immune diseases were combined with the response to the open questions
on 'immune disorders', 'inherited illness', 'unusual illness', and 'anything else which runs in
the family' to form a composite auto-immune disease variable. Again, if possible the number
of relatives with the particular disease were analysed as two (>1, 0) or three levels (>2, 1, 0).
IM in a first degree relative was analysed. IM was analysed as a continuous variable:
number of episodes of IM in family member / number of close blood relatives (weighted by
age for risk of IM) as for YHHCCS. Also in order to make the analysis results more easily
understood, a separate variable was constructed as a dichotomy (no relatives with IM vs. one
or more relatives.
Factors controlled for in the analysis:
Risk of HD is associated with socio-economic status (SES), age and sex. HD has a
bimodal pattern of presentation and males tend to have a higher risk than females (see
Chapter 1). Young adults of higher SES have a higher risk ofHD possibly related to delayed
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exposure to infection (see Chapter 1). Many of the risk factors analysed e.g. tonsillectomy,
appendectomy, IM, are also associated with SES.
All analyses were performed adjusted for age (in 10 year groups) and sex. They were
additionally adjusted for Carstair's index. Carstair's index is a measure of SES based on
residence at diagnosis (cases) or pseudo-diagnosis (controls). Carstair's index is constructed
using the index postcode to give a census area (ward) code of the address and from this the
Carstair's index can be calculated based on four census variables: unemployment,
overcrowding, non-car ownership, low social class (Jarman et al, 1991). The index has 7
levels ranging from 1 (least deprived) to 7 (most deprived). As for YHHCCS Carstair's
index was not available for a number of cases and controls and all analyses that are adjusted
for this variable involve the loss of a small amount of data.
Analyses were also performed adjusted for potential confounding factors that reflect
childhood social class: parental education, sibship size, and birth order (as for YHHCCS).
All family health analyses were performed adjusted for age and sex, adjusted for
age, sex, and Carstair's index, and for the number of first degree relatives. Cancer questions
only were adjusted for the weighted sum of first degree relatives at risk based on age or age
and sex to find if this resulted in a better fit of the model than adjusting for number of
relatives alone.
EBVStatus and Histoyatholosy.
Paraffin embedded biopsy material was retrieved from cases and histopathological
review is being performed by the staff of the LRF virus centre in Glasgow under the
leadership of Professor Ruth Jarrett. However, the review had not been finished when the
analyses presented here were performed (data available for 173 (35.0%) of cases). Therefore,
none of the analyses have been performed on histological subgroups.
Cases are described as EBV +ve if the HRS cells scored positive for EBER ISH or
LMP-1 immunohistochemistry. EBV status was available for 323 (65.5%) cases. EBV
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testing had not been finished at the time of this analysis. It is anticipated that EBV status will
become available for almost all cases.
HLA DPB1 typing'.
Typing of the HLA DPB1 alleles by Dr Malcolm Taylor was not complete when
these analyses were performed and therefore no comparison with YHHCCS results is
possible.
Statistical methods:
Logistic regression was used for all analyses on SAS 6.11 using PROC LOGISTIC.
The results are reported as Odds Ratios (OR) with 95% Confidence Intervals (95% CI).
Analyses were applied to the total series of all subjects, the series split by age at presentation
in groups (16-34 and 50+ yrs and also age 16-24 yrs for comparison with YHHCCS results),
and the subset for which EBV status was known, and with EBV status known by age
subgroup (16-34 and 50+ yrs). The age groups 16-34 and 50+ years were first suggested to
be separate aetio-subgroups by MacMahon (1966) (see Chapter 1).
To reduce the total number of tests performed only confounder variables that
resulted in a statistically significantly better fitting model were considered in the sub-group
analyses.
To investigate whether associations with case status differed by age-at-diagnosis
group (16-34 vs. 50+) models were produced comparing the variable of interest if associated
with case status age 16-34 or age 50+ yrs in the series of the two age groups combined with a
model including the variable if it occurred age 16-34 & age 50+ yrs. The deviance difference
between this and the model with the single variable of interest (common effect across age
groups) was then compared with the chi-square distribution on 1 degree of freedom.
Similarly to find if risk factors differed by EBV status a series consisting of all cases
with available EBV status was constructed and the variable of interest was analysed with
EBV status as the dependent variable. If the OR was positive it meant the risk of EBV +ve
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HD was higher and vice versa (if the OR was statistically significant this signified a
significant difference in effect between the EBV subgroups).
8.3 Results:
The main characteristics of the cases and controls are given in Table 8.1. The
majority of cases were male and in the young adult peak (age 16-34 yrs). The table also
shows how successful the methods used in calculating the number of controls (Chapter 5)
were in producing a similar distribution of controls to the expected number of cases. This
observation applies as well to the age groups when observed separately. The only slight
difference between the cases and controls is in the Carstair's index where more cases than
controls are in the 'most deprived' category and more controls than cases in the 'least
deprived' category. EBV data were only available for 323 of the cases and one third of these
were EBV +ve. In the age groups the proportion of EBV +ve cases was smaller (26.2%) in
the 16-34 years age group than in the 50+ years age group (45.2%).
General Health:
The results for index general health in the total series are in Table 8.2. There were
very few statistically significant results. Eczema is associated with a statistically significant
increase in risk of HD. There is little evidence of an effect on risk of removal of the tonsils
or appendix, or auto-immune diseases in the total series. Chronic infections (age >11 and >5
yrs) are associated with a statistically significant increased risk ofHD.
The results for index general health by age-at-diagnosis subgroups are in Table 8.3.
Again there are very few statistically significant results, especially for HD presenting after
age 50 years. The results for age 50+ years are very similar to those for the total series. In the
16-34 years age group there are few statistically significant results due to the small number
of positive responses. However, receiving a blood transfusion and removal of the tonsils are















































































































































































































































































































































































































































tonsil removal remained after adjustment for total number of childhood infections (age 0-4
and >5 yrs) and IM.
The results for the total series by EBV status are in Table 8.4. Again very few of the
results are statistically significant. The association with eczema is limited to EBV +ve HD.
The only other statistically significant result is for atopic illness in EBV +ve HD. This latter
result may be due to the fact that the atopic variable includes eczema. There are no
statistically significant differences between EBV +ve and EBV -ve HD apart from those for
eczema (OR EBV +ve vs. -ve cases 2.23, 1.11-4.49) and atopic illness (OR EBV +ve vs. -ve
cases 2.06, 1.28-3.30). The results for general health variables by EBV status and age at
diagnosis are in Tables 8.5 and 8.6. In the 16-34 age group EBV +ve HD was statistically
significantly associated with eczema but none of the other results were significant. EBV -ve
HD in this age group was associated statistically significantly with removal of the tonsils and
lrti. The only statistically significant difference between EBV +ve and EBV -ve HD in the
16-34 age group was for eczema with EBV +ve HD 3 times more likely to be associated with
this illness (OR 2.97, 1.23-7.13). In the 50+ age group none of the results in either EBV
subgroup were statistically significant.
Infectious Illness'.
The results for combined infectious illness in the total series are in Table 8.7. All the
age groups of infection for childhood infectious illness have been given to allow a
comparison with YHHCCS. In the total series more childhood infections at any age is
associated with a lower risk ofHD; if infection occurs early risk is lower but if it occurs later
risk is elevated. However, none of the results are statistically significant for the dichotomous
variables. Only the results for infectious illness at any age are presented for the other groups
of infections. Greater frequency of clinical illness due to herpes viruses is statistically
significantly protective. When split by age group this protective effect is seen for each age
group but especially so if the analysis is limited to first episode of herpes viruses after
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leaving school. 'Additional' infections are associated with a statistically significant increased
risk of HD. When childhood and 'additional' infections are combined the effects of each are
diminished. Analyses of combined infections by age of infection were uninformative.
The results of total infections by age at diagnosis group are in Table 8.8. In the 16-
34 years age group there are no statistically significant results, except for a greater number of
infectious illnesses aged >5 years being associated with a lower risk of HD. Herpes viruses
combined are associated with a lower risk of HD, when the levels are examined those cases
with the most herpes infections have a statistically significantly reduced risk of HD. When
split by age group of infection a higher risk of HD is associated with more late herpes
infections (2vs. 0 age >11 yrs OR 3.01, 1.29-7.01; 3 vs. 0 age >5 yrs OR 2.30, 0.42-12.58; 2
vs. 0 first episode after leaving school OR 6.89, 0.83-57.09).
In the 50+ years age at diagnosis group the total number of childhood infectious
illnesses at any age is associated with a statistically significant lower risk of HD. Total
herpes virus infections at all ages is associated with a statistically significant lower risk of
HD. More 'additional' infectious illness were associated with a statistically significant
increase in risk ofHD if they occurred age >5 (OR 1.85. 1.06-3.25).
The results for the total series by EBV status are in Table 8.9. None of the total
infectious illness variables are statistically significantly associated with risk of EBV +ve or
EBV -ve HD. The EBV subgroups were not significantly different from each other.
The results for the EBV subgroups for age at diagnosis groups 16-34 yrs are in Table
8.10. Again there are no statistically significant results for total childhood infectious illness.
However, when the number of childhood infections aged >5 are examined the difference
between the EBV +ve and -ve subgroups is statistically significant with a larger number of
infections in this age group associated with twice the risk of EBV +ve HD (p=0.034). When
childhood and 'additional' infectious illnesses are combined the effect is again very similar
in both EBV subgroups for all ages of infection. However, again there is a statistically
215
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significant difference between the EBV subgroups by number of infections aged >5 yrs.
These are associated with a hugely increased risk of EBV +ve HD and essentially a null
finding for EBV -ve HD. The difference between the EBV subgroups is statistically
significant (p=0.043). When all infectious illnesses are combined the results are very similar
for both EBV subgroups, but again there is a different effect of total infections age >5 yrs.
More total infections at this age are associated with a lower risk of EBV -ve HD (OR 2-5 vs.
1 0.59, 0.36-0.96) and an increased risk of EBV +ve HD (OR 1.97, 0.81-4.83). The
differences between EBV +ve and -ve HD are statistically significant with the greater
number of infections age >5 yrs associated with 3 times the risk ofEBV +ve HD (p=0.012).
The results for EBV status by age at diagnosis 50+ years are in Table 8.11. More
total childhood infections at any age are associated with a statistically significant decreased
risk of both EBV +ve and EBV -ve HD. However, none of the other results were statistically
significant and none of the comparisons between EBV +ve and EBV -ve HD are statistically
significant.
The results for the analysis of individual infections are shown in Table 8.12 for the
total series and in Table 8.13 for the age at diagnosis groups. Only results for individual
infections at any age have been presented as there were very few significant results. Full
results for measles are given to compare with YHHCCS. In the total series scarlet fever
statistically significantly increased risk ofHD. The rest of the ORs were near to the null.
When the age groups (16-34 and 50+ yrs) were analysed separately there were again
very few significant results (Table 8.13). Chicken pox was associated with a statistically
significant increased risk of HD age 16-34 yrs, especially if chicken pox occurred age >11
(OR 1.65, 1.01-2.68). In this age group measles age >5 was associated with a statistically
significantly decreased risk ofHD. Most of the other ORs are near to the null. In the 50+ age
at diagnosis group chicken pox is statistically significantly protective. In the total series and




















































































































































































































































































































































































































































































































































































































































>5 yrs) are put in a multivariate model none of the infections have any statistically
significant results. The statistically significant effect of scarlet fever seen in the total series is
confined to the 50+ years age at diagnosis group.
The results for the total series by EBV status for individual infections are in Table
8.14. There are very few statistically significant results for the individual infections and the
ORs are very similar in both EBV subgroups. Formal comparison of the EBV subgroups
reveals none of the differences were statistically significant.
The results for EBV subgroups for age 16-34 years age at diagnosis are in Table
8.15. Again very few results were statistically significant. Measles is associated with an
increased risk of EBV +ve HD and a null finding for EBV -ve. Measles aged >5 years is
associated with an increased risk of EBV +ve HD and a statistically significantly decreased
risk of EBV -ve HD. Measles was the only infection that differed statistically significantly
between the EBV subgroups with late measles (age >5 yrs) significantly more likely to be
associated with EBV +ve HD (OR 3.26, 1.49-7.11, p=0.003).
The results by EBV status by 50+ age at diagnosis group are in Table 8.16. The risk
of HD associated with measles was similar by EBV subgroup and close to the null.
Whooping cough is strongly associated with both EBV +ve and EBV -ve HD (OR 7.21,
1.09-47.58 EBV +ve; OR 5.87, 0.93-37.13 EBV -ve). There were no statistically significant
differences between the EBV subgroups.
The main individual infection of interest is IM, both in the index and first degree
relatives. The results for the total series are in Table 8.17 and by age at diagnosis group in
Table 8.18. From Table 8.17 it can be seen that IM in the index, however it is defined, is
associated with a statistically significant increased risk of HD. IM in a first degree relative is
also associated with an increased risk but this is not statistically significant. When HD is
split by age at diagnosis IM is associated with a statistically significantly increased risk of
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HD aged 16-34 but has not aged 50+ years (Table 8.18). This contrast is also seen for IM in
a first degree relative.
Results for IM by EBV status in the total series are in Table 8.19 and for separate
age at diagnosis groups in Tables 8.20 (16-34 yrs) and 8.21 (50+ yrs). The effect of IM in the
index was not limited to the EBV +ve cases in the total series or in either age at diagnosis
group. However, in the 16-34 years age at diagnosis group definite IM is associated with a
greater risk of EBV +ve HD than EBV -ve, but the difference between the subgroups is not
statistically significant (case series comparison EBV +ve vs, EBV -ve OR-1.82, 0.54-6.11).
There is little effect of IM in the 50+ years age group (EBV +ve or EBV -ve). IM in a family
member is associated with a greater risk ofEBV +ve HD in the total series and the 16-34 age
group but not the 50+ years. It is only in the 16-34 years age at diagnosis group that the
effect is statistically significantly different between EBV +ve and -ve HD with the chances
ofEBV +ve HD following IM in a first degree relative being 3 times that ofEBV -ve.
The effect of IM was considered after adjustment for the presence of the five
childhood infections (plus scarlet fever in the 50+ yrs age at diagnosis group) age 0-4 and >5
years to see if IM was merely a marker for late age at first infection. While none of the
childhood infections were individually statistically significant when adjusted for on another,
IM in the total series in all its forms was associated with a statistically significantly increased
risk of HD. This relationship was seen in the 16-34 but not the 50+ years age group. The
effect of IM in the EBV subgroups was also analysed after adjustment for the childhood
infectious illnesses and removal of the tonsils. The results for IM in both EBV subgroups at
all ages, age 16-34, and age 50+ years was unaffected by these adjustments.
Family Health:
Results for family health variables for the total series are in Table 8.22. There are
very few statistically significant results. There is evidence that malignancy in a family
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particularly so for HD in a first degree relative (OR 5.17, 1.12-23.79) or haematological
malignancy combined (OR 2.39, 1.07-5.36). The patterns of risk for family health variables
are the same for the age at diagnosis subgroups (Table 8.23).
Results for family health variables by EBV status are in Table 8.24. The results for
cancer in a first degree relative are similar in the EBV subgroups. However, when all
malignancies in first degree relatives are considered there is a statistically significant
increase in risk of EBV +ve HD but little effect on risk of EBV -ve HD. When the two are
formally compared the excess risk of EBV +ve HD, compared with EBV -ve HD, is almost
statistically significant (p=0.064). Results for the 16-34 and 50+ years age at diagnosis
groups by EBV status are in Tables 8.25 and 8.26 but none are statistically significant.
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8.4 Discussion:
The effects of many health variables on the risk of HD have been analysed on data
from the SNEHD case-control study. In contrast to YHHCCS the effect of each variable has
been analysed in the total series (age 16-74 years) as well as different age groups (16-34 and
50+ yrs). These two age groups were described by MacMahon (1966) (see Chapter 1).
However, as with YHHCCS, few of the analyses have given rise to statistically significant
results. In the total series and the analysis by age at diagnosis groups the results are unlikely
to be due to a lack of positive responses. However, when looking at EBV status the number
of cases with these data available were limited as when analysis began EBV status was not
confirmed for all cases. EBV status is only available at present for 323 cases and therefore,
the statistical power of EBV-status subgroup analyses is very limited. This applies
particularly to EBV-status subgroups in young adults and older people respectively.
Infectious Mononucleosis'.
IM has frequently been reported to be associated with an increased risk of HD (see
Chapter 1). The SNEHD results support this relationship with a statistically significant
increased risk of HD following IM in the total series whether IM was confirmed or
suspected. This statistically significant effect appears to be limited to the young adult peak
(age 16-34 yrs). This supports the results of YHHCCS which found an increased risk of HD
in a subset of the young adult peak (age 16-24 yrs). The total number of HD cases with a
history of IM and EBV status known in this study is very small. The increased risk of HD
associated with IM was found in both EBV subgroups in the total series but this effect was
driven by the results in the young adult peak. The odds ratios associated with EBV +ve HD
were higher, especially in the young adult age group. However, none of the ORs were
statistically significantly different from one another. When IM in a family member was
analysed the differences between the age at diagnosis groups and the EBV status groups are
even clearer. IM in a family member as a continuous variable is associated with a
substantially increased risk of HD in the young adult peak, but not in the 50+ years age at
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diagnosis group. The difference in the effect family IM is limited to EBV +ve HD, especially
in the 16-34 years age at diagnosis group. In this age group the OR ofEBV +ve vs EBV -ve
HD is almost 4. This finding for family IM in the young adult peak is the opposite to that
found for YHHCCS (where risk of EBV -ve HD was increased and EBV +ve HD was
decreased) and much more plausible.
As for YHHCCS the role of IM is not completely limited to EBV +ve HD but the
suggestion of a relationship is strongest in this group. Also the age at diagnosis subgroup
analyses and comparisons lend support to hypothesis that IM is only associated with HD in
the 16-34 years age group. The SNEHD results contrast with the results of a case series by
Sleckman et al (1998). These authors found no association between IM and EBV status of
HD. The broader age range (16-55 yrs) that Sleckman et al analysed may have masked any
differences related to the effect of IM being limited to a specific EBV subgroup AND age
group. The results of SNEHD and YHHCCS suggest a specific causal association of recent
EBV exposure with EBV +ve HD and a weak positive association of EBV -ve HD with
prior IM.
Infectious illness:
Analysis of the SNEHD study allowed the testing of hypotheses generated by
YHHCCS e.g. more childhood infections are associated with a lower risk ofHD in the young
adult peak and the same finding for measles. The wide range of ages in the SNEHD study
allowed the effect of these and other infectious illnesses to be analysed in the total series and
in specific age groups (16-34 and 50+ yrs) and EBV subgroups. The statistically significant
effect of childhood infectious illnesses observed in the YHHCCS analysis was not seen in
the young adult peak (age 16-34 yrs) in SNEHD, nor in the 16-24 years age group (results
not presented). There was some suggestion that more childhood infectious illnesses aged >5
years was associated with a decreased risk of HD age 16-34 years. Under the late-host-
response model one would expect more late infections in this age group to increase risk.
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However, there is no definition of what would constitute early or late infection. In the 50+
years age at diagnosis group more childhood infectious illnesses were associated with a
decreased risk of HD, especially if they took place age 0-4. More infections (age >11 yrs)
were associated with an increased risk. The effect of the combined herpes virus on increasing
risk is limited to the 16-34 years age group. The effect of 'additional' infections led to a
universal increase in risk of HD in the total series and in each age group. The problem of
combining several infections, some of which have opposite effects, is seen when looking at
the total infection variable in SNEHD. Most of these results are very close to the null. This
could suggest that it is not the overall total number of infections that are associated with an
increased risk ofHD but rather it is the result of specific infections.
Sleckman et al (1998) took as a prior hypothesis that EBV +ve cases would show
evidence of childhood experience conducive to late exposure to infectious agents but failed
to find any supportive evidence. Interestingly the finding from YHHCCS that EBV +ve HD
is associated with more childhood infectious illness aged >5 years and EBV -ve HD is
associated with fewer infections at the same age is confirmed in the 16-34 years age group in
SNEHD. The difference between the subgroups in this case was statistically significant. In
SNEHD this effect is also seen when the childhood and 'additional' infections are combined
and the total number of infections are analysed. Thus, the results from SNEHD and
YHHCCS support the hypothesis that EBV +ve HD in the young adult peak should have
evidence of late (interpreted as age >5 yrs) exposure to infectious agents. These are the only
statistically significant differences between the EBV subgroups in SNEHD for infectious
illness.
The analysis of individual infections in YHHCCS revealed very little about the
effect of childhood infectious illness on the risk of HD apart from a protective role for
measles. Measles' protective effect in the young adult peak was again seen in the SNEHD
data but only if measles occurred age >5 years. However, when all the childhood infectious
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illnesses were entered together into a multivariate regression model none of the infections
had a statistically significant effect on risk of HD. In contrast to what was said above for
total infections this suggests that no one infection has an individual effect on risk of HD but
there may be a combined effect.
A great number of infectious illnesses have been analysed in SNEHD and with the
age at diagnosis and EBV status subgroups this has resulted in a large number of regression
models. Thus, it could be that the results that are statistically significant have occurred by
chance and are false positives. However, a number of the hypotheses tested here were stated
a priori e.g. the effect of childhood infectious illness, the effect of IM by age and EBV status.
These are the results that should be considered most sound. Many of the results should be
regarded as hypothesis generation for future research e.g. total infections, individual
infections.
It seems likely that it is the combined number of infections that is more important
than any specific infection in the impact cf risk of HD. This is particularly suggested for
EBV +ve HD where it is the late infections in total that increase risk while the single
infection results are quite unimpressive. The only exception to this is IM whose significant
effect remained (in the 16-34 years age group) after adjustment for the presence of all the
childhood infections.
Removal ofthe Tonsils and the Appendix:
Removal of the tonsils and the appendix are two of the most analysed general health
factors for their effect on the risk ofHD (see Chapter 1). As with all published studies ofHD
that adjust for SES there is no effect of appendectomy on risk of HD in SNEHD. The
analysis of SNEHD allowed a comparison of the effect of appendicitis and appendectomy.
The ORs associated with each were identical and very close to the null. In agreement with
published studies the results of SNEHD confirm a role for tonsillectomy in increasing risk of
HD in the young adult peak. Four of six published studies have found the risk of HD in
young adults to be increased following tonsillectomy after adjustment for SES. Of these,
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three had statistically significant results (Vianna et al, 1971; Johnson et al, 1972; Vianna et
al, 1974). The effect of tonsillectomy remained after adjustment for the five childhood
infectious illnesses and IM. However, in agreement with YHHCCS when the analysis of
tonsillectomy are limited to the 16-24 years age group in SNEHD there was no effect. The
tonsils can act as filter barriers to infection (Vianna et al, 1971) and it appears that the
removal of this barrier has the most effect in the young adult peak where the evidence of an
infectious aetiology for HD is greatest.
Family Health Variables'.
There is little evidence of an effect of family health factors on the risk of HD apart
from those relating to IM and cancer in first degree relatives. Familial HD is usually found in
the literature as a risk factor for HD and SNEHD concurs with this finding. All familial
cancers and haematological malignancies alone had the same pattern of risk in the total
series and both age at diagnosis groups. However, only the ORs for the total series were
statistically significant. There was no statistically significant difference between the EBV
subgroups when analysed for family cancer. Unfortunately due to the lack of completion of
the histological review it was not possible to check the assertion by Ferraris et al (1997) and
Mack et al (1995) that familial HD is more closely related to the NS subtype. In the analysis
ofYHHCCS the construction of a family history score (FHS) based on the age of the relative
resulted in a significantly better fitting model than using the number of relatives alone.
SNEHD analyses of cancer in first degree relatives were adjusted in the same way and also
using a more comprehensive FHS. However, neither FHS resulted in better fitting models
than those using the number of first degree relatives. In fact none of the adjustments for
number of first degree relatives or either FHS resulted in statistically significantly better
fitting models.
The analysis of the SNEHD case-control study has allowed the investigation of
many risk factors for HD including some new hypotheses generated by the YHHCCS
analysis. Some of the results seen in YHHCCS have been reproduced but others have not,
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even when the subset of 16-24 years age at diagnosis cases and controls has been compared.
The large size and age range of the SNEHD study has allowed the investigation of many
variables in age at diagnosis groups and EBV subgroups. It appears that different risk factors
act differently between the age at diagnosis groups of HD e.g. IM, infectious illness,
tonsillectomy, and cancer in first degree relatives. These risk factors appear to have effects
more concentrated in the young adult peak. There appear to be fewer differences associated
with EBV status in the total age at diagnosis groups. This maybe because de novo EBV
infection could be important in the paediatric group, a reactivation of latent infection,
possibly as a result of decreasing T-cell immunity more likely in older cases (Jarrett et al,
1991). Young adult EBV +ve HD may be close in time to EBV exposure. The mam
differences in SNEHD associated with IM and total number of infections age >5 years in the
16-34 years age group. Other studies are needed to test these findings in other settings. The
results of SNEHD and YHHCCS emphasise the need to include age group and EBV status in
any study investigating risk factors for the development ofHD.
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9 Risk ofHP associated with physical activity
9.1 Introduction:
There is a variety of evidence that suggests that HD risk is affected by variables
associated with the hormonal and immune systems. The evidence of an effect on the
hormonal system includes the differing incidence between men and women and the lower
risk of women who have had children (see chapter 1). An impact on the immune system is
inferred from the fact that people with HIV infection have a much greater risk of HD and, in
the young adult peak, removal of the tonsils is also associated with increased risk (see
chapter 1). Physical activity can have an effect on both the hormonal and immune systems. It
appears that moderate levels of activity boost the immune system but prolonged activity at
high intensities suppresses immune function (discussed in detail chapter 3). Physical activity
changes the concentration of various hormones including oestrogen and testosterone
(discussed in detail chapter 3). It seemed appropriate to include in SNEHD an investigation
of the hypothesis that physical activity would impact on the risk of HD; if so the probable
biological pathway would be via the hormonal and immune systems. It was hypothesised
that the effect would be that those people who exercised moderately would have a lower risk
of HD while those who were very active would be at increased risk. However, very little
work has been published on the risk of HD associated with physical activity. Only two
studies have appeared in the literature (Whittemore et al, 1985; Paffenbarger et al, 1987).
Both of these studies found a non-significantly decreased risk of HD associated with greater
physical activity. This chapter will investigate the hypothesis outlined above on data from
the SNEHD study in total and also in subgroups based on age, EBV status and sex.
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9.2 Methods:
A fLill description of the SNEHD study is given in Chapter 4.
Interview data:
Trained interviewers conducted face-to-face interviews. The period of interest for
the total interview was from birth up to the date of diagnosis for each case and a randomly
allocated date of pseudo-diagnosis for controls. Information was requested on many health
variables but this chapter will concentrate on physical activity.
Questionnaires'.
The actual pages used for eliciting information on physical activity are in Appendix
C. It can be seen that the period of interest was from age 7 to 39 years. It was decided not to
ask about lifetime activity as many of the SNEHD participants were over 50 years of age and
the level of detail for each activity was quite great resulting in recall problems. Splitting the
questions into three sections allowed easier directions to be given to the respondents. For
physical activity at school ages normal timetabled physical education was not included as it
was assumed that all children would have approximately the same levels of this activity.
Within each section participants could report up to 5 activities. For each activity the
participant had to report the number of hours per week they took part in the activity in that
age group. Respondents were guided when calculating these hours of participation. The
maximum number of hours averaged over a three-month period in the age range was
recorded. Hours were recorded to the nearest half-hour (rounding down). Also the proportion
of the year the activity took place was elicited: habitually (>8 months per year), seasonally
(4-8 months per year), or occasionally (<4 months per year). If the respondent had not
reached any of the age groups on a page then these ages were considered to be 'not
applicable'. However, if the index was one or more years into that age range the activity was
recorded and used for analysis.
In addition questions were asked about more recent physical activity, in the last 5
years before diagnosis/ pseudo-diagnosis. These were much more simple questions and
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asked people to rate their own activity and also a sweating question. Using these different
methods had the added benefit of allowing a comparison of physical activity scores based on
in-depth questions about activities and these more simple questions based on self-assessment
and sweat episodes in cases and controls aged less than 40 years.
Categories of interest:
As mentioned in Chapter 2 there are a variety of methods of measuring physical
activity in questionnaires. There are also a great number of ways of analysing the data once it
has been collected. It was decided to compare four methods that have been found from the
literature on the SNEHD data to see if the different methods give rise to different results.
Three of the methods involve the use of MET (metabolic equivalents) scores. The MET
scores used in this analysis come from the work of Ainsworth et al (1993) and this
compendium is frequently cited by other authors in this field. The use ofMET scores has the
advantage of allowing activity intensity to be investigated. In this study MET scores of 4.5-
5.5 were considered to be moderate activity and those of over 6 to be vigorous (White et al,
1996). The other physical activity score was based on time.
In general energy expended per week is calculated by multiplying the MET scores of
an activity by the weight in kilograms of the person by the number of hours the activity is
performed and summing across activities. However, in SNEHD the subject's body weight
was not known. This is not a problem, however, as methods that take account of body weight
can produce errors because estimates of energy expenditure may more closely reflect body
weight rather than activity levels (Ainsworth et al, 1993).
A common calculation for all the methods was to make some allowance for the
amount of time during the year that the activity took place e.g. habitual, seasonal, occasional.
The number of hours spent in habitual activities (>8 months of the year) was multiplied by
10/12, hours spent in seasonal activities (4-8 months of the year) was multiplied by 6/12, and
the hours spent in occasional activities (1-4 months of the year) by 2/12.
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Method 1: following White et al (1996). Activities were divided into three groups: low,
medium, and high intensity based on their MET score (<4.5, 4.5-5.5, >6 respectively). These
three groups were then allocated kilocalorie scores of 4.5, 5, and 6 kilocalories per minute.
These values were than multiplied by the number of minutes spent on each activity in each
age group. All activities were than summed within each age group. The continuous number
of kilocalories was then split into those people with no activity in an age group and quartiles
of activity based only on those subjects who had performed any activity. This method of
division was used for each age group.
Method 2: following Min-Lee et al (1992). Sports of <4.5 METS were rated at 5 kcal/min
while those of >4.5 METS were rated at 10 kcal/min. The number of hours spent in physical
activity were summed for each age group and split as for method 1.
Method 3: The most frequently used method used to score physical activities at present is to
use MET hours/ week. These are calculated by multiplying the time (in hours) spent on each
activity by its MET score. The number ofMET hours spent on each activity are summarised
within each age group and summed for each age group and split as for method 1.
Method 4: It was also decided to use a method of summation that took no account of the
intensity of the activity. The number of hours spent in physical activity were summed for
each age group and split as for method 1.
The activities from the three pages of the questionnaire were combined into the six
age groups. This involved the addition of the school activities age 7-11, 12-14, 15-leaving
from page 1 to the 'other' activities in the same age groups from page 3. The competitive
activities from page 2 age leave-21, 22-29, and 30-39 years were added to the 'other'
activities from page 3 in the same age groups. For the total series and the 16-34 years age at
diagnosis group details for the school period of activity (ages 7-11, 12-14, 15-leave school)
only were used to prevent the dropping of data in those subjects who had not reached the
older ages (leave school-21, 22-29, 30-39 yrs). In contrast all the activity ages were used for
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the 50+ years age at diagnosis group. The odds ratios presented for each period of activity
are adjusted for the other activity periods used for that age group i.e. in the total series
activity age 7-11 years is adjusted for activity at ages 12-14 and 15-leave school.
The effect of consistent activity (top quartile in each age group (7-11, 12-14, 15-
leave school, leave school-21, 22-29, and 30-39 yrs)) or inactivity (no activity in each age
group) was also investigated. As for the activity levels only school activity was used in the
total series and the 16-34 yrs age group and all 6 age groups for the 50+ yrs age group.
However, no one remained in the top quartile for the six activity periods of interest and
therefore, it was only possible to investigate the effects of long-term inactivity in the 50+ yrs
age group.
The answers to the questions from page 4 were analysed separately with a three level
variable of activity levels in the five years prior to interview: little or none, moderate, a lot.
A four level sweat episode variable was created from the answers to question 2: no sweating,
less often, weekly, two or more times per week.
Potential Confounders:
A large number of confounders were considered in the analysis of SNEHD health
variables in Chapter 8. However, only age, sex, and Carstair's index were used in the
analysis of physical activity. This was because the other potential confounders were found to
have very little effect in the previous chapter and there is no evidence in the literature that




Logistic regression was used for all analyses on SAS 6.11 using PROC LOGISTIC.
The results are reported as Odds Ratios (OR) with 95% confidence intervals (95% CI).
Analyses were applied to the total series of subjects, the series split by age at presentation
(16-34 and 50+ years), EBV status, and sex.
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9.3 Results:
The questionnaire was written to elicit as much detail about physical activities as
possible. However, only around half of all those in each age group performed any activity at
all (Table 9.1). The greatest proportion of active people was seen in the 12-14 and leaving
school-21 years age groups. The observations for total activity apply as well to vigorous
activity but even fewer people performed any moderate activity (20% or less, results not
shown). The comparison of activity levels by case/control status are in Figure 9.1. The
activity levels by status are very similar in all age groups but there is slight evidence of more
controls performing no activity and more cases in the top quartile of activity. As with the
results for any activity vs. none the results for vigorous activity are very similar to those for
total activity. The numbers of people in the moderate activity are much smaller and very
variable (results not shown).
There are large differences in the activity levels of male and female subjects. There
are a higher number of females with no activity in all of the age groups of interest and a
higher number of males in the top quartile of activity.
It has been suggested that there is a greater stability in the reporting of extremes of
activity (see Chapter 2). This observation applies to SNEHD data as can be seen from Table
9.2. In every age group the highest proportion of activity reported is in the no activity and the
top quartile of activity groups. There is also evidence that the activity reported in one age
group is highly correlated with that in all other age groups (Table 9.3).
The two single questions on page 4 of the sports questionnaire were correlated
together to see if the answers to each were comparable. The answers to these questions were
highly correlated (p<0.01). Thus, two questions that appear to measure different things are
providing very similar information.
The results of regression models for activity in the last 5 years are in Table 9.4.
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groups. When divided into levels subjects with a moderate level of activity had a slightly
lower risk ofHD and those in the highest activity category had a slightly increased risk. This
pattern is seen in the total series and the 16-34 years age group but none of the results are
statistically significant and therefore are not shown. The results for sweat episodes per week
in the 5 years to diagnosis/ pseudo-diagnosis are in Table 9.5. Again there is no statistically
significant trend of risk in the total series or the age groups and all the odds ratios are very
close to the null. The results by level make it clear that those who work up a sweat less than
weekly have a lower risk ofHD than those who do so more frequently (significantly so in the
total series and the 50+ years age group). The pattern of risk across levels for this variable is
j-shaped with a lower risk ofHD for those who performed some physical activity vs. none.
The results for MET hours in the total series and the 16-34 and 50+ years age groups
are in Table 9.6. The trends of activity in the total series and the age groups are all very close
to the null. When the activity descriptions are reduced to dichotomies the results are again
very close to the null with the exception of a statistically significant increased risk ofHD age
50+ vrs for any activity age 7-11 (Table 9.7).
The results of activity presented separately for males and females are in Tables 9.8-
9.11 for the total series and the 16-34 and 50+ years age groups respectively. Very few
results are statistically significant and the pattern of risk is similar for males and females.
The effect of physical activity was compared in EBV +ve and EBV -ve HD in the
total series and by age group. There were no differences between the effect of activity in the
EBV subgroups (Tables 9.12-9.15). Very few of the results were statistically significant and
all the confidence intervals overlap.
The numbers of subjects who were consistently active (or inactive) for the total
series and by age group were quite limited. The results of the constant activity regression
models are in Table 9.16 for the total series. Inactivity ail through school is significantly
more associated with HD, while there is little effect of being in the top quartile of activity
over the same time
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period. When these variables are analysed as levels those people who had performed some
activity at some time whilst at school had a statistically significantly lower risk of HD than
those who had been inactive. This pattern is repeated in the 16-34 years age group with more
extreme odds ratios, but not the 50+ years age group.
Consistent activity was analysed by sex in the total series and the 16-34 and 50+
years age groups (Table 9.17). There are some differences between the sexes with males
showing the same pattern of risk as that in the total series. However, in females those
subjects that remained in the top quartile of activity had a decreased risk of HD (not
statistically significant) compared with an increased risk for males. Females are the same as
males in that those who did not perform any activity had a higher risk of HD. However, in
females the results were statistically significant and the odds ratios larger. In the 50+ years
age group the effect of no activity was no longer present in females but it was in males.
The results for consistent activity in the EBV subgroups are in Table 9.18. The
pattern of risk is similar to that in the total series is repeated with the most extreme odds
ratios seen in the 16-34 years age group. Those who are in the top quartile of activity have a
doubling in risk of EBV +ve HD age 16-34 years (after adjustment for age, sex, and
Carstair's index). Also the people who have done some activity had a lower risk than those
who had been in the top quartile at all ages had an increased risk (although the results were
not statistically significant). There were only very small differences in the odds ratios for
EBV +ve and EBV -ve HD.
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The SNEHD study comprised 493 cases and 512 controls. This was a large study of
HD. however, almost half of the sub jects did not report any physical activity at all. This lack
of numbers of people reporting any activity combines with the problem of ascertaining an
individual's activity level. In SNEHD the problem of recall of physical activity looms large,
as we were most interested in activity at school and afterwards up to age 39. Many of the
cases and controls are older than 50 years of age and thus may have difficulty recalling
activity levels many years previously, especially as part of a longer general health
questionnaire. This is a problem as exercise or sporting activities are subject to variation and,
therefore, are more difficult to recall (Jacobs et al, 1993). For more stable activity e.g. heavy
intensity activity, recall is not affected by the timeframe of the questionnaire, but for light or
moderate activities it is more difficult to recall the timing of the activity (Jacobs et al, 1993).
Respondents were directed using consistently applied interviewer rules at face-to-face
interview. The amount of information that could be recorded was the most it was felt
reasonable to collect in one section of a questionnaire of over 50 pages lasting more than an
hour. Respondents were asked specific questions about each activity performed to elicit
detail about the duration, intensity, and frequency (consistency) of each activity. These are
the three primary components of physical activity that can be varied and may have different
effects on carcinogenesis (Thompson, 1994).
The analysis presented here only takes account of recreational activity i.e. that
performed outside working hours. The results, therefore, do not reflect total activity and
could be criticised for this. A full employment history was recorded for each SNEHD subject
and this, in theory, could be used to calculate energy expenditure at work. However, due to
time constraints it was not possible to perform this analysis. In general occupations are more
sedentary than in the past and it is now considered that most of an individual's activity takes
place outside of the workplace (see Chapter 2) but SNEHD subjects cover a wide range of
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ages and this occupational activity may have been important for many of the older subjects.
An analysis of total activity in the future could be interesting.
When collecting the SNEHD data it was considered to be better to under-estimate
activity rather than over-report. This is why averages for the time spent in an activity were
the average of a three-month period to avoid a short burst of activity being misinterpreted as
continuous activity across a 10-year age group. Also, use of the seasonal variable allowed
the scaling down of activity levels to take account the amount of the year that the activity
was performed. Finally all the MET scores used were the average or general scores available
in the Ainsworth et al (1993) compendium. However, it could be that the methods were too
conservative and have resulted in the under-estimation of activity levels. This could
especially apply to individual's that performed more than 5 activities but time constraints
during the interview prevented the recording of any more information.
The analysis of SNEHD data attempted to compare four different methods of
collating physical activity data: two based on the calculation of weekly expenditure of
kilocalories , one based on MET hours and one based on time only. The use of MET scores
allowed the impact of activity intensity to be analysed. However, there were very few reports
of moderate activities and the odds ratios were unstable with wide confidence intervals. As
mentioned in Chapter 2 there is also no agreed definition of which MET score applies to
which activity level. The results for each of the four methods were very similar suggesting
that risk of HD may be only related to the amount of activity rather than the intensity of
activity
The results of the SNEHD analysis for physical activity are mostly negative, indeed
the ORs for activity in the five years prior to diagnosis and the investigation of activity levels
up to age 39 years are all very close to the null. This observation applies to the total series
and the series split by age, EBV status, and sex. It is only when consistent activity is
considered that the results become more compelling. There was an increase in the risk ofHD
associated with consistent inactivity in the total series and all the subgroups. The effect of
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being in the top quartile of activity was muted but based on small numbers. Those people in
the top level of activity at all ages had a higher risk of HD than those in all the other
combinations of activity combined (although the difference was not statistically significant).
Surprisingly this pattern is not seen in females. Females analysed alone had the same
increased risk of HD associated with consistent inactivity but those females who were
consistently in the top quartile of activity had the lowest risk of HD (odds ratios not
statistically significant). This pattern was seen in the total series and the 16-34 years age
group but could not be analysed in the 50+ years age group due to lack of numbers in the top
category. This result could suggest that physical activity is protective for females through a
hormonal mechanism analogous to pregnancy. Those in the top category may have fewer
menses due to high levels of activity. Alternatively activity may lower oestrogen levels
without affecting the menstrual cycle resulting in a lower risk of HD. Exercise training has
been found to lower resting levels of oestrogen in most studies (Dale et al, 1979; Boyden et
al, 1983; Bullcn et al, 1985; Nelson et al, 1988; Cauley et al, 1989; Newcombe et al, 1995;
Nagata et al. 1997: De Souza et al. 1998). In theory the effect of inactivity will not be seen in
the 50+ years age group for females but this could not be analysed due to lack of numbers.
When looking at EBV subgroups there was the doubling of risk of EBV +ve HD
associated with being consistently in the top quartile of activity. In the young adult peak (age
16-34 years) the risk of EBV +ve HD is associated with consistently high activity levels is
highest. It may be that immunosuppression caused by consistently high levels of activity
leads to inadequate immune response to new or latent EBV infection. Thus, the effect of
physical activity on EBV could be similar to the j-shaped curve proposed by Nieman &
Nehlson-Cannarclla (1992) to describe the relationship between physical activity and URTI.
This model suggests that individuals who exercise moderately have a lower risk of URTI
compared to the sedentary population; in contrast athletes undergoing strenuous training
would exhibit an increased risk of URTI. However, there is no evidence that model is correct
for EBV and HD in the presence of physical activity.
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There has been very little work performed on the impact of physical activity on the
risk of HD. There are only two studies in the literature. Both of these studies have some
evidence of an inverse relationship of physical activity and HD risk. Whittemore et al
(1985) found a non-significant decreased risk of HD associated with over 5 hours of college
sports (RR=0.73). Paffenbarger et al (1987) found a non-significant trend in risk of HD over
three activity levels in a cohort study of college alumni. However, neither found evidence of
high activity levels increasing risk.
The results of these two studies and the results from SNEHD give some credence to
the suggestion that physical activity has an impact on the risk of HD. The results from
SNEHD are the first to be statistically significant. Further support for a role of physical
activity comes from the presence of a plausible biologic mechanism. What appears to be
required is a study of people who perform more consistent levels of physical activity e.g.
athletes, dancers. Alternatively studies should take account of total activity, both
occupational and recreational. If this latter option is chosen some attempt should be made to
take account of home activities e.g. cleaning, washing, which are often ignored in studies of
physical activity. It would be necessary to use a specific activity questionnaire and
concentrate only on this topic to get as much detail as possible about all activities. A more
detailed study could also allow a more thorough investigation of the proposed j-shaped curve
of risk.
In conclusion consistent inactivity is associated with an statistically significant
increased risk of HD while consistently high activity levels may or may not increase risk.
Those who undertake moderate levels of activity have a reduced risk of HD, although this
relationship was not statistically significant. The relationship of physical activity and risk of
HD requires further investigation.
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10. Conclusions.
Analyses presented in this thesis examined risk factors for HD both in total and in
sub-groups by EBV status, age and sex. Risk factors related to an infectious aetiology,
family health and physical activity have been considered.
In agreement with Newell et al (1985), Ncilly et al (1995a & b), and Douglas et al
(1996) the analysis presented in chapter 6 found statistically significant evidence of
seasonality in the presentation of HD with a peak in January. This finding supports a
possible infectious aetiology of HD. The effect of age group and the interaction of age group
with seasonality did not reach statistical significance but seasonal presentation was most
evident in young adults (age 15-34 years), the age group with most evidence of an infectious
aetiology.
IM has frequently been reported to be associated with an increased risk of HD (see
Chapter 1). The SNEHD (chapter 8) and YHHCCS (chapter 7) results support this
relationship with a statistically significant increased risk of HD following IM. Age at
diagnosis subgroup analyses and comparisons in SNEHD suggest that the statistically
significant effect of IM is limited to the young adult peak (16-34 years). The increased risk
of HD associated with IM was found in both EBV subgroups in the young adult peak.
However, the odds ratios associated with EBV +ve HD were higher, especially in the young
adult age group in both studies but the difference (EBV +ve vs. EBV -ve) was only
statistically significant in YHHCCS. In both SNEHD and YHHCCS the role of IM is not
completely limited to EBV +ve HD but the suggestion of a relationship is strongest in this
group. The results of the SNEHD and YHHCCS analyses suggest a specific causal
association of recent EBV exposure with EBV +ve HD and a weak positive association of
EBV -ve HD with prior IM in the young adult peak. Thus, for the first time evidence is
presented that the effect of IM is limited to a specific EBV subgroup AND age group.
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Results from SNEHD and YHHCCS suggest it is more likely that it is the combined
number of infections that is more important than any specific infection in the impact of risk
of HD. This is because, apart from IM, no other individual infections, with the possible
exception ofmeasles, had an effect on risk ofHD. Very few studies have attempted to assess
the effect of childhood infectious illnesses on the risk of HD and none have attempted to
form composites of infections in total or at specific age groups. The statistically significant
protective effect of combined childhood infectious illnesses observed in the YHHCCS (age
16-24 years) analysis was not seen in the young adult peak in SNEHD (age 16-34 years).
There was some suggestion that more childhood infectious illnesses aged >5 years was
associated with a decreased risk ofHD age 16-34 years.
Sleckman et al (1998) took as a prior hypothesis that EBV +ve cases would show
evidence of childhood experience conducive to late exposure to infectious agents but failed
to find any supportive evidence. EBV +ve HD was associated with more childhood
infectious illnesses aged >5 years and EBV -ve HD was associated with fewer infections at
the same age in both SNEHD and YHHCCS. In both studies the difference between the EBV
subgroups was statistically significant. In SNEHD this effect is also seen when the childhood
and 'additional" infections are combined and the total number of infections are analysed.
Thus, for the first time the results from SNEHD and YHHCCS support the hypothesis that
EBV +ve HD in the young adult peak has evidence of late (interpreted as age >5 years)
exposure to infectious agents.
The results for tonsillectomy and physical activity give some support to the idea that
the immune system has an impact on risk of HD. A statistically significant increased risk of
HD following tonsillectomy in the young adult peak was found in SNEHD remained after
adjustment for the five childhood infectious illnesses and IM. Tonsilar tissue is part of the
immune system and the tonsils can act as filter barriers to infection (Vianna et al, 1971). It
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appears that the removal of this barrier has the most effect in the young adult peak where the
evidence of an infectious aetiology for HD is greatest.
An increased risk of HD is associated with consistent inactivity in the total series
and all subgroups (chapter 9). Those people in the top level of activity at all ages had a
higher risk ofHD than those in all the other activity levels combined (although the difference
was not statistically significant). This pattern was not seen in females which could also
suggest that physical activity is protective for females through a hormonal mechanism
analogous to pregnancy.
When looking at EBV subgroups there was the doubling of risk of EBV +ve HD
associated with being consistently in the top quartile of activity. In the young adult peak (age
16-34 years) the risk of EBV +ve HD is associated with consistently high activity levels is
highest. It may be that immunosuppression caused by consistently high levels of activity
leads to inadequate immune response to new or latent EBV infection. Thus, the effect of
physical activity on EBV could be similar to the j-shaped curve proposed by Nieman &
Nehlson-Cannarclla (1992) to describe the relationship between physical activity and URTI.
This is the first statistically significant evidence of an effect of physical activity on risk of
HD and the first results that suggest, albeit tentatively, that the effect may be limited to
specific EBV status, age and sex subgroups.
Different risk factors act differently between the age at diagnosis groups of HD. The
effects of IM, infectious illness, tonsillectomy, and possibly physical activity are
concentrated in the young adult peak. There are fewer differences associated with EBV
status. The main differences in SNEHD and YHHCCS by EBV subgroup are IM and total
number of infections age >5 years in the 16-34 years age group. Other studies are needed to
test these findings in other settings. The results of the analyses presented emphasise the need
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Appendix A
Wood-related occupations:
The occupation that has been most frequently investigated for an association with
HD is woodworking. The results of case/control and cohort studies investigating this
relationship have been reasonable consistent.
Six studies have described a statistically significantly elevated risk of HD occurring
in those working with wood (Milham & Hesser, 1967; Petersen & Milham, 1974; Fonte et al,
1982; Acheson et al, 1984; Brownson & Reif, 1988; Wiklund et al, 1988) with relative risks
of HD ranging from 1.8-7.2. However, in the Wiklund et al (1988) study the majority of the
men in the exposed group (silviculture workers) were employed in administrative positions.
This result, therefore, may be more related to social class rather than exposure to wood. A
further study found a statistically significant relationship with mortality of HD in white
males in states of the USA with the percentage of pine forest in each state (Spiers, 1969).
However, in this study the proportion of people employed in the lumber industry was not a
significant predictor of HD mortality. Five other studies have found a non-statistically
significantly increased risk of HD associated with woodworking (Grufferman et al, 1976;
Greene et al, 1978; Abramson et al, 1978; Kirchoff et al, 1980; McKinney et al, 1990).
While the results of Abramson et al (1978) were not statistically significant for total HD
working with wood was associated with a significantly increased risk of MC subtype
(RR=5.2) when analysed separately. In the study by McKinney et al (1990) exposure to
wood dust was found to increase risk of HD if exposure took place in a hobby setting but
there was no relationship with occupational exposure to wood dust. This could be due to the
use of protective equipment at work. Not all studies have found an elevated risk of HD
associated with woodworking (Milham, 1974a; Olsen & Sabroe, 1979; Rang & Acheson,
1981; Miller et al, 1989; La Vecchia et al, 1989; Franceshi et al, 1991).
All authors have not used the same definition of woodworking. This could account
for some of the discrepancies in results. Carpentry (Greene et al, 1978; Brownson & Reif,
1988), working with wood including paper (Petersen & Milham, 1974; Greene et al, 1978),
membeiship of furniture making unions (Milham, 1974a; Olsen & Sabroe, 1979, Miller et al,
1989), and silviculture workers (Wiklund et al, 1988) have all been considered as the
exposed group. These subjects would have had heterogeneous contact with wood.
In the aggregate the available data suggests that woodworkers have an increased risk
of HD. This association may be due to exposure to wood dust, preservatives or particular
chemicals within these industries.
Agriculture and food processing:
Farmers have an increased risk for all lymphatic and haematopoietic cancers. This
can be seen when looking at only HD. Two case/control studies (La Vecchia et al, 1989;
Franceshi et al, 1991) and one cohort study (Cerhan et al, 1998) have found a statistically
significant increased risk of HD for agricultural workers. However, in one case/control study
the exposed group included food processing workers (La Vecchia et al, 1989) and in the
other the statistically significant effect was only seen in those employed in agriculture for
over 10 years (Franceshi et al, 1991). A further four case/control studies (Pearce et al, 1985;
Bernard et al, 1987; Brownson & Reif, 1988; McKinney et al, 1990) and three cohort studies
(Kravdal & Hansen, 1993; Wiklund et al, 1988; Pukkala & Notkola, 1997) found an
increased risk of HD but the results were not statistically significant. Pukkala & Notkola
(1997) found the effect of agriculture was limited to men but Kravdal & Hansen (1993)
found female farmers in their cohort to be at increased risk.
Increased risk in agricultural workers may possibly be due to exposure to animal
viruses e.g. bovine leukaemia virus (Brownson & Reif, 1988). Indeed, livestock fanners, as
compared with other farmers, show the highest OR for HD (Reif et al, 1989) while vets and
meat workers (Johnson et al, 1986; Blair & Hayes, 1982; Pearce et al, 1988) share with
farmers an increased risk of lymphoid neoplasms. This suggests that exposure to animals
may be involved. However, the results of studies designed to test the zoonotic hypothesis
have been equivocal (Brownson & Reif, 1988). Alternatively exposure to herbicides and
pesticides, especially phenoxy acids, may be responsible.
Appendix B
General health Page 01
Please can I ask for some details about your general health.
1. CASES: Prior to your diagnosis with Hodgkin's Disease have you ever suffered
from, any of the following illnesses?
CONTROLS: Prior to your birthday have you ever suffered from, any of the




1 = (Previous) cancer, leukaemia, lymphoma or tumour | j
2= Diabetes [ J
If yes, do you take insulin? l=Yes, 2=No
3 =Thyroid disease [ j
If yes, was it l=underactive,2=overactive
4=Rheumatoid arthritis
5 = Pernicious anaemia □
6=Multiple sclerosis □
7=Systemic lupus I 1
8=Sjogren's syndrome j j
9 = Immune disorders [^]
10=Asthma | I
ll =Eczema j |
12=Glandular fever □
If yes, was it confirmed by a blood test?
13 =Chronic or recurrent infection - specify j j
14=Appendicitis [^]
If yes, was your appendix removed?
15= Epilepsy j ]
16=Have you had your tonsils or adenoids removed? □
17=Have you ever had a transplant? [^]
18=Have you ever had a blood transfusion or received blood products? Q ]
19= Have you ever had a serious or unusual illness? I j
If yes to any of these please complete a record for each condition, enter the total number of
illnesses below and say:
□
□
Now 1 shall ask you for further details about this illness / some of these illnesses.
General Health Page 02
Condition I ICD Code 1 . J
1. (For codes 1, 3, 8, 9, 13, 19)What exactly was wrong with you?
When was this? Year or Age
Did you have treatment from 1 = Hospital 2=GP 3 =Neither
If hospital:
3a. (Code 1 only)What treatment did you have?
3b. (Code 18 only)Did you have l=a transfusion of plasma or whole blood /
2= concentrated blood products?
Condition | | | ICD Code | . | [
1. (For codes 1, 3, 8, 9, 13, 19)What exactly was wrong with you?
2. When was this? Year| | | or Age | j |
years
3. Did you have treatment from 1 =Hospital 2=GP 3=Neither
If hospital:
3a. (Code 1 only)What treatment did you have?
3b. (Code 18 only)Did you have l = a transfusion of plasma or whole blood /
2=concentrated blood products?
Condition | | | ICD Code
1. (For codes 1, 3, 8, 9, 13, 19)What exactly was wrong with you?
2. When was this? Year| | [ or Age
years
3. Did you have treatment from l =Hospilal 2=GP 3 =Neither
If hospital:
3a. (Code 1 on/ylWhat treatment did you have?
3b. (Code 18 only)Did you have l=a transfusion of plasma or whole blood /
2=concentrated blood products?
mn
Infectious Illness Page 01
Prior to CASES: your diagnosis with Hodgkin's Disease.
CONTROLS: your birthday.




If Yes, when? If NK
school
stage
If Yes, when? If NK
school
























Family Health: general Page 01
The next series of questions apply to your parents, full or half brothers and sisters, children
and anyone who lived in the same household while you were young. 1 shall call these
'relatives'. We already have lists of these people.
INTERVIEWER: GO QUICKLY THROUGH FORMS ON PAGES AND READ OUT
THE NAMES OF THE CANDIDATE RELATIVES.
Have any of these relatives ever suffered from any of the following illnesses:
No.
Yes= l of




lymphoma or tumours □
2. Multiple sclerosis □
3. Glandular fever □
4. Diabetes □
5. Thyroid disease □
6. Rheumatoid arthritis □
7. Pernicious anaemia □
8. Systemic lupus □
9. Sjogren's syndrome □
10. Immune disorders □
11. Inherited disease □
12. Unusual illness □
13. Anything else which
runs in the family □
IF YES TO ANYOF THESE PLEASE COMPLETE A RECORD FOREACH CONDITION
AND ENTER THE TOTAL NUMBER OF ILLNESSES BELOWAND SAY:
I shall now ask you details of each of these.
Total number of illness records following
Family health: general Page 02
Please complete section for each relative - illness combination in Section 6a page 1.
Relative No: I T "1Name of Relative:
Condition:
1. (Omit for codes 2, 3, 6, 7, 8)
What exactly was wrong with them?_
2. When was it first diagnosed? Year
Code:
1 9 or Age 1
3. Were they treated in hospital? 1 =Yes 2=No 9=NK
Name of Relative:
Condition:
1. (Omit for codes 2, 3, 6, 7, 8)
What exactly was wrong with them?_
2. When was it first diagnosed?










1. (Omit for codes 2, 3, 6, 7, 8)
What exactly was wrong with them?_
2. When was it first diagnosed?
no
Year or Age
3. Were they treated in hospital? 1 =Yes 2= No 9 =NK
Appendix C
Sport and Athletics Page 01
This section is about your sporting and athletic activities while you were at school.
1. Did you ever belong to a school team for any sport or athletics?
1 = Yes 2= No
If yes- la. Which activity or sport(s)?
2. At that time did you represent a sports club or similar in competitions?
1 = Yes 2= No
If yes: 2a. Which activity or sport(s)?
If there is no "yes" answer to question I or 2, go to next page.
3. Did you compete at regional or national level? l =Yes 2=No
4. I shall now ask for more details of your main sporting activities at different stages of
schooling. [You have mentioned...but can you choose the five most important].
ACTIVITIES AGE 7-11 years AGE 12-14 years AGE 15-18 years
Activity 1 Hrs: Hrs: Hrs:






MET Score: 3=0 3=0 3 =0







MET Score: 3=0 3=0 3=0
Activity 3 Hrs: Hrs: Hrs:
Code: 1 =H 1 =H 1 =H
MET Score: 3=0 3=0 3=0
Activity 4 Hrs: Hrs: Hrs:
Code: 1 = H 1 = H 1 = H
MET Score: 3=0 3 =0 3=0
Activity 5 Hrs: Hrs: Hrs:
Code: 1 =H 1 = H 1 = H
MET Score: 3=0 3 =0 3=o
5. Did your sporting activities include touring for competitions or training camps?
1 = Yes 2 = No 9 = NK
Ifyes: 5a. How many nights were spent away per year?
While aged 7-11 years
12-14 years
15-18 years L_l__l_
5b. How many other people stayed with you?
l=none / 2=lor2 / 3=3-5 / 4=6-10 / 5=more than that.
Sport and athletics Page 02
Current age
1. Since leaving school, have you ever taken part in competitive sport or athletics?
1 = Yes 2 = No
If yes: la. What activity or sport(s)?
If No, go to next page.
2. Did you compete at regional or national level? l=Yes 2= No
3. I shall now ask for more details of your main sporting activities since you left school.
[You have mentioned but can you choose the five most important].
ACTIVITIES Leaving School-21 years AGE 22-29 years AGE 30-39 years







MET Score: 3 =0 3=0 3=0
Activity 2 Hrs: Hrs: Hrs:




MET Score: 3=0 3=0 3=0
Activity 3 Hrs: Hrs: Hrs:




MET Score: 3=0 3=0 3=0






MET Score: 3=0 3=0 3=0






MET Score: 3=0 3=0 3=0
4. Did your sporting activities include touring for competitions or training camps?
l = Yes 2= No 9=NK
If yes: 4a. How many nights were spent away per year?
While aged Leaving school-21 years
22-29 years
30-39 years [__1__L_
4b. How many other people stayed with you?
l=none / 2=lor2 / 3 = 3-5 / 4=6-10 / 5=more than that.
Sport and athletics Page 03
1. Apart from what we have discussed have you regularly done any other strenuous
physical activity, at school or later to...
your 40th birthday? (older respondents) l=Yes
your diagnosis with Hodgkin's Disease? (younger CASES) 2 — No
your th birthday? (younger CONTROLS) 9= NK
If No go to next page.
If yes: la. What activities?
End age:
2. I shall now ask for more details of these activities.
[You have mentioned.... but can you choose the five most important].
□












Activity 1 Hrs: Hrs: Hrs: Hrs: Hrs: Hrs:
Code: 1 =H 1 = H 1 = H 1 =H 1 =H l =H
MET Score: 3 =0 3=0 3=0 3 =0 3=0 3 =0
Activity 2 Hrs: Hrs: Hrs: Hrs: Hrs: Hrs:
Code: 1 =H 1 =H 1 =H 1 = H l =H l =H
2-S
MET Score: 3=0 3 = 0 3=0 3= 0 3 =0 3 =0
Activity 3 Hrs: Hrs: Hrs: Hrs: Hrs: Hrs:
Code: 1 = H 1 = H 1 = H 1 = H 1 =H 1 =H
MET Score: 3=0 3=0 3=0 3=0 3=0 3 =0























1 = H 1 =H 1 = H 1 = H
MET Score: 3=0 3 =0 3=0 3=0 3=0 3=0
3. Did these activities involve residential training or touring ?
1 = Yes 2 = No 9 = NK
If yes: 3a. How many nights were spent away/year on average?







3b. How many other people stayed with you?
l=none / 2=lor2 / 3=3-5 / 4=6-10 / 5=more than that. □
Sport and athletics Page 04
This section considers your more recent physical activity. In the 5 years up to....
either your diagnosis with Hodgkin's Disease,
or your birthday.
1. How much exercise did you get from your recreational activities in a typical week?
1 =a lot / 2=Moderate amount / 3 = Little or none.
2. Did you regularly engage in any physical activity such as walking, jogging, cycling
for long enough to work up a sweat?
l=Yes 2= No
If Yes: 2a. How often?
l=at least twice a week / 2=weekly / 3=less often.
